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ABSTRACT
The ultimate goa ls  of this s tudy were  to develop  and  define a 
subcu taneous  t issue cham ber  a s  a  suitable device for establishing a 
Pasteurella haemolytica soft- tissue infection model in cattle and 
to use  this model to study the in vivo efficacy and  distribution of a 
po tent ia ted  sulfa antimicrobial.
Developmental s tudies  resulted in the selection of a  suitable tissue 
c h a m b e r  des ign  that  maximized the c h a m b e r  penetra t ion of an 
intravenously administered lipid-soluble drug. This cham ber  could be 
sam pled  with e a s e  and  conta ined enough  ch am b er  fluid to allow 
repetit ive sampling.
Cy to log ica l  a n d  c h e m ic a l  in v es t ig a t io n  r e v e a l e d  th a t  th e  
composi t ion of fluid within c h a m b e r s  a p p ro a ch ed  the  theoret ical 
composi t ion  of t rue  interstitial fluid a s  t ime af ter  implantation 
in c re a se d .  Despi te  an  ongoing low-grade chron ic  inflammatory 
reac t ion  result ing in fibrous  en c ap s u la t io n  of c h a m b e r s ,  the  
vasculari ty  of c h a m b e r  t i s sue  did not diminish with time after 
im plan ta t ion .
P h a rm a c o k in e t ic  s tu d i e s  c o n d u c te d  using lipid-soluble a g e n t s  
dem ons t ra ted  that  penetration from blood into ch am ber  fluid could 
be  descr ibed  by a  two-compartment pharmacokinet ic  model,  where 
t issue  cham bers  matched  the description of a  "deep" compartment.
xvi
Diffusion of nonlipid-soluble agen ts  sugges ted  that  the permeability 
ch a rac te r is t ic s  of the  diffusional barr ier  s e p a ra t in g  blood and 
cham ber  fluid were  similar to those  of capillary endothelial walls, 
and that  t issue  ch am b ers  formed true interstitial compartments .
Inoculation of P a s te u re l la  haem oly tica  into t i s su e  c h a m b e r s  
resulted in the es tabl ishment  of a  localized sub cu ta n eo u s  infection 
which w a s  s imilar  to the  lung le s ions  s e e n  in pneum on ic  
p a s te u re l l o s i s .  T i s s u e  c h a m b e r  p e n e t r a t io n  of in t ravenous ly  
adm in is te red  sulfadiazine/ t r imethoprim in c re a se d  af ter  infection. 
Despite the m a in tenance  of c h am b er  antimicrobial concentra t ions  
which e x c e e d e d  minimum bacteriocidal levels e s tab l ished  in vitro, 
the  infect ions w ere  not steril ized. This lack of efficacy w as  
assoc ia ted  with d e c re a se d  pH and increased protein concentrat ions 
in cham ber  fluid after inoculation.
Infection with bovine viral d ia r rhea  virus, which is thought  to 
dep ress  host defenses ,  had no effect on the response  of Pasteurella 
h a e m o ly t ic a  to sulfadiazine/ tr imethoprim therapy.  Observat ion of 
r e s p o n s iv e  an t ibody  ti ters ,  bac ter ia l  p h a g o c y to s i s ,  an d  high 
leucocy te  viability within P a s te u re l la  h a e m o ly t ic a  infected 
ch am b ers  d em o n s t r a te  that  the model can  be u sed  to study the 
re sp o n se  of bac ter ia  to specific concentrat ions  of antimicrobials in 
the p resence  of functional host defenses .
CHAPTER 1
INTRODUCTION
Success fu l  antimicrobial therapy  d e p e n d s  on the  a t ta inm ent  of 
a d e q u a te  concentra t ions  of active drug at  the  site of infection. 
Except in the c a s e  of septicemias  or infections involving cells of 
hematopoietic  and  lymphatic origin, bacterial pa th o g en s  generally 
res ide within the  interstitial fluid s p a ce s .  Therefore, knowledge of 
the  concentra t ions  of antimicrobials in the interstitial fluid s p a ce  
and  the efficacy with which bacterial  infections a re  combat ted  
within this s p a c e ,  is n e e d e d  to es tab l ish  effective therapeu t ic  
regimens. Such information cannot  be gained by sampling serum, but 
must  be derived from s tudies  involving the use  of interstitial fluid 
models.
The interstitium cons is t s  primarily of minute clefts filled with a  
h e t e r o g e n o u s  mixture of co l lagen  fiber bund les ,  pro teog lycan  
filaments,  and t issue fluid. Most of the fluid is en trapped between 
the proteoglycan filaments to form a  t issue  gel, and only a  very 
small portion of this fluid exists a s  rivulets and  vesic les  of free 
fluid. The direct sampling of t i ssue  fluid is, therefore, extremely 
difficult. Indeed, even micropuncture techniques  can be expected to 
disrupt the  de l ica te  ul t ras t ruc ture  of the  interstitial  s p a c e .  In 
addition, the  small s am ple  volume delivered by th e se  techniques  
c o m p l i c a t e s  an t im ic rob ia l  a s s a y .  C re a t io n  of an  artificial
l
2com par tment  that  is in direct communication with the  interstitium 
provides  a  conven ien t  method  for obtaining s a m p le s  tha t  are  
rep resen ta t ive  of interstitial fluid. Such a  c o m p ar tm e n t  can  be 
c rea ted  by the su b c u ta n e o u s  implantation of a  perforated t issue 
chamber .  After implantation, the cham ber  becom es  vascularized by 
granulat ion t i ssue  buds  growing in through the perforations. The 
t ransuda te  that accum ula tes  within the cham ber  has  been  found to 
closely resemble  interstitial fluid, and sam ples  of ad eq u a te  volume 
can be obtained by percutaneous  aspiration. Furthermore, inoculation 
of the cham ber  with bacterial pa thogens  results in the formation of 
a  localized soft-tissue infection, which can then be used as  a  model 
to evaluate  the in vivo efficacy of antimicrobials.
Factors  affecting distribution of antimicrobials into the interstitial 
s p a c e  include : (1) pKa and  lipid solubility of the  antimicrobial 
agent;  (2) pH gradient  between the blood and interstitial fluid; (3) 
d e g re e  of protein binding exhibited by the antimicrobial;  and  (4) 
nature of the cellular barriers between the  circulation and the site 
of activity. Bacterial colonization of the intercellular clefts can be 
expec ted  to alter the pH gradient  be tween  blood and  interstitial 
fluid, in c rease  the protein concentrat ion ■ in the interstitial space ,  
and  disrupt the cellular barriers be tween the circulation and the 
s ite  of activity. Thus,  antimicrobial concen t ra t ions  ach iev ed  in 
infected  t i s s u e s  a n d  c o m p a ra b le  hea l thy  t i s s u e s  may differ 
considerably. A thorough understanding of the effect of bacterial 
infection on drug distribution is crucial for effective antimicrobial 
therapy. Relevant  information can easily be collected using a  soft-
3t issue infection model es tablished by inoculation of a  subcutaneous  
t issue chamber.
Effective antimicrobial therapy  relies on the  cooperat ion of host 
d e f e n se  m echanism s .  This is particularly true when bacter iostatic 
a g e n t s  a re  used ,  a s  t h e s e  antimicrobials  do not kill bacterial 
p a th o g en s  but simply inhibit their multiplication. In vitro studies 
eva lu a t in g  th e  sensi t iv i ty  of b a c te r i a  to an t im icrob ia ls  a r e  
conduc ted  in the  a b s e n c e  of a  co m p e ten t  immune sys tem  and 
there fo re  provide incomplete  information regarding antimicrobial 
efficacy. Furthermore, t h e s e  s tudies  do not take into account  the 
e f fec ts  of pos t -an t ib io t ic  leu co cy te  e n h a n c e m e n t ,  fluctuating 
an t im ic rob ia l  c o n c e n t r a t i o n s ,  an t im icrob ia l  d e g r a d a t i o n ,  an d  
in t race l lu la r  d is t r ibut ion  of an t im icrob ia ls .  S y s te m ic  d i s e a s e  
models  can  be used  to study antimicrobial efficacy in the p resence  
of hos t  d e f e n s e s ,  but c a n n o t  be  u s e d  to cor re la te  bacterial  
sensitivity with drug concen tra t ions  a t the  locus of infection. In 
contras t  to in vitro s tudies  and  systemic d i s e a se  models,  in vivo 
s tu d ie s  utilizing s u b c u t a n e o u s  t i s s u e  c h a m b e r s  e x a m in e  the  
r e s p o n s e  of b a c t e r i a  to known t i s s u e  c o n c e n t r a t i o n s  of 
antimicrobials in the  p r e s e n c e  of hos t  d e fe n se s .  The effect of 
immunosuppress ive viruses,  like bovine viral diarrhea  virus (BVDV), 
on antimicrobial efficacy should also b e  cons idered:  Clinical and 
experimental evidence su g g e s t s  that exposure  to BVDV predisposes  
cattle to pneumonic  Pasteurella  haemolytica  (Ph) infection. This 
sy n e rg i sm  is ap p a ren t ly  d u e  to a  s u p p re s s io n  of r e s i s ta n c e  
m echanisms  c a u se d  by BVDV. Thus, initial exposure  to BVDV may
4substantia lly  affect antimicrobial therapy  d irected  aga ins t  Ph in 
bovine respiratory d isea se .  This possibility can be studied using a 
su bcu taneous  cham ber  infection model. Indeed, the availability of a 
s t a n d a rd i z e d  so f t - t i s su e  infection model  in ca t t le  would be 
invaluable for s tudying the interaction b e tw ee n  ant imicrobials,  
bacterial pathogens  and host defenses .
Although th e r e  a r e  s e v e ra l  r ep o r t s  of in v e s t ig a to r s  us ing 
su b c u ta n e o u s  ch a m b e r  infection models  to eva lua te  antimicrobial 
efficacy, no controlled s tudies  have been  conducted in cattle. The 
purpose  of this study w as  to develop and define a  s tandardized Ph 
soft-tissue infection model in cattle and to u se  this model to study 
the  in vivo efficacy an d  distr ibution of a  po ten t ia ted  sulfa  
antimicrobial. The potential benefits of this research  extend beyond 
the u se  of this model to study the  efficacy and distribution of 
antimicrobials,  to include the ability to study the pa thogenes is  of 
the  Ph- induced  lesion a s  well a s  the  synerg is t ic  relationship 
between Ph and BVDV.
CHAPTER 2
LITERATURE REVIEW
The study of antimicrobial penetration and  efficacy p resen ts  unique 
diff icult ies  a s s o c i a t e d  with th e  interstit ial  location of m ost  
pa thogen ic  bacter ia .  In con tras t  to most  o ther  drugs  which are  
d es igned  to alter the homeosta t ic  m echan ism s  of the host anirrial 
itself, the  ta rge ts  in antimicrobial therapy  are  bacterial invaders 
residing within the confines of the host interstitial space .  Thus, to 
be  effect ive,  an t imicrobials  must  p e n e t r a te  into the  interstitial 
fluid in a d e q u a t e  c o n c e n t r a t i o n s .  An a p p re c ia t io n  of drug 
d is t r ibu t ion  a n d  e f f icacy  in inters t i t ial  fluid is crucia l  to 
s u c c e s s f u l  t h e r a p y .  U nfo r tuna te ly ,  d i r e c t  m e a s u r e m e n t  of 
antimicrobial concen tra t ions  and  action in the  interstitial fluid is 
s e r io u s ly  re s t r i c te d  b e c a u s e  of t h e  inaccess ib i l i ty  of this 
c o m p a r tm e n t .  To c i rcum ven t  this problem,  inves t iga to rs  have  
employed a  number  of indirect techniques .  In this review, current 
research  relating to the physiology of the interstitial s p a ce  and the 
use  of indirect techniques  to evaluate  antimicrobial penetration and 
efficacy within this space ,  will be examined.
A. P h y s io log y  of th e  interst i tia l  s p a c e
Except  in the  c a s e  of bone,  extracellular material cons is ts  of a 
three-dimensional  collagen and  elastin fiber network em bedded  in a
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6gel-like ground s u b s tan ce  (Comper & Laurent,  1978; Liotta et a l.t 
1983). Severa l  structural co m p o n en ts  of the  extracellular  matrix 
can  be identified in most  soft t i s sues .  The external domains  of 
integral membrane  proteins a s  well a s  other molecules more loosely
adheren t  to the cell surface make up a  glycocalyx which coats  the
cell su r face  (Luft, 1976). In differentiated t issues ,  dissimilar cells 
are  usually separa ted  by a  basal  iamina (Heathcote & Grant, 1981; 
Kefalides et at., 1979). This lamina consis ts  of a  relatively thick (10 
nm) lamina densa which is separa ted  from the p lasma membrane by 
a  thinner (2-5 nm) electron-lucent lamina rara. In som e tissues, the 
basal  lamina may be reinforced by a  layer of fibrillar e lements  to 
form a  basem en t  membrane.  Beyond the basal lamina is the ground 
s u b s t a n c e ,  which c o n s i s t s  of a  h e t e r o g e n o u s  mixture  of
m a c r o m o l e c u l e s ;  p r e d o m in a n t ly  a n io n ic  p r o t e o g l y c a n s  an d  
glycoproteins,  and  a  relatively large amount  of interstitial fluid. The 
extracel lular  matrices  of different t i s su es  differ from one  another  
in the  am ount  and  type of matrix com ponen ts .  The th ree  most 
p r ev a len t  c l a s s e s  of m o lecu le s  in the  interstitial  s p a c e  a re
c o l l a g e n o u s  a n d  n o n - c o l l a g e n o u s  g l y c o p r o t e i n s ,  a n d  
g lycosaminoglycans .
At leas t  five genetically  distinct types  of col lagen have  been  
identified. T h e se  types  differ both in their primary s tructure  and 
their distribution in var ious  t i s su es  (Liotta et al., 1983; Alitalo & 
Vaheri, 1982). For example, collagen type IV is found only in the 
lamina densa of basem en t  membranes,  whereas  type I is present in 
skin, tendon and cornea.
7The bes t  studied non-collagenous glycoprotein is fibronectin, which 
is an  e longated molecule containing an array of binding sites  for 
co l lagen ,  g ly c o sa m in o g ly c a n s  an d  cell m e m b ra n e  c o m p o n e n t s  
(Pearls te in  et al., 1980).  Fibronectin, together  with several  other 
noncol lagenous  glycoproteins is thought  to be responsib le  for the 
a t t a c h m e n t  of cells to co m p o n en ts  of the  extracel lu lar  matrix 
(Kleinman et al., 1981).
The s tructures  of the glycosaminoglycans are  similar in that  they 
all cons is t  of l inear polymers of hexosam ine  and  hexuronic acid 
(Comper & Laurent, 1978). They do not exist a s  free polymers, but as  
pro teoglycans  in which chains  of repea ted  d isacchar ide  units are 
covalently linked to a  protein core.
The carboxylate,  sulfate es te r  and sulfamino groups p resen t  on the 
g l y c o s a m i n o g l y c a n s  h a v e  low i so e le c t r i c  p o in t s  a n d  a r e  
consequently  negatively charged  at physiological pH. This results in 
higher concentrations of K+ and Na+ and lower concentrations of Cl­
in the interstitium, relative to p lasma (Haljamae et al., 1974).
Approximate ly  37 .5%  of th e  total body w a te r  in adu l t s  is 
extracellular  (Guyton, 1981). Eighty pe rcen t  of this extracellular  
fluid is conta ined within the interstitial s p a c e s  and  the remaining 
20% exists a s  p lasma water. The interstitium, therefore, represents  
an extremely large reserv/pir for drug distribution. Although most of 
t h e  intersti t ial  fluid is e n t r a p p e d  b e tw e e n  th e  f i lam en tous  
proteoglycans to form a  gel, small rivulets and vesicles  of free fluid 
may occasionally be present  (Guyton, 1981). Because  of the gel-like
8nature of the interstitium, fluid flow through the intercellular space  
is extremely slow (Guyton et al., 1966). Instead, movement of water 
and solutes  through the  t issue gel occurs  mainly by diffusion at a 
rate which is 95% to 99% that of diffusion through gel-free fluid. 
The dens ity  of the gel is such tha t  molecules  with molecular 
weigh ts  g re a te r  than 100,000 a re  general ly  exc luded  from the 
extracellular  matrix (P e a rc e  & Laurent,  1977). However,  smaller  
proteins and drugs bound to these  proteins apparently p a s s  through 
the  matrix more rapidly than unbound drugs  (Bergan, 1981). The 
prote in  co n cen t ra t io n  in interstitial  fluids is be l ieved  to be 
considerably lower than the concentration in p lasm a (Calnan et al., 
1972a).  Despite the  rapid transport  of albumin and albumin-bound 
drugs  within the  interstitial space ,  albumin d o e s  not p a s s  readily 
th rough  capi llary walls,  with the  resul t  th a t  prote in  binding 
generally d e c r e a s e s  drug penetration into the interstitial space .
Earlier  s tu d ie s  using n eed le  punc tu re  t e c h n iq u e s  led to the 
conclusion that the fluid p ressu re  within the interstitial s p a c e  was 
posit ive (Burch & S o d e m a n ,  1937). Guyton (1963), however,  
subsequent ly  showed that  the  interstitial fluid p ressu re  w as  in fact 
negative.  This conclusion w as  b a s e d  on s tudies  conduc ted  using 
perforated capsu le s  implanted in t issues.  Two to three w eeks  after 
im p la n ta t io n ,  t h e s e  c a p s u l e s  fil led with in te rs t i t ia l  fluid. 
Intracapsular  p ressu re  w as  then m easu red  by insertion of a  small 
needle  through the skin and one of the capsule  perforations into the 
inner cavity. This s tudy  r ep re s e n t s  the  first u se  of implanted
9ch am b ers  to s tudy interstitial physiology. The role played by this 
negat ive interstitial p ressu re  in drug distribution is unclear.
In summary,  the interstitial s p a c e s  consis t  of a  complex meshwork 
of fibers  in te rsp e rsed  b e tw een  a  s tab le  but dynam ic  ground 
su b s ta n c e .  Although the  gel-like nature  of the ground su b s tan ce  
preven ts  free flow of fluids, diffusion results in rapid distribution 
of so lu te s  b e tw een  capil lar ies  and  cells,  and  th roughout  the 
interstitium. This equilibration is a ided  by the ex tremely  small 
d is tances  between capillaries and soft-tissue cells.
B. Ant im icrob ia l  p e n e t r a t io n
Factors  affecting distribution of drugs  in t i s sues  are  well known 
and have been the subject of several reviews (Baggot, 1977; Levine, 
1973). To reach  bac ter ia l  invaders  s i tua ted  in the interstitial 
s p a c e s ,  ant imicrobia ls  m ust  t r a v e r s e  one  or more  biological 
barriers,  the  most  important  of t h e s e  being the  capillary wall. 
Movement of drugs  from the blood into the interstitium generally 
occurs  by passive  diffusion, the rate of which is determined, in part, 
by the  m agn i tude  of the  concen tra t ion  g rad ien t  b e tw ee n  the 
circulation and  the interstit ium, the th ickness  of the  biological 
barriers that must be t raversed,  and the a r e a  of capillary surface 
available for diffusion. The m ain tenance  of a  high concentration 
gradient  and the large surface  a rea  available for diffusion in highly 
per fused  o rgans  results in rapid equilibration of d rugs  in th e se  
a re a s .  Conversely, drug equilibration in poorly perfused  a r e a s  is 
usually delayed. Transport of drugs across  the capillary wall usually
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o cc u r s  e i the r  by diffusion th rough  the  lipid m e m b r a n e s  of 
endothelial cells or by p a s sa g e  through aqueous  channels.
Diffusion ac ross  lipid m em branes  occurs when drugs are  sufficiently 
lipid-soluble.  Lipid solubility is de te rm ined  by the  p r e s e n c e  of 
nonpolar or hydrophobic groups  (e.g. alkyl groups) in the structure of 
the drug molecule and the degree  of ionization. Most drugs are  weak 
acids  or weak b a s e s  and  can exist  in solution a s  the  ionized or 
nonionized forms, depending on the pKa of the particular agen t  and 
the pH of the immediate environment.  A pH gradient  be tween two 
com par tm en ts  (e.g. be tween blood and interstitial fluid) can result 
in uneven drug equilibration, a  phenom enum  called "ion trapping". 
General ly ,  acidic d ru g s  accu m u la te  within b as ic  env ironments ,  
w h e reas  basic  drugs accumula te  within acidic environments.
Water-soluble com pounds  that have a  low d eg ree  of lipid solubility 
can  c ro ss  the  capillary m em b ran e  by moving through a q u e o u s  
channe ls .  This p ro c e ss  is te rmed  filtration s ince  it involves bulk 
flow of water  down a  p ressu re  gradient. Movement is thought to 
occur  through g a p s  be tween  the capillary endothelial cells,  since 
electron microscopy has  failed to identify any channels  through the 
lipid m em branes  of the endothelial cell itself. The chief determinant 
of the rate of t ransport is the hydrated molecular size; the smaller 
the  size of hydrated water-soluble molecules,  the fas ter  they move 
through aqueous  channels.
The  d e g r e e  of protein binding exhibited  by a  drug exer t s  a 
cons iderable  influence on its distribution into interstitial s p ac e s .  In
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this respect ,  albumin is quantitatively by far the most important of 
the  p lasm a proteins.  The albumin molecule is too large to p a s s  
th rough  a q u e o u s  c h a n n e l s  and  a l though  smal l a m o u n t s  a re  
transported through the  capillary membrane  by pinocytosis (Guyton, 
1981),  m os t  of the  p ro te in -bound  drug is res t r ic ted  to the 
circulat ion. At equi librium, the  co n cen t ra t io n  of drug in the 
r e l a t iv e ly  p r o t e i n - f r e e  in te r s t i t i a l  fluid will e q u a l  th e  
concentration of unbound drug in p lasma (assuming similar ratios of 
ionized to nonionized drug). Avid protein binding, therefore, results 
in there  being less  drug avai lable for distribution into interstitial 
f luids.
To be effective, a  drug must be present at  the site of action in high 
e nough  concen t ra t ions  for an  a d e q u a te  period of time. This is 
par t icula r ly  t ru e  of an t imicrobia l  a g e n t s  which m us t  at tain 
m in im um  inhib i tory  c o n c e n t r a t i o n s  in t h e  in te rs t i t ium  to 
effectively inhibit bacter ia .  Several  different m ethods  have  been  
dev ised  to e s t im a te  the  penetrat ion of antimicrobial a g en t s  into 
soft t i ssues .
1. Methods used  to evaluate  antimicrobial penetration
a. Apparent volume of distribution
Baggot  (1977) defined the  apparen t  volume of distribution (Vd) as; 
"the volume of fluid which would be required to contain the amount  
of drug  in th e  body if it w e re  uniformly d is t r ibuted  at a 
concentrat ion equal  to that  in plasma". The V<j is calculated using
p h a r m a c o k in e t i c  p a r a m e t e r s  d e r iv ed  from t h e  a n a ly s i s  of
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i n t r a v e n o u s  drug d ispos i t ion  d a t a .  An an t im icrob ia l  which 
pene tra tes  well into t i ssues  has , at  equilibrium, a  lower proportion 
of the total d o s e  in the  circulation, and  therefore  a  high V^.
Conversely, an antimicrobial which is highly protein-bound has  a 
higher proportion of the total dose  in the circulation and a  low V^. 
The Vd does  not represent a  real volume and should not be associated 
with any particular physiological space .  The assumpt ion  is made 
tha t  the  drug is evenly  dis tr ibuted th roughou t  its vo lum e of 
distribution, a  situation that  is seldom true. Indeed, accumulation of 
antimicrobials  within hard and  soft t i s su es  occurs;  te tracyclines 
and gentamicin are  known to be concentrated within bone and renal 
tubular cells respectively (Ibsen & Urist, 1964; Luft & Kleit, 1974). 
The Vd for a  particular  antimicrobial revea ls  little information
concerning the  ex tent  of penetrat ion.  An antimicrobial which is 
highly p lasma protein-bound and has  a  small Vd may never the less
ach ieve  low concen tra t ions  in all t i s sues ,  even  th o se  that  are 
barrier-restricted. On the other  hand, an antimicrobial with a  high 
volume of distribution may be restricted from entering specialized 
c o m p a r tm e n ts  like the ce rebrosp ina l  fluid. Despite  the  obvious 
d i sa d v a n ta g e s  of using volumes of distribution to e s t im a te  the 
d e g ree  of interstitial penetration, this method is still widely used 
to establish effective d o sa g e  regimens.
b. Tissue homogenates
This method of evaluating antimicrobial penetration involves biopsy 
of t i ssues  at  intervals after parenteral drug administration. Tissue 
specimens are usually ground, suspended  in buffer, homogenized and
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then  rep ea ted ly  s o a k e d  in buffer to ex t rac t  the  antimicrobial 
(Haddad et al., 1986). Alternatively, excised ti ssues  can be placed on 
a g a r  p la t e s  p re in o c u la te d  with sen s i t iv e  m ic ro o rg an ism s  for 
microbiological a s s a y ,  without previous  homogenizat ion  (Cars  & 
Ogren ,  1980). Methods utilizing whole t i ssue  sec t ions  make the 
analysis  of extremely small quantities of t issue possible,  and da ta  
resulting from such techniques  has  been  found to correlate well 
with da ta  obtained using homogenization (Holm et al., 1978).
Interpretat ion of d a t a  der ived from t i ssue  h o m o g e n a te  s tud ies  
becom es  difficult when one  considers  that t issue samples  consist  of 
many different c o m p o n en ts  such a s  interstitial fluid, intracellular 
fluid, lymph, blood and specialized secretions like bile (Wise, 1986). 
Thus ,  predic t ions  of antimicrobial c o n cen t ra t io n s  in interstitial 
fluid cannot  be made unless the data  are adjusted to com pensa te  for 
the p re sen ce  of th e se  other components .  Corrections employed can 
be summ arized  by express ing them in the form of the  following 
equation:
C j f j  = (Cpf + Cpb)(1 - H)fb + CeHfb + Cjfj + Ccfc + Csfs
where  C cor responds  to antimicrobial concentrat ions  and f, to the 
relative volume of various components  identified by the subscripts T 
(whole tissue),  pf (portion of antimicrobial not bound to serum 
proteins),  pb (portion of antimicrobial bound to serum proteins), b 
(blood), e  (erythrocytes), i (interstitial fluid), c (t issue cells), and s 
(specialized com ponents ,  e.g. ,  bile and urine). H rep resen ts  blood 
hematocrit .  Clearly, the  complexity of the calcula t ions  and  the
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variability of correc t ions  u s e d  by different r e s e a r c h e r s  provide 
potential s o u rc e s  of er ror  in the  es timat ion of interstitial fluid 
concentrat ions.  Indeed, so m e  investigators have proposed  that the 
e r ro rs  a s s o c i a t e d  with making su ch  a d ju s tm e n t s  provide  a 
sufficient reason  to completely disregard the relative contributions 
of different t issue  com ponents ,  a  situation that  contr ibutes to the 
uncertainty of da ta  interpretation (Bergan, 1981).
The methodological problems a s so c ia ted  with this technique  also 
inc lude  e r ro r s  re su l t ing  from an t im icrob ia l  inac t iva t ion  in 
homogenized t i ssues  (Bergan, 1981). This is particularly true when 
antimicrobials are  exposed  to endogenous  enzym es  during prolonged 
p e r i o d s  of h o m o g e n i z a t i o n  a n d  e x t r a c t i o n .  F u r th e r m o r e ,  
concentration s tandards  that are  com posed  of exactly the s a m e  type 
of material a s  the hom ogena te  a re  difficult to prepare .  Despite the 
obvious limitations assoc ia ted  with the u se  of t issue  hom ogena tes  
to es t im ate  antimicrobial penetrat ion in the therapy of infectious 
d i s e a s e s ,  t h e s e  techn iques  do provide accu ra te  and  appropria te  
t issue residue data  that can be used to recommend withdrawal times 
in food animals.
c. Skin blisters
Severa l  r e s e a r c h e r s  have  u sed  skin blisters  to eva lua te  t issue 
penetrat ion of antimicrobials.  Blisters can  be produced by suction 
(Schreiner  et al., 1978; Schreiner  et al., 1981) or by the application 
of inflammatory agen ts ,  e.g,  canthar idin (Simon et al., 1978). A 
suction- induced blister provides an easily access ib le  extracellular
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fluid reservoir  tha t  c o m m u n ic a te s  with th e  circulation via a 
noninflammed,  p e rm e a b le  barrier.  Protein co n c e n t ra t io n s  within 
t h e s e  blisters a re  approximately 60% of se rum  levels.  The fluid 
c o n ta in e d  within c a n th a r id in - in d u c e d  b l i s te r s  r e s e m b l e s  an 
inflammatory exudate  and usually has  a  protein concentration 70%- 
80% of that  in serum. Therefore , protein concentra t ions  in both 
suc t ion- induced and  canthar id in-induced  blisters  a re  significantly 
higher than the levels believed to be p resen t  in interstitial fluid; a 
factor that has  to be taken into considerat ion when distributions of 
highly protein-bound antimicrobials are  being studied (Barza, 1981). 
Never theless ,  the  low fluid volume to t issue surface  a r e a  ratio of 
th e se  small reservoirs and the ab sen ce  of any permeability barriers, 
results  in a  rapid transfer  of antimicrobial be tween  the circulation 
and  blister fluid; a  situation that  probably exists  in true interstitial 
fluid. Therefore ,  skin blisters  do provide a  reliable m e a n s  of 
e s t i m a t i n g  t h e  t i s s u e  p e n e t r a t i o n  of n o n p r o t e i n - b o u n d  
antimicrobials.  However,  the use  of this technique  is restricted to 
those  spec ies  that have relatively thin skin that blisters easily.
d. Lymph
Periphera l  lymph, obta ined  by cannulat ion of lymphatics  in the 
extremit ies ,  is co n s id e red  to b e  in equilibrium with interstitial 
fluid. Experimenta l  ev id en ce  su p p o r t s  the  c o n c e p t  tha t  lymph 
reflects the interstitial fluid from which it is derived and  that the 
composition of th ese  two fluids is identical (Courtice, 1971). Before 
so lu tes  can  p a s s  from interstitial fluid into lymphatics,  they have 
to t raverse  the  lymphatic endothelium; a  barrier that  rep resen ts  a
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subs tan t ia l  h indrance  to p ro te in -bound  ant imicrobia ls  (Bergan,  
1981). The re levance  of this barrier in the evaluat ion of t issue  
penetra t ion is ques t ionab le  however ,  s ince  the  protein level in 
interstitial fluid is low and relatively little drug in the interstitial 
s p a c e  would be protein-bound.  The protein con ten t  of peripheral 
lymph is similar to that  of interstitial fluid; approximately 20-25% 
of the serum level (Barza, 1981). An inverse relationship between 
serum  protein-binding and  the ratio of peripheral lymph to serum 
concentra t ions  of antimicrobial a g e n t s . h a s  been  dem ons tra ted .  A 
similar  r e la t ionsh ip  is b e l ieved  to ex is t  in th e  inters ti t ial
compartment.  Indeed, sampling of peripheral lymph represents  one of 
the  more  reliable m e th o d s  u sed  to e v a lu a te  drug distribution. 
Disadvantages  of the model include; the variability of da ta  resulting 
from c h a n g e s  in lymph flow d u e  to m u scu la r  activity,  and  
diff icult ies a s s o c i a t e d  with th e  c a n n u la t io n  of in a c c e s s ib l e
peripheral lymphatics.  In contrast  to peripheral lymph, thoracic duct
(central) lymph is not representi t ive of normal interstitial fluid, 
b e c a u s e  it h a s  a  high protein c o n te n t  an d  c o n ta in s  large
contribut ions  from o rg a n s  that  have the capaci ty  to metabol ize,  
e x c re te  an d  a c c u m u la te  d rugs ,  e .g . ,  the  liver, k idneys  and  
gastrointest inal tract (Verwey et al., 1966).
e. Fibrin clots
Fibrin clots were  first used  by Weinstein et al. (1951) to predict 
antimicrobial c o n c e n t r a t i o n s  in a v a s c u la r  s i t e s  s u c h  a s  the  
v eg e ta t io n s  formed on hea r t  va lves  during endocard i t i s .  More 
recently, they have been  used  by Barza (1976), Barza & Weinstein
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(1974) and Bergeron et al. (1978) to study the t issue  penetration of 
a  wide range  of antimicrobials. In t h e s e  s tudies ,  preformed fibrin 
c lo ts  w e re  implanted  s u b c u ta n e o u s ly  in rabbits ,  af ter  which 
antimicrobials  were  adm in is te red  parentera l ly .  At intervals after 
a d m i n i s t r a t i o n ,  c l o t s  w e r e  r e m o v e d  a n d  a n t im ic ro b ia l  
c o n c e n t r a t io n s  d e te rm ined .  P ea k  c o n c e n t r a t io n s  in clots  were  
substantially lower and delayed compared to those  in serum, and the 
half-lives of elimination w ere  longer.  Clearly, fibrin clots a re  
poorly pene tra ted  by most  antimicrobial agen ts ,  particularly those  
that a re  protein-bound, and therefore cannot  be used a s  a  model for 
the interstitial sp ace .  Furthermore,  e a c h  fibrin clot provides only 
o n e  c o n ce n t ra t io n  v e r s u s  time d a t a  point.  This n e c e s s i t a t e s  
implantation of many clots in subcu taneous  sites that may differ in 
their  vasculari ty ,  thus  contributing to exper imenta l  error. Also, 
surgical implantation c a u s e s  an inflammatory reaction which may 
affect both the  protein concentration of the t ransuda te  surrounding 
the fibrin clot and  the integrity of the s u b cu ta n eo u s  t issues.  Not 
only can  t h e s e  inflammatory c h a n g e s  affect the distribution of 
an t im icrob ia ls  into c lots  but  varying d e g r e e s  of inflammation 
surrounding different clots may further add  to experimental error. 
Use of this model is appropriate only when antimicrobial penetration 
into dense ,  avascular  t issues  is being studied.
f. Skin Windows
Abrasion of small a reas  of skin to remove the epidermis and expose  
the underlying dermis  c rea te s  "skin windows" through which drug 
distr ibution can  occur.  Antimicrobial pene t ra t ion  can  then  be
18
e s t i m a t e d  by a llowing drug  equ i l ib ra t ion  b e t w e e n  d e rm a l  
interstitial fluid and  p a p e r  d iscs  (Raeburn,  1976) or saline-filled 
cham bers  (Tan et al., 1972; Tan et al., 1974a; Tan & Salstrom, 1977; 
Tan & Salstrom, 1979) applied to the d enuded  area .  Despite the 
inflammatory na ture  of the  exuda te  der ived from skin windows, 
protein concen tra t ions  in saline-filled c h a m b e r s  a re  low (Barza, 
1981). This is probably due  to the dilution of a  small volume of 
t issue  t ransudate  in a  relatively large volume of protein-free saline. 
Studies  by Tan et al. (1972, 1974a) ,  conduc ted  with saline-filled 
cham bers ,  have  dem ons tra ted  an inverse relationship between the 
d e g re e  of protein binding of antimicrobials and  their distribution. 
However,  Raeburn  (1971,1976),  using p ap e r  discs ,  reported that 
an t imicrobia ls  with a  high d e g r e e  of p la sm a  protein binding 
distributed well into exudates .  This finding correlates  well with the 
high prote in  c o n c e n t r a t i o n s  s e e n  in inf lammatory e x u d a t e s ,  
especial ly  immediately af ter  skin abras ion .  A cons is ten t  problem 
associa ted  with the use  of the skin window model is the amount of 
bleeding resulting from skin abrasion. No matter  how carefully the 
epidermis is removed, a  small amount of bleeding can be expected. 
Despite this d isadvantage ,  the skin window model is considered to 
be one  of the most  effective m ethods  of evaluat ing antimicrobial 
penetration (Bergan, 1981).
g. Subcutaneous  discs
Direct sampling of interstitial fluid may be ach ieved  by touching 
filter p ap e r  d iscs  to minimally t raumatized s u b c u ta n e o u s  t issues .  
Diffusional paths  a re  short,  resulting in rapid equilibration between
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blood a n d  e x t r a v a sc u la r  fluids. Thus ,  antimicrobial levels  in 
su b c u ta n e o u s  d iscs  closely parallel th o se  in blood (Barza, 1976; 
Barza  & Weinstein,  1974). The small ratio of p ap e r  volume to 
diffusional a rea  and the short diffusional d is tances  make this model 
representat ive  of the situation occurring in highly perfused tissues,  
where rapid drug distribution is thought to occur. The disadvantages  
associa ted  with the u se  of subcu taneous  discs are  similar to those 
experienced with fibrin clots; viz, variability in da ta  c a u se d  by the
d e g r e e  of inflammation resulting from surgical e x p o su re  of the
subcu taneous  tissues.
h. Fluids from body cavities
Antimicrobial pene t ra t ion  into the  per itoneal ,  joint, pleural and 
pericardial cavities can be  a s s e s s e d  by a s sa y  of fluids from these  
com par tm en ts .  Although such s tud ies  facilitate the  calculation of 
e f f icac ious  d o s a g e  r e g im e n s  for the  th e ra p y  of infect ious  
peritonitis,  synovitis,  pleuritis and  pericarditis,  little contribution 
is m ade  to the understanding of penetration into other  interstitial 
s i tes .  Long diffusional d i s t a n c e s  resul t  in a t tenua t ion  of the
f luc tua t ions  in s e ru m  co n c e n t r a t io n s  (Barza ,  1981)  and  the
specialized na tures  of the  m em b ra n es  lining th e se  compartments ,  
particularly joints,  p reven ts  extrapolat ion of d a ta  to soft - tissue 
interstitial  s i tes .  Except  for the  joint and  per i toneal  cavities,  
a c c e s s  may be difficult. Furthermore, the amount  of fluid available 
for sampling is spec ies-dependen t ;  eg, multiple sampling of bovine 
peritoneal fluid is virtually impossible.  Despite the apparently poor 
correlation be tween  penetrat ion into body cavities and  soft-tissue
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interstitial s p a c e s ,  the factors  affecting distribution ap p e a r  to be 
similar. An inverse re lationship be tw een  the  d e g re e  of protein 
binding and  penetration has  been  demonstra ted  in synovial (Howell 
et al., 1972), peritoneal (Guerrero & MacGregor, 1979), pericardial 
(Tan et al., 1974b), and pleural fluids (Lode & Dzwillo, 1978).
i. Wound exudates
Analysis of fluids derived from surgical wounds provides valuable 
information concerning the  efficacy of antimicrobials administered 
before ,  during and  af ter  surgical intervention. General ly ,  peak  
antimicrobial concentrat ions in wound exuda tes  are lower than the 
corresponding peaks  in serum. However,  wound exudate  levels are 
higher towards the end of the d o sag e  interval, compared  to serum 
levels (Ellis et al., 1975; Alexander  et al., 1973).  Although da ta  
derived from studies  of wound exudates  are directly relevant to the 
th e rap y  of pos t-opera t ive  infections, they ca n n o t  be u se d  to 
e s t im a te  antimicrobial penetration into untraumatized t i ssues ,  a s  
the  bleeding and acute  inflammation associa ted  with surgery can be 
expected  to alter drug distribution.
i.Tissue chambers
Tissue  cham bers ,  implanted subcutaneously  and in other  t issues,  
were first used  by Guyton (1963) to dem onstra te  the negativity of 
interstitial fluid p ressu re .  After implantation, the interior of each  
cham ber  becomes  vascularized by tissue buds growing in through the 
perforations. The t ransuda te  that  accum ula tes  within the cham ber  
after implantation resem bles  interstitial fluid and can  be sampled
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by inserting a  needle into the chamber  cavity. Waterman and Kastan 
(1972) w e re  the  first to u s e  t i s s u e  c h a m b e r s  to e v a lu a te  
ant im icrob ia l  d is t r ibu t ion .  They  s tu d ie d  the  p e n e t r a t io n  of 
cefalothin sodium into the  t ransuda te  conta ined within undisturbed 
a n d  par t ia lly  d i s s e c t e d  m ul t ipe rfo ra ted  p o ly p ro p y len e  balls.  
S u b se q u en t  to th e se  studies ,  t issue cham bers  have  been  used to 
study the penetration of many different antimicrobials in a  wide 
variety of t issues  and species.  Tissue chambers  have been implanted 
subcu taneously  (Adam et al., 1978), in the peritoneal cavity (Gerding 
et al., 1976),  and  within various o rg an s  including the  prosta te  
(Eickenberg et al., 1976b) and the kidney (Eickenberg et al., 1975; 
Eickenberg et al., 1976a).
Tissue cham bers  used have  varied in composition, shape ,  and size. 
Compounds that have been used to construct t issue chambers  include 
methacrylate,  polyvinyl chloride (PVC), s ta in less  s teel and silicone- 
b ased  plastics. The composition of the cham ber  can be expected to 
determine, to a  large degree ,  the amount of t issue reaction occurring 
a round  the  ch a m b e r  an d  therefore the  rate of drug penetration. 
Despite the importance of this factor, few s tudies  have compared 
the performances  of cham bers  constructed of different compounds.  
Holm et al. (1978) implanted sil icone and  steel m esh  cylinders in 
rabbits and  found that ampicillin and  tobramycin concentrat ions  in 
the metal ch am b e r s  were  higher than  in the sil icone cham bers .  
However,  the ratios of diffusible surface a rea  to cham ber  volume for 
the two cham ber  types were  different, thus making a  comparison of 
ch a m b e r  composit ion impossible.  Calnan et al. (1972a) com pared
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PVC and silicone cylindrical cham bers  in rabbits and found that the 
silicone chambers ,  at  3 to 6 weeks after implantation, had a  thinner 
covering and lining of connective tissue than the PVC ones.
The various s h a p e s  utilized range from perforated s p h e re s  (usually 
pract ice golf balls or perforated  table- tennis  balls) to perforated 
cylinders and  s ta in less  stee l  spirals.  The role played by cham ber  
s h a p e  becom es  important when one considers the influence of shape  
on the ratio of diffusible surface  a r e a  to c h a m b e r  fluid volume. 
Drugs p resen t  in the interstitial s p ac e  a re  p resented  with extremely 
large surface  a r e a s  through which they can penetra te  neighboring 
t i s sues .  In contrast ,  t i s sue  c h a m b e r s  form large fluid reservoirs 
su r ro u n d ed  by relatively small diffusible s u r face  a r e a s .  T issue  
c h a m b e r s  t h a t  h a v e  very  small  ra t io s  a r e  p ro b ab ly  not 
representa t ive  of normal interstitial s p ac e s ,  excep t  in the  c a s e  of 
those  t i ssues  that are  poorly vascularized. This is especially true of 
spherical cham bers  that have few perforations.
The extent  of t i ssue ingrowth into cham bers  varies among chamber  
types  and animal spec ies  studied. Piercy (1978) examined the tissue 
in and around silicone cylindrical cham bers  implanted in ca lves  and 
dogs.  Ten weeks  after implantation, cham bers  excised from calves 
w ere  su r ro u n d ed  by a  thick connec t ive  t i s su e  capsu le .  Tissue  
ingrowth into t h e s e  c h a m b e r s  w a s  ex tens ive ,  resul t ing in a 
reduction of the lumen s p a c e  available for t issue fluid. In contrast,  
c h a m b e r s  recovered  from dogs  had a  thinner  c a p su le  and  only 
m o d e r a t e  ingrowth of highly v a s c u la r i z e d  g ranu la t ion  t i s sue .  
Mult iperfora ted sp h e r ica l  po lye thy lene  c h a m b e r s  im plan ted  in
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rabbits for a s  long a s  three years  do not beco m e  obliterated by 
ingrowing t issue  al though they do becom e surrounded  by a  thick 
connective t issue capsule  (Tight & White, 1980). A similar response  
occurs  when steel  m esh  cylinders a re  implanted in rabbits;  only 
moderate  t issue ingrowth is s een  after 12 w eeks  (Rylander et al., 
1978). However,  similar cham bers  a re  unsuitable for use  in cattle 
b e c au se  they become completely obliterated only 3 to 5 weeks  after 
im plan ta t ion  ( B e n g t s s o n  et al., 1984).  S ta in le s s  s tee l  spirals 
implanted in rats also becom e obliterated by fibrous organization 
only 3 to 4 weeks after implantation (Gardner et al., 1973).
The type of t i ssue reaction occurring in and around tissue chambers  
a f te r  implan ta t ion  a p p e a r s  to b e  i n d e p e n d e n t  of c h a m b e r  
composition and shape .  Immediately after implantation, the chamber  
b e c o m es  filled with ex travasa ted  blood which first clots but then 
becom es  liquified (Guyton et a l ., 1971). Erythrocyte counts  d ec re a se  
rapidly af ter  implantation (Tight et al., 1975). Air left within the 
c h a m b e r  at  implantation is a bso rbed  within 7 to 9 days ,  during 
which time the  ch am b e r  fills with fluid. Within a  few w eek s  of 
implantation loose areolar  connective t i ssue  grows in through the 
perforations to form a  highly vascularized inner lining (Bengtsson et 
al. ,  1984;  Rylander  e t al., 1978).  At this s ta g e ,  per ivascu la r  
infiltrates of inflammatory cells can be seen .  With time this t issue 
increases  in collagen content to become thicker and d en se r  until the 
ch am b e rs  b e co m e  e n cap su la ted  by a  fibrous m a ss  c o m p o sed  of 
col lagen,  fibroblasts,  and  fibrocytes,  with little ev idence  of any 
in f lam m atory  r e s p o n s e  (C a lnan  et al., 1972a;  Ryan, 1978).
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Vascularization, however, does  not diminish and  blood vesse ls  can 
b e  s e e n  i n t e r s p e r s e d  b e tw e e n  whorls  of c o n n e c t iv e  t i s s u e  
( B e n g t s s o n  et al., 1984;  Calnan et al., 1972a) .  Long term 
implantation in cattle results in calcification of the fibrous t issues  
(Bengtsson et a l ., 1984).  The inflammatory cell infiltration into the 
c h a m b e r  fluid reflects the  progression from an acu te  to a  more 
chronic  r e sp o n s e .  Initially, po lymorphonuclear  cells predominate ,  
but  within a  few w e e k s  af ter  implantation m on o n u c lea r  cells 
become more numerous. This change  is accompanied by a dec rease  in 
total white cell counts  (Tight et al., 1975).
A knowledge  of protein concen tra t ions  in t i s su e  c h am b e r  fluid 
b e c o m e s  important when one  cons ide rs  the influence of protein 
binding on drug distribution. This is particularly true of albumin 
which is responsible  for the binding of many acidic antimicrobials. 
Protein-bound drugs are  transpor ted ac ross  the capillary membrane 
very slowly and  therefore remain s e q u e s te red  in the  compartment  
with the highest  protein concentration. Reversible binding to protein 
e n su re s  a  ba lance  in the  s teady s ta te  concentrat ions of total drug 
b e tw een  two co m p ar tm en ts  that  is in proportion to the  protein 
levels  in th o se  com par tm e n ts ,  a s sum ing  the  a b s e n c e  of other  
factors, e.g. ion trapping.
Concentrations of total protein and albumin in t issue  cham ber  fluid 
are  consistently lower than  corresponding serum concentrations, and 
d e c r e a s e  with time after implantation. In cattle,  concentra t ions  of 
total proteins in ch a m b e r  fluid obtained from silastic subcu taneous  
cham bers  declined from 36.0 ± 3.13 g/l at 5 weeks to 21.2 ±  2.71 g/l
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15 weeks  after implantation. Albumin concentrat ions d e c e a s e d  from 
21.6 ±- 2.33 g/l to 14.0 ±- 1.55 g/l during the s a m e  time interval 
(B en g ts so n  et al., 1986).  Numerous  s tud ies  have  reported total 
protein and  albumin concentrat ions in cham ber  fluid that  a re  lower 
than corresponding serum concentrat ions (Bergan, 1981; Calnan et 
al., 1972b; Calnan et al., 1972a).  Haljamae et al. (1974) conducted a 
c o m p a ra t iv e  a n a ly s i s  of fluid o b ta in ed  from s u b c u ta n e o u s ly  
im p lan ted  p e r fo ra te d  t i tanium c a p s u l e s  a n d  interstit ial  fluid 
s a m p le d  using the  "liquid-paraffin cavity" tech n iq u e  (Hal jamae, 
1970). Six w eeks  after implantation, total protein concentrat ions  in 
interstitial fluid (0.32 ±- 0 .02 g/100ml) w ere  significantly lower 
than those  of chamber  fluid (0.43 ± 0.03 g/100ml).  Albumin:globulin 
ra t ios  w e r e  similar,  but co n s id e rab ly  h igher  than  the  ratio 
de termined in plasma.  Although there a re  differences between the 
protein content of cham ber  and interstitial fluid, th e se  s tudies  have 
shown that the protein composition of cham ber  fluid approaches  that 
of interstitial fluid a s  a  function of t ime after implantation. This 
ev idence  supports  the u se  of su b cu ta n eo u s  ch am b ers  to compare  
inters t i t ial  p e n e t r a t io n  of s imilar  an t im ic rob ia ls  th a t  exhibi t  
different de g re e s  of protein binding.
Chisholm et al. (1976) compared  the penetration of two penicillins 
tha t  hav e  different d e g r e e s  of protein binding. This s tudy was 
conducted using subcu taneous  silicone cham bers  implanted in dogs. 
Equivalent  d o s e s  of ampicillin (17% bound) and  cloxacillin (97% 
bound)  resul ted  in cons ide rab ly  higher  levels  of ampicillin in 
cham ber  fluid. Although small differences in molecular weight could
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have contributed to this difference in distribution, the high protein 
binding of cloxacillin w as  cons idered  to be  the most likely cause .  
Similar observat ions  were  m ade when cefaloridine (39.5% bound), 
cefazolin (92.5% bound), and cefamandole (88% bound) were injected 
in tramuscular ly  in rabbi ts  (Carbon et al., 1977).  Cefalor id ine  
activity in s u b c u ta n e o u s  silastic c h a m b e r s  w a s  d e te c te d  more 
rapidly and  at ta ined higher levels than the  other two antibiotics 
within the  first 4 hours.  A high degree  of protein binding does  not 
necessar i ly  exclude  an  antimicrobial from the  interstitial sp ace .  
Levels of total cefazolin in multiperforated polypropylene cham bers  
were generally higher than  those  of cefaloridine (Waterman et al., 
1976). However,  unbound levels are  more relevant to therapeutic 
efficacy, s in c e  pro te in -bound  drug lacks  an t ibac ter ia l  activity 
(Barza, 1981).
Conflicting results have been reported by researchers  studying the 
electrolyte composi t ion of t i s sue  c h am b e r  fluid. Haljamae et al. 
(1974) m e a s u re d  c h a m b e r  Na+ and K+ concentra t ions  that were  
higher than the corresponding plasma levels. Chloride levels , on the 
other hand, were  lower in cham ber  fluid. They sugges ted  that  this 
im b a lan ce  w a s  d u e  to the  p r e s e n c e  of negat ively  c h a rg e d  
g lycosaminoglycans  in c h am b er  fluid. In con tras t  to this finding, 
Calnan et al. (1972b) reported that the level of K+ w as  significantly 
lower and  Cl- higher in ch am ber  fluid com pared  to serum. This 
observat ion could be explained by the Gibbs-Donnan effect which 
d esc r ib e s  the  unequal  distribution of diffusible ions be tween two 
com par tm en ts  when on e  of th o se  com par tm en ts  conta ins  a  non-
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diffusible ion (in this c a se ,  negatively charged  p lasm a protein). In 
ano ther  study (Bengtsson  et al., 1984), levels of Cl- and K+ were 
both higher in chamber  fluid than in serum. This study also described 
C a ++ and Mg++ levels that were lower in chamber  fluid compared to 
serum.
Despite the important effect "ion trapping" h a s  on drug distribution, 
few studies  have a d d re s s e d  the questions  relating to pH gradients 
between p lasma and cham ber  fluid. Gerding et al. (1976) measured 
the pH of cham ber  fluid and described an increase  in pH with time 
after implantation, but failed to m easure  blood pH thus  making the 
detec t ion  of a  pH grad ien t  be tw een  blood and  c h a m b e r  fluid 
impossible.  Carbon et al. (1978) measured the pH of p lasma (7.43 ± 
0.04) and  c h a m b e r  fluid (7.31 ±- 0.03) but omitted a  statistical 
comparison.  In another  study, Calnan et al. (1972b) failed to detect  
any significant difference in pH between cham ber  fluid and blood in 
rabbits.  However, PO2  in chamber fluid was  significantly higher than 
in serum, and the PCO2  significantly lower.
Information ob ta ined  abou t  the pH, electrolyte composit ion and 
protein content  of c h a m b e r  fluid has  led to the conclusion that 
t i s s u e  c h a m b e r s  a r e  in continuity with the  interstitial  sp a ce .  
However ,  b e c a u s e  drug penetrat ion is a  dynamic  p rocess ,  the 
dynamic communication between the blood circulation and chamber  
fluid h a s  to be  inves t iga ted  an d  c h a ra c te r iz e d  before  valid 
es t imates  can be m ade  concerning the distribution of antimicrobials 
into the interstitial space .  Few studies have a d d ressed  this concern. 
Calnan et al. (1972b) studied the rate of transfer of 24Na into tissue
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c h a m b ers  after ei ther  intravenous administration or injection into 
one  of the t i ssue  cham bers .  When injected intravenously, activity 
within c h a m b e rs  w as  first de tec ted  after 30 minutes.  Thereafter ,  
activity leve ls  c o n t in u e d  to i n c r e a s e  until t h ey  e x c e e d e d  
c o r re sp o n d in g  blood levels  90 m inu tes  af ter  injection. After 
injection into one  of the tissue chambers ,  activity was  m easured  in 
the  circulating blood within a  few minutes  and  r e a ch ed  peak  
c o n c e n t ra t io n s  in o the r  t i s su e  c h a m b e r s  a t  approx imate ly  60 
minutes.  Simultaneous injection of two .different isotopes  of sodium 
into a  t issue cham ber  and a  knee joint resulted in identical ra tes of 
c lea ran ce  from the two compar tments .  Equilibration of Br occurs  
even more rapidly (Carbon et al., 1977). After intravenous injection, 
82Br w as  de tec ted  in ch am ber  fluid within 5 minutes  and s teady 
s ta te  w as  achieved at approximately 60 minutes.  When injected into 
the tissue  chamber , 82Br appeared  in p lasma within 3 minutes.  These 
s tudies  show that  although small molecules have  ready a c c e s s  to 
ch a m b e r  fluid there  is a  short  lag period before s teady  s ta te  is 
achieved. This lag period becomes  more evident when the transfer of 
com pounds  that  have larger molecular weights is studied. The half- 
life of elimination of cefuroxime from ch am ber  fluid after injection 
into the  c h a m b e r  w as  found to be  slower  than the half-life of 
elimination from blood af ter  in travenous  injection (Ryan, 1978). 
Furthermore, the  rate a t  which cefuroxime en te red  the  circulation 
following injection into a  su b cu ta n e o u s  ch a m b e r  w as  slower than 
the  rate  at  which cefuroxime e n te re d  the  blood af ter  normal 
s u b c u ta n eo u s  injection. The results of this s tudy s u g g e s t  that the 
dynamic communication between blood and  ch am b er  fluid may be
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less  intimate com pared  to the communication be tween  blood and 
true interstitial fluid. This conclusion gains  support  from a  study 
conduc ted  by Hal jamae et al. (1974). Using the  "liquid-paraffin 
cavity" technique  to collect interstitial fluid, they  found that  the 
t ransfer of 131 l-labelled albumin from p lasm a  into c h a m b e r  fluid 
w as  much slower than the  transfer  from p la sm a  into interstitial 
fluid. Equilibration of albumin between blood and  c h am b e r  fluid 
occurs rather slowly and the s teady sta te  concentrations achieved in 
cham ber  fluid a re  always lower than those  in blood (Calnan et al., 
1972b). In contras t to albumin, s teady sta te  concentrat ions of inulin 
in chamber  fluid are similar to those in plasma (Calnan et al., 1972b). 
Since inulin is distributed through the extracellular fluid sp ace  only, 
this  o b s e rv a t io n  infers  th a t  the  t i s s u e  c h a m b e r s  r e p re s e n t  
ex t race l lu la r  fluid c o m p a r tm e n ts .  The inability of albumin to 
achieve equal concentrat ions  in blood and cham ber  fluid shows that 
t h e s e  extracel lular t i s su e  c h am b er  com p ar tm en ts  a re  s e p a ra te d  
from th e  circulation an d  can  there fo re  be  r e g a rd e d  a s  true 
interstitial  co m p a r tm e n ts .
2. Pharmacokinet ics  of t issue  distribution
The pharmacokinetic characterization of t issue penetration has  been 
ex tens ive ly  rev iewed by Bergan  (1981,  1978). Distribution of 
antimicrobials into non-specialized t issues  is a  passive process  and 
obeys Picks' law of diffusion:
At = (AxD/T)(cp - q)
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w here  At is the total am ount  of drug diffusing into an interstitial
compartment,  A is the diffusible surface a rea ,  D is the diffusion 
coefficient, T is the distance, and cp and Cj a re  the concentrations of
an t im icrob ia l  in t h e  p l a s m a  a n d  in ters t i t ia l  c o m p a r t m e n t s  
respectively. This relationship can be simplified by considering the 
s ituation w here  an  interstitial focus  (e.g. a  t i s sue  chamber)  is 
exposed  to a constant  concentration of drug. In this case ;
At = 2Ac(Dt/7i)i/2
where  c is the constant  concentration at the boundary of the focus 
and  t is time. This equation can  be manipulated to render  the 
following:
Cj = (2Ac/Vj)(Dt/7i) i /2
w here  Cj is the concentration within the focus and Vj is the volume 
of the  focus .  Examinat ion of this equa t ion  r ev ea l s  tha t  the  
c o n c e n t r a t i o n  of a n t im ic rob ia l  a c h i e v e d  in an  inters t i t ia l  
co m par tm e n t  is proport ional  to the  diffusible su rface  a r e a  and 
inversely proportional to the  volume of the  com par tm en t .  This 
e x p la in s  th e  poor  d is tr ibution of an t im ic rob ia ls  into t i s su e  
c h a m b e r s  tha t  have  small ratios of diffusible su r face  a r e a  to 
volume. The importance of this ratio has  been confirmed using an in 
vitro  model (Van Etta et al., 1982).  This equation also illustrates 
tha t  the re  is a  l inear relationship be tween  the  concentrat ion of 
antimicrobial within a  focus and the square  root of time.
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First-order pharmacokinetic  models  can  be used  to descr ibe  the 
distribution of drugs  into peripheral compar tments .  Generally,  the 
one-compartment ,  open model has  been  applied (Fig. 1). This model 
d e s c r ib e s  the  pene t ra t ion  into and  elimination from a  single 
compartment.  A two-compartment,  open model which recognizes the 
interaction between intravascular and extravascular  concentrations, 
is also applicable (Fig. 2). This model explains the effect of the rate 
of elimination from the central compartment on the penetration into 
and  elimination from the  interstitial com par tment .  Antimicrobials 
that a re  eliminated slowly from the central compartment,  such that 
Kqi and K|c a re  not limiting, exhibit similar dispositional profiles in
serum and  cham ber  fluid. Chamber  concentrat ions of antimicrobials 
that  have  short  serum elimination half-lives, generally lag behind 
serum concentrations. In this instance, the relatively low Kci and K|c
limit diffusion into and out of the central compartment.  The delay in 
pene tra t ion  and  the  reduction in peak  interstitial com par tm en t  
concen t ra t ions  is even  more pronounced  when Kci and K|q are
especial ly  low, which is general ly the  c a s e  when the interstitial 
compartment has  a  small ratio of diffusible a rea  to volume and when 
diffusional bar r ie rs  ex is t  b e tw een  the  centra l  and  interstitial 
com par tm en ts .  Such a situation fits the  descript ion of a "deep 
compartment",  which is thought  to represen t  a b s c e s s e s  and  poorly 
vascular ized  infectious foci.
Bergan (1978) has  dem onstra ted  the validity of using a r e a s  under 
the  se ru m  and  interstitial com par tm ent  cu rves  ( A U C S and AUCj
respectively) to describe  drug penetration into peripheral foci. The
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Fig. 1 - One-compartment ,  open pharmacokinetic model.
Kq h  = kinetic constant for drug penetration into interstitial compartment 
K ^ l = kinetic constant for drug elimination from interstitial compartment
Fig. 2 - Two-compartment,  open pharmacokinetic model.
Central compartment
I n te rs t i t ia l
compartment
Ke l  = kinetic constant for drug elimination from central compartment 
Kqi = kinetic constant for drug penetration into interstitial compartment 
K|q  = kinetic constant for drug elimination from interstitial compartment
33
a r e a  under  the  cu rve  a t  a  par t icula r  e x t r a v a sc u la r  focus  is 
proportional to the a rea  under  the curve in serum. This relationship 
appl ies  to both total a r e a s  a s  well a s  to confined per iods  of 
observation. Thus, the extent of penetration can be described by the 
ratio AU Cj :A UCs .
3. Effect of infection on antimicrobial distribution and activity
S evera l  fac tors  can  be  e x p e c te d  to a lter  the  pene t ra t ion  of 
antimicrobials into infected foci. T h e s e  include: (1) c h a n g e s  in 
protein levels within the a rea  of infection; (2) ch an g es  in the pH of 
the infected interstitium; and  (3) alterations in vascularization due 
to either disruption of the cellular barriers between the circulation 
and  the  site of infection or chronic encapsula t ion .  The possible  
effects of infection on antibiotic activity have been  d i s c u s se d  by 
B a rza  (1981).  They  include:  (1) en zy m a t ic  inact ivat ion; (2)
nonenzymatic  binding and  inactivation by cons t i tuents  of purulent 
exudate; (3) the development of an  anaerobic environment within the 
site of infection; and  (4) d e c r e a s e d  efficacy of bacteriocidal cell- 
wall active antibiotics d u e  to a  d e c r e a s e  in bacterial multiplication 
in densely populated sites of infection. The combined influence of all 
t h e s e  f ac to rs  m ay  lead  to e i th e r  i n c r e a s e d  or d e c r e a s e d  
c o n c e n t r a t io n s  of ac t ive  ant imicrobial  in an  infected  locus, 
depending on the type of antimicrobial being used,  the duration of 
infection and  the specific bacterium involved.
Rylander et al. (1981a) com pared  the penetration of aminoglycosides 
into noninfec ted  an d  infected s tee l  net  c h a m b e r s  implanted
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su b c u ta n eo u s ly  in rabbits .  Inoculation of c h a m b e r s  with gram- 
n ega t ive  ae ro b ic  b a c te r ia  resu l ted  in r e d u c e d  pene tra t ion  of 
gentamicin,  amikacin, an d  netilmicin. Furthermore,  elimination of 
t h e s e  aminoglycosides  from infected ch am b e r s  w a s  slower  than 
from the  non in fec ted  o n e s .  The  poor penetrabil i ty  of t h e s e  
antibiotics into infected cham bers  w as  considered  to be primarily 
due  to the development of a  penetration barrier. The pH of infected 
fluid w as  found to be lower than in noninfected fluid but this could 
not have contributed to the d e c rea se  in penetrability, since a  lower 
pH should favor accumulation of basic aminoglycosides . A similar 
d e c r e a s e  in penetrability has  been  observed by the s a m e  group in 
s tu d i e s  involving norfloxin (R y lander  & Norrby, 1983)  and  
metronidazole (Rylander et al., 1981b). These  s tudies  supported the 
conclus ions  of an  ear lier  study by Holm et al. (1978) in which 
similar s teel ne t  ch a m b e rs  were  infected with E. coli. This study 
sh o w ed  tha t  the  concentra t ion  of cefaloridine w a s  significantly 
lower in infected ch am b e rs  during the first day of t rea tment  but 
increased when the number of bacteria in the cham bers  decreased .  
Q uan t i ta t ion  of an t imicrobia l  levels  in in fec ted  a n d  s ter i le  
su bcu taneous  a b s c e s s e s  in mice has  yielded similar results (Joiner 
et al., 1981). Sterile a b s c e s s e s  were  produced by inoculation of 
a u to c la v e d  c ec a l  c o n te n t s ,  w h e r e a s  infected a b s c e s s e s  were  
produced by inoculation of autoclaved cecal contents  combined with 
B acte ro id es  frag ilis . P e a k  c o n c e n t r a t i o n s  of c e f a lo th in ,  
ce foperazone  and  ceforanide in sterile a b s c e s s e s  were g reater  than 
maximal levels in infected a b sc e sse s .  O'Keefe et al. (1978) compared 
the effects of d e c re a se d  penetration and inactivation on the therapy
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of experimental infections induced by inoculation of intraperitoneal 
c h am b ers  with Bacteroides fragilis. The degree  of penetration into 
infected and  noninfected ch a m b e rs  w a s  a s s e s s e d  by measuring 
rad ioac t iv i ty  in c h a m b e r s  a f te r  i n t r a m u s c u la r  in ject ion of 
radiolabelled penicillin. Antimicrobial inactivation w as  de termined  
by bioassay  of cham ber  fluids. This study showed that  there was  a 
small d e c r e a s e  in penetrat ion of penicillin into infected cham bers  
but a  striking d e c r e a s e  in antibiotic activity. Extensive inactivation 
of cefalothin in infected foci has  also been reported (O'Keefe et al., 
1978).
In contras t  to the s tudies  above, Luthman et al. (1984) described  
higher antimicrobial levels in infected cham bers  than in noninfected 
chambers .  Unfortunately, these  observations did not em ana te  from a 
controlled study, a s  infection of cham bers  resulted from accidental 
contaminat ion  and  not from purposeful inoculation with specific 
microorganisms. T hese  results have, however, been  supported by a  
report  tha t  a  n um ber  of different ant imicrobials  attain higher  
co n ce n t ra t io n s  in infected pericardial fluid than  in noninfected  
pericardial fluid (Tan et al., 1974b).
C h a n g e s  in protein levels within infected a r e a s  affect both the 
penetrat ion and  the  activity of antimicrobial agen ts .  Pe terson  and 
G erd ing  (1978)  s tu d ie d  the  effec t  of e x t r a v a s c u l a r  protein 
concentra t ion  using noninfected subcu taneous ly  implanted Visking 
cham bers .  Cefazolin (95% protein-bound) concentrations  in chambers  
filled with se ru m  w ere  reported to be  considerably  higher  than 
concen t ra t ions  in saline-filled c h am b ers ,  thus  dem onstra t ing  the
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importance of protein binding within ex travascular  sites.  Although 
high protein levels in infected sites  may lead to drug accumulation, 
this does  not necessari ly  result in increased efficacy, s ince binding 
to protein usually inactivates  antimicrobials.  Indeed, the  extent of 
protein binding has  b e e n  directly corre la ted  with a  d e c r e a s e  in 
therapeutic  efficacy (Merrikin et al., 1983).
C. Antimicrobia l  e f f icacy
In vivo antimicrobial ef ficacy  is d e te rm in e d  by a  n u m b er  of 
different but re lated factors .  T h e se  include: (1) concentrat ion of 
antimicrobial a t  the  s i te  of infection; (2) c o m p e te n c e  of host  
d e f e n s e  m echan ism s ;  (3) bacterial sensitivity to the antimicrobial 
used;  and  (4) antimicrobial inactivation by either binding to protein 
or structural alteration. An evaluation of th e se  factors is crucial to 
effective antimicrobial therapy.  Methods used  to study antimicrobial 
efficacy include the  u se  of in vitro bacter ia l sensitivity testing,  
systemic d i sea se  models  and localized infection models.
1. Methods used  to evaluate  antimicrobial efficacy
a. In vitro sys tems
Bacteria l sensitivity test ing is usually co n d u c ted  in vitro using 
either  diffusion or dilution techniques  (Carter,  1984). This method 
isolates  and  exam ines  the  interaction between bacter ia  and graded 
levels of antimicrobial. Results  a re  usually exp ressed  in terms of a 
minimum inhibitory concentration (MIC) which is the concentration
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of antimicrobial a t  which growth of the  inoculated organism is 
prevented .  This is a  m e asu re  of the  bacter iostat ic  effect of the 
antimicrobial. Minimum bacteriocidal concentrat ions (MBC) may also 
be de termined.  T h e se  a re  concentra t ions  at which dea th  of the 
organisms occur.
In vitro sensitivity testing d o es  not allow evaluation of the role of 
host  d e fe n se  m echan ism s  or antimicrobial binding and  inactivation 
within infected  s i t e s ,  an d  th e re fo re  p rov ides  only a  rough 
approximation of potential in vivo efficacy. Despite  the  obvious 
d i s a d v a n ta g e s  of this m ethod ,  MICs a re  f requent ly  u s e d  in 
conjunction with in travenous pharmacokinet ic  s tudies  to formulate 
appropria te  d o s a g e  reg imens  (Hjerpe & Routen, 1976). Bacterial 
sensitivity testing does ,  however,  provide a  m e a n s  of identifying 
potentially effective antimicrobials,  but final selection and d o s a g e  
calculation should be b ased  on data  derived from in vivo s e n s i t iv i ty  
testing.
b. Systemic d i s e a se  models
Two types  of systemic d i s e a se  models a re  used:  screening models 
and  specific d i s e a s e  models.  Screening models  usually se rve  to 
identify potent ial ly useful  antimicrobial ac t ions  of exper imenta l  
compounds.  The most commonly used screening model is the mouse 
protective tes t  (Bergeron, 1978). In this model, mice are inoculated 
with on e  or seve ra l  s t ra ins  of bac ter ia  and  then  t re a ted  with 
different  d o s e s  of the  drug. The e f fec t iveness  of antimicrobial
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therapy is de termined by survival ra tes  e x p re s s e d  a s  the ED5 0 , 
which is the dose  required to ensure  a  50% survival rate.
Specific d isea se  models can be useful in determining the therapeutic 
efficacy of antimicrobials utilized in the therapy of specific d isease  
complexes; e.g.  bovine pneumonic pasteurellosis (Ames et al., 1987) 
or eq u in e  s t r ep to co cca l  s e p t ic e m ia  (Varma et al., 1984).  The 
efficacy of therapy is usually descr ibed  by a  health index which 
quanti ta tes  the clinical s ta te  of the animals (Powers  et al., 1984). 
Health indices  a s c r ib e  s c o r e s  to clinical s igns  tha t  can  be 
objectively quant i ta ted ,  and  therefore  provide d a t a  tha t  can be 
sub jec ted  to statistical analysis .
S y s tem ic  d i s e a s e  m o d e ls  provide a  m e a n s  of s tudying the  
disposi t ion of antimicrobials  in d i s e a s e d  animals .  Although the 
effect of antimicrobials on bacterial p a thogens  in the p re se n ce  of 
host d e fe n se s  is examined,  no at tempt is m ade to correlate  these  
resul ts  with levels of antimicrobial a t ta ined  within the  site of 
infection.
c. Localized infection models
Localized soft-tissue infections can be es tablished by inoculation of 
t i s su es  (Eagle  et al., 1952),  t i s sue  c h am b ers  (Arko, 1972; Arko, 
1973) or implanted media preparations (Werner et al., 1954a; Werner 
et al., 1954b). Most recen t  s tud ies  have utilized t i ssue  cham bers  
s ince  this model allows multiple, serial sampling of exudate .  The 
re sp o n se  to systemic  antimicrobial therapy is usually evaluated by
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correlating drug concentrations with bacterial counts  at  the site of 
inoculat ion.
Various types  of t i s sue  c h a m b e r s  have  been  used  to es tabl ish 
localized infections. W a g n e r  et al. (1986) inocula ted modified 
Sykes-Moore c h a m b e r s  fitted with filters that  did not allow the 
p a s sa g e  of cells. Peterson et al. (1984) used similar semipermeable  
membrane  cham bers  that prevented the free diffusion of subs tances  
with m olecu la r  w e igh ts  g r e a t e r  than  10,000.  Although t h e s e  
cham bers  prevented the systemic sp read  of the inoculated organism 
and  blocked t i s sue  ingrowth, they a lso  excluded  hos t  d e fen se  
mechanisms.  Since the interaction of host d e fen se s  is one  of the 
chief a d v an tag es  a s so c ia ted  with localized infection models,  these  
cham bers  can  be expected  to yield da ta  that is more comparable  
with in vitro bacterial sensitivity testing data.
More meaningful s tud ies  were  conducted  by Holm et al. (1978), 
Rylander  et al. (1981a).  Rylander et al. (1981b), and  Rylander & 
Norrby (1983) using subcutaneous  steel mesh chambers  and Kaye et 
al. (1979) using intraperitoneal perforated sphere  chambers .  These  
cham bers  allow the p a s s a g e  of leucocytes  and antibodies  and can 
th e re fo re  be  u s e d  to s tudy  bac te r ia l  sensi t ivi ty  to specific  
antimicrobial co n cen t ra t io n s  in the  p r e s e n c e  of hos t  d e fen se s .  
Viable bacterial counts  in cham bers  inoculated with various strains 
of E. coli, Proteus mirabilis, and Proteus morganii were only slightly 
d e p re s s ed  with aminoglycoside therapy (Rylander et al., 1981a).  The 
poor therapeu t ic  r e s p o n s e  w as  corre la ted  with low penetrability 
into infected chambers  and an increase in the in vitro MICs when the
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organisms were cultured in an anaerobic environment with a  low pH, 
conditions which exist  within infected chambers .  In contras t  to the 
am inog lycos ides ,  the  penetra t ion  of norfloxacin into c h a m b e r s  
inoculated with E. coli or Klebsiella pneumoniae w as  good, resulting 
in complete  and lasting sterilization of the  infections 7 days  after 
the  t rea tm en t  period (Rylander  & Norrby, 1983). Inoculation of 
ch am b e rs  with both Bacteroides fragilis and  E. coli resulted in a 
slower and  less  pronounced reduction of Bacteroides fragilis dur ing 
metronidazole  therapy than w as  observed  in ch am b ers  inoculated 
with Bacteroides fragilis a lo n e .
2. Therapy of Pasteurella haemolvtica in bovine respiratory d isea se
Bovine pneum onic  pas teure l los is  is one  of the most  important 
c a u s e s  of d ea th  and  d i s e a s e  in feedlot cattle and  rep re sen ts  a 
significant economic loss  to the cattle industry. Although various 
viruses ,  bacter ia ,  m ycop lasm as  and chlamydia, either singly or in 
combinat ion,  have  b e en  implicated in this d i s e a se ,  P a s te u re lla  
haem olytica  (Ph) is r ega rded  a s  the most  important etiological 
agent .  J e n s e n  et al. (1976) conducted a  year-long survey in which 
they studied the incidence of d i sea ses  affecting a  large population (> 
400,000)  of yearling feedlot cattle. Respiratory d i s e a s e s  accounted 
for 75% of the clinical d iagnoses  and 64% of the fatalities recorded 
during the survey period. Ph was  isolated from the majority of the 
animals  necropsied.  Although considerable  effort and  funding have 
been  committed to the deve lopm ent  of effective vaccinal control
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m e a s u r e s ,  ant imicrobial  th e rap y  still co n s t i tu te s  an  important  
component  of feedlot health m anagem ent  (Miles, 1984).
Unfortunately, Ph is r e s i s tan t  to many of the  commonly used  
antimicrobials (Fales  et al., 1982).  Potentia ted sulfa combinations  
have  been  found to be more effective than sulfas alone (Bushby, 
1980). The synergy between sulfas and trimethoprim arises  from the 
sequent ia l  inhibition of e n zy m es  responsible  for folate production 
by sensitive bacteria (Mandell & Sande,  1985). Despite the reported 
in vitro efficacy of potentiated  sulfas,  subclinical c a s e s  of bovine 
pas teure l los is  may still persis t  after therapy (Ames et al., 1987). 
This could be  d u e  to poor penetrabil i ty  an d /o r  antimicrobial 
inactivation. Thus, effective therapy relies on an understanding of 
the interaction be tween bacterium, host d e fen se s  and  antimicrobial 
in the infected area.
R ecen t  ev idence  confirms that  exposu re  to bovine viral d iarrhea 
virus  (BVDV) p r e d i s p o s e s  ca t t le  to Ph infection. P n eum on ic  
p a s te u re l l o s i s  is regular ly  p ro d u c e d  w hen  th e  bac te r ium  is 
inoculated by aerosol 10 days after BVDV inoculation, but d isease  is 
not produced when the bacterium follows the viral inoculation by 6 
days  (Corstvet & Panciera,  1982). BVDV is believed to impair certain 
host d e fe n se s  thus  facilitating the colonization of Ph. The efficacy 
of antimicrobials in the  t rea tment  of bacterial infections depends ,  
to some extent, on the cooperation of host defense  mechanisms. This 
is particularly true of bacter iostat ic  agen ts .  Thus, initial exposure  
to BVDV may substantia l ly  affect antimicrobial the rapy  directed 
against Ph in bovine respiratory d isease.
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Recent  in vivo s tudies  have sugges ted  that the synergism between 
BVDV and Ph is due  to a  systemic effect and not a  local lung effect. 
BVDV infection in ca lves  interferes with normal blood c lea rance  
m e ch an ism s  resulting in bac te rem ias  a s so c ia ted  with leucopenia  
(Reggiardo & Kaeberle,  1981). Polymorphonuclear leucocyte function 
is also affected (Ketelsen et al., 1979). Although there  is no effect 
on oxidative metabolism, the myeloperoxidase, hydrogen peroxide, 
and halide sys tem s  are  impaired (Roth et al., 1981). In contrast  to 
the profound systemic effects of BVDV, most  s tudies have failed to 
reveal any direct pneumopathogenic i ty .  In one  study, inoculation 
with BVDV n e i th e r  h a d  a n y  s ig n i f i c a n t  e f fe c t  on th e  
neutrophil /macrophage ratio in the bronchoalveolar  lavage nor was  
it able  to induce gross  or microscopic lesions in the lungs (Lopez et 
al., 1986). The exact  nature of the bacterial/viral synergism is still 
unresolved.
The p a thogenes is  of bovine pasteurel losis  involves a  migration of 
n eu t ro p h i l s  into t h e  s i te  of infect ion. After in t rabronchia l  
inoculation in calves, neutrophils were found to be the predominant 
cell type at 2 hours (G osse t  et al., 1984).  Experimental  aeroso l  
e x p o s u r e  to Ph i n d u c e s  a  m a r k e d  i n c r e a s e  in t h e  
neu trophi l /m acrophage  ratio (Lopez et al., 1986). T h e se  ch a n g es  
correlate well with the reported histological ch an g e s  in which small 
airways becom e plugged with purulent exudate.  Neutrophil depletion, 
using hydroxyurea, protects  calves  from the pathogenic effect of Ph 
( S lo c o m b e  et al., 1985).  This finding s u g g e s t s  tha t  the  rapid 
accumulation of degranulating neutrophils may in fact c a u se  the lung
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injury. Indeed, a  study of the evolution of pulmonary lesions caused  
by intrabronchial inoculation of Ph reported  tha t  the  influx of 
neutrophils p receded  evidence of pulmonary d a m ag e  (Turk et al., In 
P ress). In contrast to in vitro studies,  in vivo s tudies  using Ph and 
indwelling can n u lae  have dem ons t ra ted  that  phagocytos is  by the 
alveolar macrophage is not an important host defense  after onse t  of 
infection and  d i s e a s e  (Walker et al., 1980; Corstvet et al., 1984). 
Thus, considerable  evidence exists showing that  major components  
of the inflammatory response  involve cells and de fense  mechanisms 
not unique to the lung.
Since both the synergism between BVDV and Ph and the pathogenesis  
of the pneumonic lesion involve cells and defense  mechanisms that 
are  not unique to the lung, the interaction between BVDV, Ph and 
ant imicrobials  can  be s tudied using an extra-pulmonary model.  
Indeed, use  of the subcu taneous  tissue  cham ber  p resen ts  one  with 
the  opportunity to study this interaction in the  a b s e n c e  of lung 
factors such a s  surfactant,  alveolar m acrophages ,  cells associa ted  
with alveoli, and  parenchymal  cells, thus  providing a  model that 
isolates  what  s e e m  to be the most important com ponen ts  of the 
inflammatory response  s een  in pneumonic pasteurellosis.
CHAPTER 3
EXPERIMENTAL GOALS AND DESIGN
The ultimate goal of this exper iment  was  to define, and eventually 
validate,  a  s u b c u ta n eo u s  t issue ch am ber  a s  a  suitable device for 
establishing a  localized soft-tissue infection, which could then  be 
u se d  a s  a  model for studying the  distribution and  efficacy of 
antimicrobial drugs. The study included 4 phases:
1. P h a s e  I - Developmental  s tu d ie s
Prel iminary s tu d ie s  c o n d u c te d  in h o r s e s  h av e  shown tha t  a  
thermoplastic cell collector (Jeffers & Enright,1985) can be used  as  
a  subcu taneous  tissue cham ber  to study the distribution and in vivo 
efficacy of antimicrobial agen ts  (Short et al., 1987; Beadle et al., In 
P r e s s ) .  In t h e s e  s tu d ie s ,  t i s s u e  c h a m b e r s  w e re  implanted  
subcutaneously  in the lateral neck region of horses .  Inoculation of 
Streptococcus zooepidem icus  into the cham ber  cavity resulted in 
the  e s t a b l i s h m e n t  of a  localized so f t - t i s sue  infection. T h e s e  
cham bers  were not obliterated by ingrowing t issue  and were easily 
sampled.  The goal of the developmental s tudies  was  to determine 
w h e th e r  th is  "prototypal"  t i s su e  c h a m b e r  could  s e rv e  a s  a 
sa t is fac tory  model for studying the  penetra t ion  and  efficacy of 
antimicrobial agen ts  in cattle,  and if not, to modify the "prototypal" 
design so a s  to maximize the penetration of drugs into the chamber
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and minimize the amount  of t i ssue  reaction occurring around the 
chamber, without losing the functional advantages  of the design.
2. P h a s e  II - Histo logical ,  cytologica l ,  and  chem ica l  s tu d ie s
Before a  subcu taneous  t issue chamber  can be used  to represent  a 
peripheral interstitial compar tment,  a  similarity be tween  cham ber  
fluid and  interstitial fluid must  be demonstra ted .  Furthermore, the 
composition of ch am ber  fluid should remain fairly s table  and the 
cham ber  should not be obliterated by ingrowing tissue. Therefore,
this p h a s e  was  concerned  with the characterization of t issue and
fluid c h a n g e s  occurring within the cham ber  a s  a  function of time 
after  implantation.
3. P h a s e  III - P h a rm aco k in e t ic  s tu d ie s
To be useful from a  pharmacokinetic viewpoint, the chamber  should 
not only be in continuity with the interstitial s p ace  but should also 
reflect the  dynamic communicat ion existing be tw een  blood and 
interstitial fluid. The purpose  of this p hase  was  to character ize  this 
dynamic relationship by evaluating the rate of penetration of various 
endogenous  and pharmacological agents.
4. P h a s e  IV - Antimicrobial  eff icacy  s tu d ie s
This p h a se  consis ted  of validation s tudies  conducted using specific 
pa thogens  and  antimicrobials.  The in vivo response  of Pasteurella  
h a e m o l y t i c a  to  s y s t e m i c  a d m i n i s t r a t i o n  of
s u l f a d i a z in e / t r im e th o p r im  w a s  e x a m i n e d .  In add i t ion ,  the  
interaction between antimicrobials, bacteria  and host de fen ses  was
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studied by examining the effect of a  previous bovine viral diarrhea 
virus infection on the r e sp o n s e  of P as teu re lla  h aem olytica  to 
su lfad iaz ine / t r im ethopr im  therapy.
CHAPTER 4
SPECIFIC OBJECTIVES. MATERIALS AND METHODS. AND RESULTS 
PHASE I - Developmental studies
Study #1 
O b j e c t i v e s :
1. To develop a  satisfactory surgical technique  for implanting 
th e rm o p la s t ic3 tissue  chambers  subcutaneously  in the paralumbar 
fo s sae  of s teers .
2. To determine whether  these  cham bers  could be easily sampled 
by percu taneous  aspiration.
3. To examine the cytological and electrolyte c h a n g e s  occurring 
within the cham bers  over a  period of time after implantation.
4. To determine the extent of t issue ingrowth into chambers  after 
implan ta t ion .
Materials  and  M ethods:
A nim als  - Four cross-bred  s tee rs  (weighing approximately 350-400 
kg) were  held on pasture  for the duration of the experiment.
3 Delrin® E.l. du Pont de Nemours and Co., Inc., Wilmington, DE
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Implantation of tissue chambers - Two-piece tissue cham bers  were 
c o n s t ru c te d  of Delrin® thermoplast ic  (Fig 3). The b a s e  of this 
"prototypal" ch a m b e r  w as  0.3 cm thick and  m e a su re d  7 cm in 
diameter. The chamber cup measured 3.8 cm ID, 4.4 cm OD and 2.2 cm 
in depth. Twelve, 0.4 cm diameter  holes were distributed over the 
top half of the b a s e  of the cham ber  cup. The cham ber  cup was 
covered  with a  0 .178 mm-thick s h e e t  of medical g rad e  sil icone 
rubber*3 which was  held in place by an overlying ring which was  0.3 
cm thick and  had inner and outer  d iameters  of 4.4 cm and 7 cm 
respectively. Assembled  ch am b ers  were gas-s ter i l izedc before use. 
Two t issue cham bers  were implanted subcutaneously in each  steer,  
one  in each  para lumbar  fossa,  using paravertebral  analgesia .  The 
skin dorsal  to a  15 cm incision w as  undermined to crea te  enough 
dead  s p a ce  to position the chamber . Each chamber  was  stabilized in 
the underlying subcu taneous  t issue using #1 nylon suture  material, 
and  the  skin incision w as  then c losed  with #2-0 nylon using 
interrupted, half-thickness,  cruciate  sutures .
Cham ber fluid sampling  - Five ml of chamber  fluid w as  aspirated 
from the t issue cham ber  in the left paralumbar  fossa  of each  steer,  
using a  sterile technique.  The a r e a  was  clipped, scrubbed  with a 
povidone- iodine solut iond and wiped with isopropanol. A 20 gauge 
needle  w as  then inserted through the skin and covering membrane 
into the ch am ber  cavity. A 21 gau g e  needle  a t tached to a  0.2 pm
b Silastic®, Medical-Grade Sheeting (Reinforced), Dow Corning Corp., Midland, Ml 
c Anprolene®, H.W. Andersen Products, Inc., Oyster Bay, NY 
d Betadine Surgical Scrub, The Purdue Frederick Co., Norwalk, CT
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millipore d ispos ib le  filtere se rved  a s  an air-inflow port to relieve 
any negative pressure  created during sampling. Fluid was  sampled at 
weekly intervals after implantation for a  period of 8 weeks.
Cytological, bacteriological and chemical analysis of chamber fluid 
- Total leucocyte  coun ts  and  erythrocyte counts  were  conducted  
using a  cell counted.  Total protein concentrations were  determined 
by r e f r a c t o m e t r y 9 . The  sterility of the  c h a m b e r  fluids was  
monitored by culturing portions of the aspirates  on 5% bovine blood 
a g a r  fortified with 1% h o r se  s e ru m  an d  1% filtered y e a s t  
hydrolysate.  Aspira tes  were  also inoculated into a  thioglycolate 
broth with 1% ad d e d  horse  serum. Na+ , CI-, and K+ levels were 
determined by the ion-specific electrode method*1.
Extent o f tissue ingrowth - One  ch am b er  (situated in the right 
paralumbar fossa)  was  removed from one animal every two weeks, 
starting one  w eek  after implantation. Each ch am b er  was  carefully 
d i s s e c te d  free from the  surrounding t i s sue  and  the  volume of 
capsu lar  fluid was  recorded. Chambers  were then opened,  and the 
degree  of t issue ingrowth was  examined.
R e s u l t s :
Surgical implantation of t issue chambers  in three of the four s teers  
w as  followed by rapid healing of the  skin incision without any
e Acrodisc®, Gelman Sciences Inc., Ann Arbor, Ml 
f Coulter Counter®, Coulter Electronics Inc., Hialeah, FL
9 American Optical Instruments, Buffalo, NY 
h Beckman System EA4, Beckman Instruments Inc., BREA, CA
Table 1 - Mean (± SD) data derived from the analysis of non-infected chamber fluid (n
Weeks after 
implantation
Leucocyte
count/p.l
Erythrocyte 
count /pi
Total 
protein (g/dl) N a+(MEq/l) K+(MEq/l) CI'(M Eq/l)
1 1967 ±  750 21600 ±- 10037 6.0 ± 0.3 139 ±  1 4.1 ± 0.1 104 ±  2
2 1250 i  71 50567 ±- 65408 6.6 ±  1.0 137 ± 3 4.4 ±  0.1 101 ± 2
3 943 ±- 330 21533 ±- 4909 6.1 ±  0.8 137 ± 4 4.4 ±  0.1 103 ± 3
4 1850 ±  1626 17750 ±  5020 * 138 ± 3 4.4 ±  0.2 102 ± 2
5 1800 ±  2081 8267 ±- 5029 5.4 ±  0.8 138 ± 3 4.4 ±  0.3 102 ± 3
6 3133 ±. 3262 32567 ±- 22108 4.9 ±  0.3 138 ± 3 4.4 ±  0.2 102 ± 4
7 2167 ±. 1607 53333 ±  23094 4.6 ±  0.4 139 ± 3 4.4 ±  0.1 102 ± 2
8 1567 ±  1250 44200 i  5940 4.5 ±  0.5 136 ±  2 4.4 ±  0.1 101 ± 2
Insufficient sample to conduct analysis
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excess ive  signs  of inflammation. Sterility checks  on cham ber  fluids 
testified to the creat ion of sterile su b cu ta n e o u s  com par tm en ts  in 
these  three s teers .  However,  despite careful at tempts  to implant the 
c h a m b e r s  a sep t ica l ly ,  bac te r ia l  ( S taphylococcus sim ulans ) 
contamination of one  of the cham bers  in the fourth s tee r  occurred. 
Percu taneous  aspiration of cham ber  fluid in all s tee rs  was  achieved 
with e a s e  and  without any noticeable bleeding.
Red blood cell- and white blood cell- counts in noninfected chambers  
initially d e c r e a s e d  but then  s tar ted  increasing 3 to 4 w eeks  after 
implantat ion (Table  1). C h a m b e r  fluid protein levels  declined 
steadily until they were 60% of levels considered normal for bovine 
plasma,  8 w eeks  after implantation. Chamber  fluid Na+, K+, and Ch 
concentra t ions  were  similar to those  cons idered  normal for bovine 
p lasm a and  did not a p p ea r  to ch an g e  a s  a  function of time after 
implantation. Tissue ingrowth into the cham bers  a t  1, 3, 5, and 7 
w e e k s  af te r  implantation w a s  minimal and  w a s  in e a c h  c a s e  
confined to the  perforated region of the  c h a m b e r  (Fig. 4). The 
volumes of chamber  fluid aspirated from cham bers  3, 5, and 7 weeks 
after implantation increased  with time (Table 2)
Table 2 - Volumes of chamber  fluid (ml) aspirated from tissue
ch am b ers
W eeks after implantation: 3 5 7
Volume (ml): 16.5 18.6 21.5
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Fia. 3 - "Prototypal" t issue  chamber  (left) and overlying ring (right).
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Fig. 4 - Extent of t issue ingrowth into a  "prototypal" t issue chamber 
removed 7 weeks  after implantation.
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Study #2 
O b j e c t i v e :
1. To determine whether  a  modification of the "prototypal" design 
e n h a n c e d  the penetrat ion of antipyrine into a  subcu taneous ly  
implanted Delrin® tissue chamber.
Materials  and  Methods:
Im plantation o f tissue chambers - The "prototypal" des ign  was 
modified so a s  to increase  the ratio of diffusible surface  a rea  to 
cham ber  volume. This w as  achieved by changing the s h a p e  of the 
cham ber  and by increasing the number and size of perforations (Fig. 
5). The cham ber  cup of the modified "revised" design m easured  4.6 
cm ID, 5.2 cm OD, and 1.5 cm in depth. The holes in the base  of the 
cham ber  measured  0.6 cm in diameter. Seven additional perforations 
(0.6 cm diameter) were drilled in the walls of the cham ber  cup. The 
silicone rubber membrane was held in place by securing a  loop of #5 
surgical stee l  s ternotomy wire' around the rim of the cham ber  cup. 
Both "p ro to typa l"  a n d  " re v ised"  d e s i g n s  w e r e  im p lan ted  
subcutaneously in the paralumbar  fossae  of a  single adult steer,  one 
on each  side of the body. Thirty minutes prior to surgery 20 mg/kg 
c e p h a p i r in  sod iumi w a s  adm in is te red  in travenously  to prevent  
microbial contamination during and shortly after implantation.
' Ethicon Inc., Somerville, NJ 
j Cefadyl®, Bristol Laboratories, Syracuse, NY
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Drug adm inistration and blood and cham ber fluid sampling - 
Antipyrinek was  administered a s  a  bolus IV dose  (20 mg/kg), 35 days 
after implantation of the chambers.  Blood samples  were collected at 
the  following intervals:  0 (before  ant ipyrine injection),  0.0833,
0.25, 0.5, 0.75, 1, 2, 3, 4, 5, and  6 hours  after administration. 
C h a m b er  fluid s a m p le s  w ere  col lec ted a t  0 (before  antipyrine 
injection),  0.25,  0.5, 0 .75, 1, 2, 3, 4, 5, and  6 hours  after 
administration. Serum and  cham ber  fluid sam ples  were then frozen 
at -20C until analysis.
Drug assay and pharm acokinetic analysis  - Ant ipyr ine  w a s  
quantita ted using a  modification of the method reported by Prescott  
et al. (1973). Forty microliters of 5N sodium hydroxide and  2 ml of 
ethyl a c e t a t e  (conta in ing 2.5 ppm phen ace t in  a s  the  internal 
s tandard) were added in sequence  to 0.3 ml sample  and vortexed for 
30 s e co n d s .  The combinat ion was  centri fuged at 600 x g for 5 
m inu tes  a n d  the  s u p e r n a t a n t  w a s  t r a n s f e r r e d  to s to p p e re d  
disposable test  tubes.  Standards  (0.1, 0.5, 1, 5, 10, 20, 50, 100 ppm) 
were prepared by adding appropriate amounts  of antipyrine to blank 
sample .  T h e se  s ta n d a rd s  were  sub jec ted  to the  s a m e  analytical 
p rocedure  a s  the te s t  s am ples .  Antipyrine concen t ra t ions  were 
quanti ta ted  by injecting 4 pi aliquots into a  g a s  ch rom atograph1 
fitted with a  6-foot, 2-mm ID, 1/4 inch OD g la s s  column packed 
with GP 3% SP-2250-DB on 100/120 Supelcopor tm . The column, 
injection port, and  nitrogen-phosphorus detector  tem pera tu res  were
k Sigma Chemical Co, St Louis, MO
1 Model 5480A, Hewlett-Packard Co, Palo Alto, CA 
m Supelco Inc, Bellefonte, Pa.
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220, 240, and  300C, respectively. Flow rate for helium carrier gas  
w as  30 ml/minute; for detector  hydrogen, 7 ml/minute; and  for air, 
100 ml/minute.
A pharmacokine t ic  ana lys is  of se rum  drug concen t ra t ions  was  
conducted  using an iterative computer  program (Brown & Manno, 
1978).
R e s u l t s :
The serum  disposition curve for antipyrine (Fig. 6) indicated a 
d e c r e a s e  in serum concentrat ions  that w as  bes t  descr ibed  by the 
open,  two-compartment model (Baggot,  1977). Although the initial 
serum  concentrat ion (Cp°) was  high (40.1 jig/ml), and the half-life 
of elimination (ti/2(B)) from serum was  of moderate  duration (1.59 
hours), only very low levels of antipyrine were detected in chamber  
fluid o b t a in e d  from th e  "proto typal"  d e s ig n .  F u r th e rm o re ,  
concentrat ions within this chamber  had not yet peaked  by the time 
sampling w as  terminated. In contrast,  concentra t ions  of antipyrine 
within the  "revised" design were considerably higher and reached a 
peak  at approximately 1 hour after administration. Therefore , the 
change  in design resulted in improved penetration of antipyrine into 
the "revised" tissue chamber .
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Fig. 5 - "Revised" tissue chamber.
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Fig. 6 - Antipyrine concentrations in "revised" and "prototypal" design tissue chambers  and in serum
after IV bolus administration.
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Study . #-3- 
O b j e c t i v e s :
1. To further modify the  "revised" design so as  to maximize the 
penetration of antipyrine into a  subcutaneously implanted Delrin® 
t issue chamber.
2. To com pare  the d eg ree  of t issue  ingrowth into "revised" and 
"final" t issue chamber  designs.
Materials  and  Methods:
Implantation of tissue chambers - The "revised" design was  further 
modified so a s  to maximize the ratio of diffusible surface  a rea  to 
ch am b e r  volume without losing the functional a d v a n ta g e s  of the 
original "prototypal" design. This was  achieved by further increasing 
the number  of perforations in the b a s e  and walls of the "revised" 
des ign to produce a  "final" design (Fig. 7). Both the "revised" and 
"final" d e s ig n s  were  implanted subcu taneously  in the  paralumbar  
fo ssae  of a  single adult s teer,  one on each  side of the body. The 
surgical technique  and  antimicrobial cover  were  identical to that 
descr ibed in study #2.
Drug administration, drug assay and pharm acokinetic analysis - 
Antipyrine w as  administered a s  a  bolus d o se  (20 mg/kg), 25 days 
after implantation of the chambers .  Sampling techniques , drug assay
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an d  pharm aco k in e t ic  ana lys is  w ere  identical to the  m e thods  
described in Study #2.
Tissue ingrowth  - Thirty five d a y s  af ter  implantation,  both 
cham bers  were removed and the d eg ree  of t issue ingrowth into the 
interior of the chambers  was  examined and photographed.
R e s u l t s :
C o n cen t ra t io n s  of ant ipyrine within both "revised" an d  "final" 
des igns  peaked  at approximately 5 hours after administration (Fig. 
8). However,  concen tra t ions  in c h am b e r  fluid obta ined  from the 
"final" des ign  were  general ly  higher than  th o se  in c h am b er  fluid 
ob ta ined  from the  "revised design".  In both c h a m b e r s ,  t i s sue  
ingrowth w a s  conf ined  to the  p e r fo ra ted  reg ions .  Therefore ,  
increasing the  num ber  of perfora t ions  resul ted  in more  t i ssue  
ingrowth and  a  larger diffusible surface a r e a  in the "final" design 
than was  observed  in the "revised" design (Fig. 9 &10). This larger 
diffusible su r f a c e  a r e a  to volume ratio resu l ted  in in c reased  
penetration of antipyrine into the "final" design chamber.
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Fig. 7 - Unassembled (left) and assembled  (right) "final" t issue
chambers.
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Fig. 8 - Antipyrine concentrations in "revised" and "final" design tissue chambers
and in serum after IV bolus administration.
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Fig. 9 - Extent of t issue ingrowth into a "revised" tissue chamber 
removed 35 days  after implantation.
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Fig. 10 - Extent of t issue ingrowth into a  "final" t i ssue chamber  
removed 35 days  after implantation.
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Study #4 
O b j e c t i v e s :
1. To de te rm ine  w hether  coating with a  nonreact ive adhes ive  
affects  the  rate and extent  of penetrat ion of antipyrine into a 
subcutaneously  implanted Delrin® chamber.
2. To de te rm ine  w hether  coating with a  nonreact ive adhes ive  
affects the degree  and  nature of t issue reaction occurring in and 
a ro u n d  Delrin® c h a m b e r s  af ter  s u b c u ta n e o u s  implantation in 
c a t t l e .
Materials  a n d  M ethods:
Im plantation of tissue chambers - A "prototypal" t issue cham ber  
w as  coa ted  with a  s i l icone-basedn adhesive .  Coated  and uncoated 
"prototypal" d e s ig n s  w ere  then implanted su b cu ta n eo u s ly  in the 
paralumbar  fo ssae  of a  single steer,  one on each  side of the body. 
The surgical technique w as  identical to that descr ibed in study #2.
Drug administration, drug assay and pharm acokinetic analysis - 
These  were identical to those  described in Study #3.
H istopatho log ical evaluation  - Thirty five days  after implantation, 
both ch am b ers  were  removed and t issue within the cham bers  was 
subjected to macroscopic  and microscopic examination.
n Silastic®, Medical Adhesive Silicone Type A, Dow Corning Corp., Midland, Ml
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R e s u l t s :
Antipyrine co n ce n t ra t io n s  within the  S i la s t ic® -coa ted  c h a m b e r  
were  consis tent ly higher  than concentra t ions  within the  uncoated  
c h a m b e r  (Fig. 11). Furthermore,  concentra t ions  within the  coated  
cham ber  ap p ea red  to reach a  peak  at  approximately 4 hours after 
a d m in is t ra t io n ,  w h e r e a s  c o n c e n t r a t i o n s  within th e  u n c o a te d  
c h a m b e r  con t inued  to rise during the  whole sampling period. 
T h e re fo re ,  coa t ing  with a  s i l i c o n e -b a s e d  a d h e s i v e  improved 
antipyrine t issue cham ber  penetration.
Although the  connect ive  t i ssue  capsu le  surrounding the uncoated 
c h a m b er  w as  thicker than  that  surrounding the  coa ted  chamber ,  
microscopic examination of the tissue within the cham bers  failed to 
reveal any d ifferences  in ei ther  the nature  or ex ten t  of t issue 
ingrowth.
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Fia. 11 - Antipyrine concentrations in coated and uncoated tissue chambers 
and in serum after IV bolus administration.
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PHASE II - Histological, cytological. and chemical studies 
O b j e c t i v e s :
1. To describe the histopathology of t issue and the composition of 
fluid within Delrin® tissue cham bers  a s  a  function of time after 
sub cu ta n eo u s  implantation in cattle.
2. To determine the point at  which cellular even ts  within the 
c h am b er  stabilize.
3. To m easure  the rate of t ransudate  inflow into cham bers  after 
complete drainage of fluid contents.
Materials  and  M ethods:
A nim als  - Six adult s tee rs  of mixed breed (weighing approximately 
350-400 kg) were  used  in this phase .  They were  maintained on 
pasture  prior to and after implantation of the t issue chambers.
Im plantation o f tissue cham bers - Twelve "final" design t issue  
cham bers  were coated with Silastic® adhesive, assembled ,  and gas- 
sterilized before surgical implantation. Two t issue  c h am b ers  were 
implanted, subcutaneously,  in the paralumbar  fo ssae  of each  of the 
six steers,  one on each side of the body.
Cytological, bacteriological and chemical analysis of chamber fluid 
and blood - Five ml of fluid were aspirated from the chambers  on the 
left side of the body, every 10 days  for 60 days  after implantation.
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Blood w as  sampled  by venipuncture at identical time periods. The 
sterility of ch am ber  fluid w as  monitored by culturing a  portion of 
the aspirate  on 5% bovine blood agar  fortified with 1% horse serum 
and 1% filtered y e a s t  hydrolysate.  Aspirates  were  also inoculated 
into a  broth with 1% added  horse serum. Incubation was  performed at 
37C in a  candle  jar. C ham ber  fluid and blood were subjected to 
cytological and chemical  examination. Differential white cell counts 
w ere  d e te rm in e d  by examining  s m e a r s  s ta ined  with modified 
Wright's stain. Total protein, Na+, K+, and Ch concentra t ions  and 
leucocyte and erythrocyte counts  were determined using methods 
described in P h a s e  I. Albumin was  quantitated using a  commercially 
prepared bromcresol green method0 and analyserP. pH was  measured 
using a  pH/blood-gas analyser^.
H istopathological evaluation  - One cham ber  (situated on the right 
side of the body) was  removed from one s teer  each  10 days  for 60 
days, starting 10 days  after implantation. The volume of fluid within 
each  cham ber  w as  recorded and the extent of t issue ingrowth was 
m e a su re d  and photographed .  Ingrowing t i ssue  w as  then fixed in 
formalin, s ec t io n e d ,  s ta in e d  with hematoxylin  an d  eos in  and  
evaluated histologically using high power light microscopy.
M easurem ent o f transudate rate of inflow  - Sixty one days  after 
implantation, the  rate of t r a n su d a te  inflow into c h a m b e r s  after 
fluid d r a in a g e  w a s  m e a s u r e d .  All remaining c h a m b e r s  w ere
0 Centrifichem®, Baker Instruments Corp., Allentown, PA 
P Encore®, Baker Instruments Corp., Allentown, PA 
9 Corning Model 158, Corning Medical and Scientific, Medfield, MA
70
completely drained of fluid and then drained again 24 hours later. 
The volume of t ransudate  that had accumulated during the 24 hour 
interval w as  recorded and  the rate of t ransudate  inflow calculated. 
The experiment was  then repeated using a  96 hour interval.
Statistical analysis - Using paired t tests ,  compar isons  were  made 
between chamber  fluid values  and corresponding blood values at each 
of the  sampling t imes (Steel  & Torrie, 1980). The method of 
orthogonal polynomials w as  used to character ize the effect of time 
a f te r  im plan ta t ion  on th e  c o n c e n t r a t io n  of c h a m b e r  fluid 
cons t i tuen ts  (Steel  & Torrie, 1980). Total leucocyte coun ts  and 
e ry th ro c y te  c o u n t s  w e r e  norm a lized  by log t ra ns fo rm a t ion .  
Differential leucocyte  p e r c e n t a g e s  w ere  normalized by a rcs ine  
conversion. Differences between m eans  were considered significant 
at  P  < 0.05.
R e s u l t s :
H istopathological evaluation  - The proportion of cham ber  volume 
occupied by t issue d e c re a se d  with time after implantation until, 60 
days  after implantation, t issue  lining the inside of the cham ber  was 
con f ined  only to the  p e r fo ra te d  r eg io n s  ( F ig s .12-19).  This 
distribution w as  in contras t  to the almost  complete  obliteration of 
the chamber  cavity seen  in the chamber  which was  removed 10 days 
af ter  implantation.  Volum es  of fluid a sp i r a te d  from c h a m b e r s  
removed at 10 day intervals increased with time (Table 3).
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Microscopic examination of t i ssue  within c h a m b e r s  revealed  the 
p re sen ce  of an  inflammatory reaction that becam e  more chronic and 
proliferative with time af ter  implantation. The reaction within the 
cham ber  removed 10 days  after implantation (Fig. 20) matched the 
descr ip t ion  of c h a n g e s  occurring during an a c u te  e p i so d e  of 
inflammatory edem a.  This cham ber  w as  filled with t issue  consisting 
primarily of loose fibrin s trands, red blood cells, polymorphonuclear 
ce l ls ,  an d  m o n o n u c le a r  ce l ls  e m b e d d e d  in a  h o m o g e n o u s  
p ro te inaceous  material.  Tissue  ad jacen t  to ch am b er  su rfaces  was 
covered with a  thin layer of fibrin which contained a  few rounded or 
stellate fibroblasts a s  well a s  accumulat ions  of red blood cells.
Table 3 - Volumes of fluid (ml) aspirated from t issue chambers .
Days after implantation: 20 30 40 50 60
Chamber fluid volume: 14 11.5 12 16 19
An inflammatory r e s p o n s e  of a  more  proliferative na tu re  was  
o b se rv ed  in c h a m b e r s  removed 20, 30, 40, and  50 days  after 
implanta t ion (Fig. 21).  Invasion of t i s s u e  by f ibroblas ts  w as  
acco m p a n ied  by a  p rogress ive  deposit ion of collagen.  Although 
c o l lagen  depos i t ion  within c h a m b e r s  w a s  initially loose  and  
haphazard  in nature, it b ecam e  more organized with time until, 50 
d a y s  a f te r  implanta t ion ,  c h a m b e r  s u r f a c e s  w e re  lined with 
concentr ic layers of d e n s e  collagen. Collagen in deeper-lying areas,  
however, retained the more irregular arrangement.  A modification in
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fibroblast s h a p e  from rounded or stellate  to e longated or spindle, 
testified to the progress ive  maturation of fibrous t i ssue  occurring 
within chambers .  Early vascularization of t issue  was  noticed in the 
cham ber  removed 20 days  after implantation. This w as  particularly 
noticeable in deeper-lying a r e a s  where  many capillaries,  and  small 
ven u le s  and  ar te r io les  w ere  in te r sp e r sed  b e tw een  the  looser 
collagen fibers. Tissue within cham bers  implanted for longer periods 
of time did not show a  d e c rea se  in vascularity but, rather, a  further 
maturation in blood v e s s e l s  leading to the  e s tab l i shm en t  of a 
deeper-lying blood supply consist ing of larger venules ,  arterioles 
and capillaries and a  peripheral blood supply consisting of smaller 
capillaries lying be tween  the d e n s e  layers of concentric collagen. 
T he  p o ly m o rp h o n u c le a r  ce l ls  s e e n  so o n  af te r  implanta t ion 
d i s a p p e a r e d  an d  w e re  r e p lac e d  by in c reas ing  n u m b e r s  of 
mononuclear  cells and  p lasm a cells. Mild perivascular accumulation 
of th e se  cells was  observed.  Large accumulations of monocytes seen 
in peripheral regions co r responded  in location to accumulat ions of 
red blood cells s e e n  in t issue from the cham ber  removed 10 days 
af ter implantation.
Tissue from the cham ber  removed 60 days  after implantation (Fig. 
22) w as  typical of the  fibrous granulation t issue produced during 
chronic proliferative inflammation. A d e n s e  co l lagenous  capsule ,  
con ta in ing  m a tu re  e lo n g a te d  f ib rocy tes  an d  n u m e r o u s  small 
capi l lar ies ,  s u r ro u n d e d  the  d e e p e r  lying a r e a s  cons is t ing  of 
arterioles, venules  and capillaries in terspersed be tween an irregular 
a r rangem ent  of fibrous t issue.  Small numbers  of mononuclear  cells
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and  p lasm a cells,  located perivascularly, indicated the pers is tence 
of a  low grade,  chronic inflammatory response .  Central cavitation of 
the ti ssue pillars lying within cham ber  apper tures  w as  evident.
Cytological, bacteriological and chemical analysis of chamber fluid 
and blood  - Microbiological cultures of all ch am ber  fluid samples  
were  negative, thus  indicating that the production and  composition 
of cham ber  fluid w as  not influenced by the p re se n ce  of infectious 
agents .
C h am b er  fluid red cell- and  white cell-counts were  at  all t imes 
lower than  corresponding blood cell counts .  White cell counts  in 
c h a m b e r  fluid (Fig. 23)  d e c r e a s e d  linear ly with t ime af te r  
implantation until the m ean  value at 60 days  (286 ±- 196 cells/pl) 
w as  approximately 3% of the corresponding blood value (9967 ±. 
2301 cells/jo. I).
The d e c r e a s e  in ch am ber  white cell counts  w as  accompanied  by a
quadrat ic  d e c r e a s e  in the ratio of polymorphonuclear  cells to total
leucocytes  (Fig. 24). At 60 days, 79% of ch am ber  fluid leucocytes 
w ere  m o nonuc lea r  cells,  thus  indicating tha t  cellular  dynamics
within cham ber  fluid and  cham ber  tissue were similar.
C h am b er  fluid red cell coun ts  d e c r e a s e d  quadratically  with time
after implantation (Fig. 25), reaching a  mean value of 3033 ± 2019 
cells /j i l ,  40 d a y s  af ter implantation. Thereaf ter,  va lues  remained 
fairly s table .
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Cham ber  fluid total protein concentration (6.15 ±- 0.21 g/dl) was , at 
10 days ,  lower than the  corresponding blood concentrat ion (7.45 ±. 
0.35 g/dl), and d ec re a se d  quadratically with time until, a t  60 days, 
the value was  48% of the blood value (Fig. 26). Part of this decrease  
w as  due  to a  change  in the concentration of albumin, which was 
consis tently lower than blood concentrat ions , and d e c r e a s e d  in a 
linear fashion throughout the sampling period (Fig. 27).
N a + and Ch concentrat ions in cham ber  fluid increased linearly with 
t ime af ter  implantat ion and ,  a t  60- days ,  w e re  h igher  than  
corresponding plasma levels (Figs. 28 & 29). K+ concentrat ions  did 
not c h an g e  during the period of sampling but were  consistent ly 
higher than p lasma concentrations (Fig. 30).
Chamber  fluid pH was  consistently lower than blood pH, and did not 
change  with time after implantation (Fig. 31). Blood PCO2  on days 10
(44.0 ±- 3.0) and 60 (35.9 ±- 1.3) were  significantly lower than 
chamber  fluid PCO2  on days  10 (62.4 ± 4.2) and 60 (52.6 ± 3.0).
Measurem ent of transudate rate of inflow - Chambers  had not had 
enough  time to completely fill with fluid during ei ther  of the two 
m e a s u re m e n t  per iods.  The rate  of t ra n su d a te  inflow af ter  t issue  
cham ber  drainage was  0.25 ml/hour during the 24 hour interval. The 
rate  of inflow during the 96 hour interval w as  0.09 ml/hour. This 
indicated a  d e c r e a s e  in the  rate  of t ransuda te  inflow with time 
after comple te  fluid drainage.
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Fig. 12 - Extent of t issue ingrowth into a  chamber  removed 10 days
af ter  implantation.
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Fig. 13 - Extent of t issue ingrowth into a cham ber  removed 20 days
after  implantation.
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Fia. 14 - Extent of t issue ingrowth into a  chamber  removed 30 days
af ter implantation.
78
Fig. 15 - Extent of t issue ingrowth into a  chamber  removed 40 days
af ter implantation.
Fia. 16 - Extent of t issue ingrowth into a  chamber  removed 50 days
af ter implantation.
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Fia. 17 - Extent of t issue ingrowth into a  chamber  removed 60 days
af ter implantation.
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Fia. 18 - Diagrammatic cross-sect ion through tissue  chambers  
removed 10 (A), 20 (B), and 30 (C) days  after implantation, showing
the depth of t issue ingrowth.
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Fia. 19 - Diagrammatic cross-sect ion through t issue chambers  
removed 40 (D), 50 (E), and 60 (F) days  after implantation, showing
the depth of t issue  ingrowth.
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Fig. 20 - Photomicrograph (x 275) of t issue within a  t issue chamber 
removed 10 days  after implantation, showing prote inaceous material 
(P), fibrin capsule  (F), and accumulations of erythrocytes (R).
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Fig. 21 - Photomicrograph (x 175) of t issue within a  t issue chamber  
removed 30 days  after implantation, showing blood vesse ls  (B), 
mononuclear accumulations (M), and fibrous capsule  (C).
Fig. 22 - Photomicrograph (x 175) of t issue within a  t issue chamber  
removed 60 days  after implantation, showing d en se  fibrous capsule 
(Co), irregular arrangement  of deeper  lying collagen (Ci), and well-
developed vasculature (V).
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Fig. 23 - Mean white cell counts in blood and chamber fluid.
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Fia. 25 - Mean red cell counts in blood and chamber fluid.
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Fig. 30 - Mean K+ concentrations in p lasma and chamber  fluid.
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PHASE III - Pharmacokinetic studies
O b j e c t i v e s :
1. To kinetically character ize  the cham ber  by evaluating the rate 
a n d  e x t e n t  of p e n e t r a t i o n  of s e v e ra l  e n d o g e n o u s  and  
pharmacologica l  a g e n t s  tha t  have  different  permeabil ity  and  
protein binding character is t ics .
2. To de termine  w hether  the dynamic communicat ion between 
blood and chamber  fluid c h an g es  with time after implantation.
3. To compare  the tissue  chamber  a s  a  model for evaluating drug 
p e n e t r a t io n  with o th e r  exis t ing m odels ;  viz. th e  u s e  of 
pharmacokinetic simulation and the skin window model.
Materials  a n d  M ethods:
A nim als  - The six Holstein s teers  used  in this p h a se  were  held on 
pas tu re  for the  duration of the experiment.  Their weights  ranged 
from 261 kg to 447 kg.
Implantation of tissue chambers - One tissue cham ber  of the "final" 
d e s ig n  w a s  c o a t e d  with non reac t ive  a d h e s iv e  and  implanted 
subcutaneously in the paralumber fossa  of each  steer.  The assembly, 
sterilization and  surgical implantation of the t i ssue  ch am b ers  was  
identical to that of P h a se  I.
Pharm acokinetic  studies - Thirty days  after implantation of the 
cham b ers ,  antipyrine w a s  adminis tered  intravenously a s  a  bolus
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d o s e  (20 mg/kg) to each  of the s tee rs .  Blood w as  sampled  at 0 
(before injection), 0.033, 0.083, 0.166, 0.333, 0.5, 0.75, 1, 2, 3, 4, 6 , 
8 , 12, 16, and 24 hours  after administration. C ham ber  fluid was  
sampled at 0 (before injection), 0.25, 0.75, 1.5, 2.5, 4, 6 , 8 , 12, 16, 
and 24 hours after administration. Serum and  cham ber  fluids were 
frozen at -20C until analysis.
Thirty five days  after ch am ber  implantation, p heny lbu tazone1- was 
administered intravenously a s  a  bolus dose  ( 6  mg/kg) to all s teers .  
Blood w as  col lected at 0 (before injection), 0.033, 0.083, 0.166, 
0.333, 0.75, 1, 1.5, 2.5, 4, 8 , 12, 16, 24, 48, 72, 96, and 120 hours 
af ter  administ rat ion.  C h a m b e r  fluid w as  s am p led  a t  0 (before 
injection), 0.5, 1.5, 3, 6 , 12, 24, 48, 72, 96, and 120 hours after 
administration. Serum and cham ber  fluids were frozen at  -20C until 
ana lys is .
Forty five days  after implantation, a  seco n d  kinetic study using 
antipyrine w as  conducted.  Drug dose ,  administration and  sampling 
w ere  identical to m ethods  employed 30 days  after implantation, 
except  that  additional sam ples  were  collected using a  skin window 
model.  A skin window ch am ber  w as  constructed by attaching the 
sawn-off end of a  10 ml syringe barrel to a  3 ml syringe via a  3-way 
stop cock (Fig. 32). A #10 scalpel blade was  then used to remove the 
epidermis  from a  small a r e a  (1.5 cm diameter)  of skin on the 
longissimus dorsi a r e a  of each  steer.  Every at tempt was  made to 
avoid any overt bleeding. The cham ber  w as  applied to the abraded 
area ,  s ea le d  with petroleum jelly, and  filled with sterile saline. A
r Butazolidin® Injectable 20%, Burroughs Wellcome Co., Kansas City, MO
97
Fig. 32 - Apparatus used to create  a  saline-filled compartment over 
a  "skin window" formed by epidermal abrasion.
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negat ive p ressu re  within the cham ber  was  c rea ted  by withdrawing 
0.5 ml saline using the  3 ml syringe. This s e rved  to hold the
c h a m b e r s  in situ for a  period of 45 minutes,  at  which time the
saline was  aspirated and frozen at -20C until analysis.  Skin window 
samples  were collected at 0 (before drug administration), 0.75, 2.5, 
6 , 16, and 24 hours after drug administration.
Fifty days  after ch am ber  implantation, ano ther  kinetic study using
pheny lbu tazone  w a s  conduc ted .  Drug administration, d o se ,  and 
sampling were identical to those  used 35 days  after administration, 
except  that  drug distribution into skin window cham b ers  w as  also 
evaluated .  The m ethods  used  to evaluate  skin window distribution 
were identical to those  employed 45 days  after implantation, except  
that  s am ples  were collected at 0 (before injection), 1.5, 3, 6 , 12, 
24, 48, 72, 96, and 120 hours after drug administration.
Fifty five days  after implantation, c h am b ers  were  drained of all 
fluid and  then  refilled with sterile saline.  This saline w a s  then 
sampled at 0 (immediately after cham ber  refill), 0.5, 1, 2, 3, 5, 8 , 
12, 18, 24, 48, 72, 96, 144, and  192 hours after cham ber  refill. 
Blood was  sampled before the chambers  were drained and at 24 hour 
intervals thereafter .  S am ples  were immediately submitted for urea  
nitrogen, creatinine, and  albumin quantitation.
Sample analyses  - Antipyrine concentra t ions  in serum,  cham ber  
fluid, and  skin window fluid were quanti tated using a  modification 
of a  method reported by Prescott  et ai. (1973). Briefly, 40 pi of 5N
99
NaOH and 2 ml ethyl ace ta te  (containing 2.5 | ig/ml p h en a c e t in s as  
the internal standard) were added in s eq u en ce  to 0.25 ml of sample 
and  vortexed for 30 seconds .  The combination was  centrifuged at 
600 X g for 15 minutes.  Two and  a  half milliliter aliquots of 
superna tan t  were transferred to clean tes t  tubes  and evaporated to 
dryness .  The precipitate w as  redissolved in 250 pi ethyl aceta te .  
Standards  (0.1, 0.5, 1, 5, 10, 20, 30, and 50 pg/ml) were prepared by 
dissolving appropriate  am ounts  of antipyrine in 0.25 ml of blank 
sample .  T h e se  s ta n d a rd s  were  sub jec ted  to the s a m e  analytical 
p r o c e d u re  a s  the  t e s t  s e ra .  Antipyrine c o n c e n t r a t io n s  were  
quantitated by injecting 3 pi aliquots of extracted sample into a  gas  
ch ro m a to g ra p h *  fitted with an automatic s a m p le r s  A 15 m, 0.53 mm 
ID, capil lary co lu m n v with a  4 p m  film of methyl 50% phenyl 
sil icone provided a d e q u a t e  s ep a ra t io n  of p eak s .  The column,  
injection port, and ni trogen-phosphorus detector  tem pera tu res  were 
200, 150, and  300C, respectively. Flow rate for helium carrier gas  
w as  1 2  ml/minute.
Phenylbu tazone  concentra t ions  in serum, ch a m b e r  fluid, and skin 
w in d o w  w e r e  q u a n t i t a t e d  by h i g h - p e r f o r m a n c e  liquid 
chromatography. Three  hundred microliters of 1N HCI, 5 pi internal 
s tandard  (1000 pg/ml meclofenamic acidw in ethyl acetate),  and 3 
ml ethyl ace ta te  were added  in s e q u e n ce  to 0.3 ml of sample. The
combination was  vortexed for 30 seconds,  centrifuged at 600 X g for
s Sigma Chemical Co., St Louis, MO
* Model 5880A, Hewlett-Packard Co, Palo Alto, CA 
u Model 7671 A, Hewlett-Packard Co, Palo Alto, CA 
v Quadrex Corporation, New Haven, CT 
w Sigma Chemical Co., St Louis, MO
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15 minutes and the organic supernatant  was  pipetted into a  clean 
t e s t  tube .  After evapora t ion  to d ry n e ss ,  the  p rec ip i ta te  w as  
redissolved in 250 pi mobile p h a s e  (70% acetonitrile,  20% 0.05N 
H3 P O 4 , and 10% double-distilled H2 O). Standard solutions (0.1, 0.5, 1 ,
5, 10, 20, 30, 50, 100, 150, 200 pg/ml) were p repared  by dissolving 
appropriate amounts  of phenylbutazone in blank sample. S tandards  
w ere  su b je c te d  to the  s a m e  analytical p rocedure  a s  the  tes t  
samples .  Twenty five microliters of extracted sample  were injected 
into a  high-performance liquid chrom atographx fitted with a  variable 
w ave leng th  de tec to ry  se t  at  240 nm. A 30 cm X 4 mm ID reverse 
p h a s e  (C-18) column 2 with 10 pm  packing was  used.  Mobile phase  
flow rate w as  0.5 ml/minute.
The protein binding pe rcen tage  of phenylbutazone was  determined, 
using 3-hour serum and  cham ber  fluid sam ples  collected after the 
s e c o n d  administrat ion of phenylbu tazone .  O ne  milliliter of each  
sample  was  pipetted into a  microconcentrator3 3  and centrifuged at 
1 ,800 X g for 30 minutes;  the  ultrafiltrate w as  a n a ly se d  for 
phenylbutazone.  Phenylbu tazone  concentra t ions  in the ultrafiltrates 
were com pared  with corresponding sample  concentrat ions,  and the 
percentage  of protein binding was  calculated.
Albumin, c rea t in in e  a n d  u r e a  n i t rogen  c o n c e n t r a t i o n s  were  
quanti ta ted using commercially p repared  bromcresol green,  alkaline
x Model 1090, Hewlett-Packard Co, Palo Alto, CA 
y Spectromonitor III, Lab Data Control, Riviera Beach, FL 
z Varian MCH-10, Sunnyvale, CA
33 Centricon 30, Amicon Division, W.R. Grace and Co., Danvers', MA.
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picra te  colorimetric,  an d  u r e a s e  and  g lu tam a te  d e h y d r o g e n a s e  
m e t h o d s bb respectively.
Pharm acok inetic  ana lys is  - Coefficients and  exponen ts  of the 
disposition curves  that bes t  described the change  in serum, chamber 
fluid, a n d  skin window fluid an t ipyrine  an d  p h e n y lb u ta z o n e  
concentrat ions  with time were obtained, using a  computer  program 
(Brown & Manno, 1978) for i terative nonl inear  l e a s t - s q u a re s  
r e g r e s s i o n  a n a ly s i s .  The  th eo re t i c a l  c u rv e  d e s c r ib in g  the  
concentra t ion  of antipyrine or p heny lbu tazone  in the  peripheral 
c o m p a r tm e n t  a s  a  function of t ime w a s  g e n e r a t e d  using the 
individual m ic ro c o n s tan ts  a s s o c i a t e d  with the  tw o-com par tm en t  
open  model (Baggot, 1977). Areas under  the serum, cham ber  fluid, 
and  skin window curves were  calculated using the trapezoidal rule 
(Edwards & Penney,  1982). The extent  of distribution of antipyrine 
and  phenylbutazone into cham ber  fluid and skin window fluid was 
d esc r ib ed  using the  ratios of the  a r e a s  under  peripheral focus 
(chamber  fluid, skin window or theoretical peripheral compartment) 
and serum curves. The time taken to achieve peak concentrations  in 
cham ber  fluid, skin window fluid, and theoretical compartment were 
calculated using differential calculus (Edwards & Penney, 1982).
The p e rce n tag e  of prote in-bound phenylbu tazone  w as  calculated,  
using the equation:
%bound = 100% - (ultrafiltrate concentration/serum concentration) X 100%
bb Centrifichem®, Baker Instruments Corp., Allentown, PA
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Statistical analysis - The effect of time after cham ber  implantation 
on drug penetrat ion w as  determined by using Wilcoxon's sign rank 
tes t  to com pare  serum and  c h am b er  fluid pharmacokinet ic values  
d e r iv e d  from th e  f irs t  a d m in i s t r a t i o n  of a n t ip y r in e  or 
phenylbutazone with th o se  derived from the seco n d  administration 
of each drug (Steel & Torrie, 1980). Wilcoxon's sign rank tests  were 
also used  to com pare  the extent  of penetration of antipyrine and 
phenylbutazone into ch am b er  fluid after the first administration of 
e a c h  drug .  P h a rm a co k in e t ic  v a lu e s  descr ib ing  antipyrine and  
phenylbutazone disposition in cham ber  fluid, skin window fluid and 
the  theoret ical  periphera l com par tm en t  were  first normalized by 
rank transformation and then analyzed by the general  linear model, 
using s tee rs  a s  blocks (Conover & Iman, 1981). Scheffe's tes t  was 
then used to compare  each  disposition model with each  of the other 
models (Steel & Torrie, 1980). Dunnett 's  test  was  used  to compare 
the mean concentrations of endogenous  creatinine or urea nitrogen in 
saline-filled c h a m b e r s  with the corresponding m ean  concentrat ion 
in serum (measured  before cham bers  were drained).  A comparison 
between mean albumin concentrat ions in saline-filled cham bers  and 
corresponding serum concentrat ions was  conducted,  using paired t 
tests .  Differences be tween m eans  were considered significant at  P 
< 0.05.
R e s u l t s :
Serum  disposi t ion cu rv es  for antipyrine (Figs. 33 & 34) and 
p h en y lb u tazo n e  (Figs. 35 & 36) indicated d e c r e a s e s  in drug
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concentra t ions  which were  b es t  descr ibed  by a  two-compartment 
o p e n  model .  C h a n g e s  in c h a m b e r  fluid a n d  skin window 
concentra t ions  of both antipyrine and  pheny lbu tazone  were  well 
e x p l a i n e d  us ing  t h e  o n e - c o m p a r t m e n t  o p e n  m odel .  The 
pharmacokinet ic pa ram ete rs  derived from analysis  of serum, tissue 
c h am b er ,  skin window an d  theoret ica l  per ipheral  co m par tm en t  
curves are presented in Tables 4, 5, 6 , and 7.
Table 4 - Mean (± SD) pharmacokinetic values derived from each 
animal's (n = 6 ) antipyrine concentration vs time profiles in serum.
Days after tissue chamber implantation
Determinant 30 45
alpha (hours-1) 5.6747 ±  3.0975 10.0735 ±  5.7136
beta (hours-1) 0.2939 ±  0.0711 0.2719 ±  0.0101
A (pg/ml) 45.72 ±  18.89 90.04 ±  42.89
B (fig/ml) 28.62 ±  10.38 33.49 ±  5.21
C ° s (pg/ml) 74.34 ±  18.65 123.53 ±  41.05
l 1/2(&) (h o u rs )* 0 .1020  (0 .0816-0 .4626) 0 .0868  (0 .0328-0 .1420)
*1/2(6) (h o u rs )* 2 .2205 (1 .9644-4 .2417)i 2 .5595  (2 .4196-2.6810)
Vc (ml/kg)* 289 (193-354) 181 . (97-204)
v d(area) (m l/kg) * 589  (522-1297) 586 (425-615)
v d(ss) (ml/kg)* 557  (492-773) 546 (398-565)
CIb (ml/hourkg)* 181 (159-217) 161 (113-172)
* = Values represent median (range).
Table 5 - Mean pharmacokinetic values (± SD) derived from each animal's (n = 6 ) antipyrine 
concentration vs time curves in tissue chamber fluid (CF), skin window fluid (SW), and the theoretical
peripheral compartment (TC).
Determinant
30 days after tissue 
chamber implantation
CF
45 days after tissue 
chamber implantation
CF SW TC
delta (hours*1) 
beta (hours*1) 
/2 (b) (hours)*
AUC/AUCS*
C(max) (M-9/ml) 
T(max) (hours)
0.5445 ±  0.3785
0.1063 ±  0.0338
6.290
(4 .5 6 8 -1 2 .9 7 3 )
0 .8756
(0 .5 9 1 1 -1 .0 6 3 0 )
6.88 ±  1.64
4.323 ±  1.409
0.4327 ±  0.0738
0.1392 ±  0.0581
5.464
( 2 .8 6 3 -9 .5 0 1 )
0 .7760
(0 .6 1 4 3 -0 .8 2 5 6 )
7.16 ±  1.86
4.029 ±  0.636
1.4653 ±  0.5960
0.1847 ±  0.0873
4.533
( 2 .1 8 1 -6 .3 9 2 )
0 .5163
( 0 .3 8 8 1 -0 .7 5 2 9 )
8.66 ±  2.69
1.850 ±  0.705
10.0906 ±  5.7182
0.2719 ±  0.0101
2.559
( 2 .4 1 9 -2 .6 8 1 )
2 .2730
(1 .1 5 5 2 -5 .4 7 6 1 )
71.52 ±  39.87
0.418 ±  0.137
* = Values represent median (range)
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Fia. 33 - Disposition (concentration vs time) curves for antipyrine in serum (S) 
and tissue chamber fluid (CF), 30 days after implantation. Antipyrine was 
administered as  an IV bolus dosage (20 mg/kg).
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Fia. 34 - Disposition (concentration vs time) curves for antipyrine in serum (S), 
t issue chamber  fluid (CF), skin window fluid (SW), and the theoretical 
peripheral compartment (TC), 45 days after implantation. Antipyrine was 
administered as  an IV bolus dosage (20 mg/kg).
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Thirty days  after t i s sue  c h am b er  implantation, the median serum 
elimination half-life ( t i /2 (B )) of antipyrine w as  2.22 hours. Median
apparent  volume of distribution, based  on total a rea  under  the serum 
disposition curve (V<j(area)), was  high (589 ml/kg). This compared
well with the median ratio of a r e a s  under  the ch am b er  fluid and 
serum  curves  ( A U C j / A U C S), which indicated extensive  penetration
into t i s su e  c h a m b e r s  (0.876).  After reaching a  m ean  maximium 
co n c en t ra t io n  ( C ( m a x )) of 6 . 8 8  ±- 1.64 pg/ml at 4.32 ±- 1.41 hours
af ter administrat ion, ch a m b e r  fluid levels d e c r e a s e d  fairly slowly 
(median t-j/2 (b) = 6 -2 2  hours). Peak  cham ber  fluid concentrat ions , 
v d(area)> *1/2(15). A U C j / A U C s , and  time taken to reach peak chamber  
fluid levels (T(max)) did not change  between 30 and 45 days  after 
im plan ta t ion .
A comparison between the antipyrine concentration vs time profiles 
in ch a m b e r  fluid, skin window fluid, and the theoretical peripheral 
c o m p a r tm e n t  revea led  c lea r  d i f fe rences  in the  s h a p e s  of the 
d ispos i t ion  c u rv e s .  Theore t ica l  per iphera l  c o m p a r tm e n t  levels  
in c reased  more  rapidly and  r each ed  higher levels than did the 
concentra t ions  in skin window fluid and t issue  ch am ber  fluid. The 
rate of penetration into skin window fluid w as  higher than the rate 
of penetrat ion into t i s sue  ch am b er  fluid. Elimination ( t i /2 (b)) from
the theoretical peripheral compartment  (median = 2.56 hours) was 
fas te r  than elimination from t issue  cham ber  fluid (median = 5.46 
hours).  Although, on examination of the  m ean  disposition curves, 
concen tra t ions  in skin window fluid a p p e a re d  to reach  a  higher 
maximum and then d e c r e a s e  more rapidly than ti ssue cham ber  fluid
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concentrations, the conservative Scheffe's test failed to show any 
differences in t i /2 (b )» ar|d C (max) betw een these two m odels. 
However, mean T (max) was longer in chamber fluid (median = 4.029 ±-
0.636 hours) than in skin window fluid (1.850 ± 0.705 hours) which, 
in turn, w as longer than the T (max) in the theoretical peripheral
compartment (0.418 ± 0.137 hours).
Antipyrine penetra t ion va lues  ( A U C j / A U C s ), determined using the 
th eo re t ica l  pe r iphera l  co m p a r tm e n t ,  skin window, an d  t i s su e  
c h a m b e r  models,  were  all significantly different.  The theoretical 
per ipheral  co m par tm en t  value  w as  the  h ighes t  while the  skin 
window model value w as  the lowest.
In contras t  to antipyrine, the t i / 2 (b> of phenylbutazone ,  35 days  
after implantation, was  long (median = 39.36 hours) and the VCj(area) 
w as  low (median = 73 ml/kg). The low Vd(area) was  in ag reem ent  
with a  similarly low A U C j / A U C s in chamber  fluid; observations that 
could be explained, in part, by the high percentage  of protein-bound 
pheny lbu tazone  in se rum  (Table 8 ). Pharmacokinet ic  pa ram ete rs  
describing phenylbutazone disposition in se rum  and  cham ber  fluid 
( t l / 2 (G)> Vd(area)> d B , delta, t-j/2 (b)« C(max)> T(max)> ar,d A U C j / A U C s ) 
did not change  between 35 and 50 days after implantation.
The phenylbutazone concentration vs time profiles in cham ber  fluid, 
skin window fluid, and the theoretical peripheral compartment,  50 
d a y s  af te r  implantation, followed pa t te rns  tha t  w ere  similar to 
t h o se  followed by antipyrine, excep t  tha t  concen tra t ions  in skin 
window fluid were lower than those  in cham ber  fluid. The relative
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distribution into skin window fluid and  c h a m b er  fluid corre lated 
well with th e  c o n c e n t r a t i o n s  of a lbumin within t h e s e  two 
com par tm en ts .  Mean C ( m a x ), A U C j / A U C s , and  rate of penetration
(delta) in skin window fluid, t i s s u e  c h a m b e r  fluid an d  the  
theoretical peripheral com par tm ent  were  all significantly different.
Table 6  - Mean (± SD) pharmacokinetic values derived from each 
animal's (n = 6 ) phenylbutazone concentration vs time profiles in
serum.
Days after tissue chamber implantation
Determinant 35 50
alpha (hours '1) 4.0224 ±  7.7389 11.1450 ±  22.1077
beta (hours '1) 0.0168 ±  0.0026 0.0133 ±  0.0028
A (pg/ml) 47.72 ±. 33.29 75.20 ±  64.46
B (|ig/ml) 82.80 ±  14.71 73.69 ±. 14.75
C ° s (ng/ml) 130.51 ±- 36.67 148.90 ±. 69.28
tl/2(fi) (h o u rs )* 0 .7489 (0 .0350-1 .7326) 0 .2633  (0 .0124-6 .6998)
*1/2(13) (h o u rs )* 39 .3614  (35 .8543-53 .3891) 54 .8806  (40 .9943-67 .3081)
Vc (ml/kg)* 46 (34-77) 50 (22-63)
v d(area) (ml/kg)* 73 (59-91) 81 (60-104)
v d(ss) (ml/kg)* 73 (59-91) 80 (60-104)
Clg (ml/hourkg)* 1.25 (0.87-1.65) 0 .96 (0.82-1.54)
* = Values represent median (range).
Table 7 - Mean pharmacokinetic values (± SD) derived from each animal's (n = 6 ) phenylbutazone 
concentration vs time curves in tissue chamber  fluid (CF), skin window fluid (SW), and the theoretical
peripheral compartment (TC).
Determinant
35 days after tissue 
chamber implantation
CF
50 days after tissue 
chamber implantation
CF SW TC
delta (hours-1) 
beta (hours'1) 
*1/2(5) (hours)4
AUCj/AUCs*
c (max) ( F 9 /m l) 
T(max) (hours)
0.0511 ±  0.0111
0.0055 ±  0.0033
160.149  
(5 7 .5 4 4 -2 2 1 .7 4 1 )
0.3071
(0 .2 5 2 8 -0 .5 2 2 5 )
14.24 ±  5.43
52.196 ±  11.785
0.0669 ±  0.0612 
0.0065 ±  0.0022 
113 .047
0.3608 ±  0.3898 
0.0140 ±  0.0073 
40 .628
(6 7 .7 9 4 -1 7 2 .8 5 6 )  (3 2 .4 7 8 -2 0 3 .2 0 8 )
0 .2912
(0 .0 9 5 5 -0 .4 6 4 3 )
12.42 ±  8.35
50.386 ±  19.370
0.0806
(0 .0 5 8 9 -0 .1 1 1 6 )
5.22 ±  1.88
13.540 ±  5.868
11.1502 ±. 22.1100
0.0133 ±  0.0029
54 .852  
(4 1 .0 1 6 -6 8 .2 7 4 )
0 .6208
(0 .2 1 0 4 -2 .1 2 4 0 )
71.70 ±  66.47
5.982 ±  9.220
* = Values represent median (range)
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Fia. 35 - Disposition (concentration vs time) curves for phenylbutazone in serum 
(S) and tissue chamber fluid (CF), 35 days after implantation. Phenylbutazone 
was administered as  an IV bolus dosage  ( 6  mg/kg)
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Fia. 36 - Disposition (concentration vs time) curves for phenylbutazone in serum 
(S), t issue chamber fluid (CF), skin window fluid (SW), and the theoretical 
peripheral compartment (TC), 50 days after implantation. Phenylbutazone was 
administered as  an IV bolus dosage  ( 6  mg/kg). 21
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Theoretical peripheral compartment values  were higher than  tissue 
chamber  values which were, in turn, higher than skin window values. 
Mean T(max) 'n skin window fluid (13.54 ±. 5.87 hours) and  the
theoretical peripheral com par tment  (5.98 ±- 9.22 hours) were both 
shorter  than in ch am ber  fluid (50.39 ±- 19.37 hours).  Despite  the 
wide range in median peripheral compartment  elimination half-lives 
(t i / 2 (B))» ^ e  d a ta  w ere  too variable to result  in any significant
differences being declared.
Table 8  - Concentrations of albumin and the percentage protein- 
bound phenylbutazone in samples  collected 3 hours after drug
adm in is t ra t ion .
Serum Chamber fluid Skin window fluid
Albumin concentration (g/dl) 3.02 ±  0.26 1.50 ±  0.34 0.30 ±- 0.25
% Protein binding 99.17 ±  0.59¥ 80.68 ±  10.95#
Data represent the mean (± SD) for n=6 animals except for ¥ where n=3 and # where 
n=5.
* Analysis not done
The ratio of the a reas  under the tissue chamber and serum curves for 
antipyrine (median = 0.876, at  30 days) w as  significantly greater  
than that  for phenylbu tazone  (0.307, a t  35 days),  indicating the 
superior penetration of antipyrine into t issue chambers .
Diffusion of u rea  and creatinine  into saline-filled t i ssue  cham bers  
(Figs. 37 & 38) occurred rapidly with s teady-s ta te  being achieved 
approximately 8  hours after t issue  ch am ber  refill. From this point
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on, mean cham ber  fluid levels were no different than mean serum 
levels.  Transport  of albumin into saline-filled ch am b ers  (Fig. 39) 
w as  extremely slow and  concentrations  were still increasing 8  days  
after ch a m b e r  refill. At this s tage ,  m ean  ch a m b e r  fluid albumin 
concentra t ions  were  less  than 50% of corresponding mean serum 
c oncen t ra t ions .
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* Mean creatinine concentrations in chamber fluid that were not significantly different 
from the mean serum concentration measured immediately before chamber refill.
Fia. 37 - Diffusion of en dogenous  -creatinine into saline-filled tissue
chambers .
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* Mean urea nitrogen concentrations in chamber fluid that were not significantly 
different from the mean serum concentration measured immediately before chamber 
refill.
Fig. 38 - Diffusion of endogenous  urea  nitrogen into saline-filled
t issue  chambers .
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Fig. 39 - Transport of endogenous  albumin into saline-filled tissue
chambers.
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PHASE IV - Antimicrobial efficacy studies
O b j e c t i v e s :
a) To de te rm ine  whether  the p r e se n c e  of a  P a s te u re lla  
h a e m o l y t i c a  in fec t ion  a f f e c t s  t h e  d i s t r ibu t ion  of 
s u l f a d ia z in e / t r im e th o p r im  into s u b c u ta n e o u s l y  im plan ted  
t issue chambers .
b) To examine the in vivo response of Pasteurella haemolytica 
to sys tem ic  administration of sulfadiazine/trimethoprim.
c) To study the effect of a  previous bovine viral diarrhea virus 
infection on the r e s p o n s e  of P a s te u re lla  haem oly tica  to 
su lfad iaz ine / t r imethopr im  therapy.
Materials  and  m e th o d s :
Experimental animals and preinoculation tests - Twenty mixed breed 
calves, ranging in weight from 166 kg to 387 kg, were used. Animals 
w ere  sub jec ted  to serological screening  prior to initiation of the 
experiment and those  shown to have been exposed  to P asteurella  
hemolytica sero type 1 (Ph-1) or bovine viral diarrhea  virus (BVDV) 
were  excluded from the  study. The ca lves  were  maintained on 
pas tu re  prior to and for 30 days  after implantation of the tissue 
chambers .  Thereafter, the calves were kept in isolation pens  and fed 
a  complete  dry ration.
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Implantation of tissue chambers - One sterile t issue chamber  of the 
"final" design was  coa ted  with a  nonreactive adhesive  and implanted 
subcu ta n eo u s ly  in the  para lum bar  fo s s a  of each  animal.  Tissue 
c h a m b e r  assem bly ,  steril ization, an d  surgical implantation were 
identical to methods described in Phase  I.
Study design  - After implantation of t i ssue  cham bers ,  the  calves  
were divided into 4 groups a s  outlined in Table 9.
Table 9 - Animal treatment groups.
Number
Group of animals Inoculation Treatment
A 5 Ph-1
B 5 Ph-1 Sulfadiazine/trim ethoprim
C 5 Ph-1 + BVDV
D 5 Ph-1 + BVDV Sulfadiazine/trim ethoprim
Thirty d a y s  af te r  implanta t ion,  pharm aco k in e t ic  s tu d ie s  w ere  
c o n d u c te d  using b o lu s  d o s e s  of su l fad iaz in e / t r im e th o p r im 00. 
Su l fad iaz ine  / t r imethoprim w a s  adm in is te red  in travenously  (I 
ml/16 kg) to the calves in group B and blood samples  were collected 
at 0 (before administration),  0.0333,  0.0833,  0.1667,  0.333, 0.5, 
0.75, 1, 2, 3, 4, 6 , 8 , 12, 16, and 24 hours after administration. 
Cham ber  fluid was  collected at 0 (before administration), 0.25, 0.75,
00 Tribrissen® 48 %, Burroughs Wellcome Co., Kansas City, MO
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1.5, 2.5, 4, 6 , 8 , 12, 16, and 24 hours after administration. Serum 
and cham ber  fluid samples  were frozen at -70 C until analysis.
Thirty five d a y s  af ter  implantation, pre-infection blood sam ples  
were collected from calves in groups C and D and then all calves in 
t h e se  groups  were inoculated with a  New York-1 strain of bovine 
viral d iarrhea  virus. An inoculation d o se  of 1 X 1 0 5  TCID5 0  (as
determined by indirect fluorescent antibody technique) in 1 0  ml was 
administered intratracheally. At 3 and 6  days after viral inoculation, 
blood samples  were collected, and lung lavage (Corstvet et al., 1982) 
w as  performed on all calves  in these  groups.
Forty days  after implantation, blood and chamber  fluid samples  were 
collected from all calves  and then all chambers  (groups A through D) 
were inoculated with a  six-hour culture of a  field isolate of Ph-1. A 
two ml inoculum containing 1x106  colony forming units (CFU)/ml 
was  injected into each chamber . Thereafter, cham ber  fluid and blood 
sam ples  were collected every 24 hours for 9 days.
Starting 36 hours after Ph-1 inoculation, s u l f a d i a z in e / t r im e th o p r im  
was  administered intravenously (1 ml/16 kg), once a  day for a  period 
of 5 days, to calves in groups B and D. A pharmacokinetic study was 
conducted  using drug disposition da ta  derived from the analysis of 
se rum  and  cham ber  fluid sam ples  collected after the first dose  of 
sulfadiazine/trimethoprim. Sampling periods were  identical to those  
used  30 days  after implantation. Serum and cham ber  fluid samples  
were  also collected immediately before all su b se q u en t  antimicrobial 
administrations and  24 hours after the last administration.
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M icrobiological assay  - The sterility of the surgical technique was 
monitored five days  after implantation, by culturing an aspirate  of 
chamber  fluid on 5% bovine blood agar  fortified with 1% horse serum 
and 1 % filtered yeas t  hydrolysate.
S t a n d a rd  te c h n iq u e s  an d  m ed ia  w ere  u sed  to d e te rm ine  the
concentrat ion of bacter ia  in t issue  ch am ber  fluid after inoculation 
(Corstvet  et al., 1978).  Briefly, cham ber  fluid w as  diluted ten-fold 
and 6  replicates of 0 . 0 1  ml from each dilution were cultured, using a  
spo t  plate technique.  After 24 hours of incubation, the number of 
colonies/spot were averaged  and the number of colony forming units 
(CFU)/mJ w as  calculated. Systemic spread  of Ph-1 was  monitored at 
each  cham ber  sampling interval by culturing 0.4 ml of venous  blood
in thioglycolate broth containing 1 % horse serum.
BVDV infection w as  confirmed by virus propagat ion and isolation
(Corstvet & Panciera,  1982; Newman et al., 1982) from peripheral 
blood leucocytes ("buffy coat") and cells collected by lung lavage, 3 
and  6  days  after viral inoculation.
Preparation o f inocula  - A P as teu re lla  h aem oly tica  biotype A 
sero type  1 , originally isolated from the t ra ch ea  of a  feedlot calf, 
w as  used  (Corstvet et al., 1973). Inoculum cultures were grown on 
supp lem ented  brain-heart  infusion agar  for 6  hours at 37C in an 
a tm osphere  of 5-7% C O 2  (Newman et al., 1982). The bacteria were
sc raped  from the ag a r  and su sp en d ed  in phosphate-buffered  saline 
solution (0.01 M, pH 7.4) at  an approximate  concentrat ion of 109
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CFU/ml, a s  de te rm ined  photometrically.  Serial  10-fold dilutions 
resulted in an inoculum concentration of 1 x 1 0 6.
A New York-1 strain of BVDV was  propagated on a  BVDV-free Madin- 
Darby kidney cell line using BVDV-free and BVDV antibody-free fetal 
calf serum. Inocula were prepared by diluting the virus suspension to 
1 x 1 0 5 TCID 5 o/ml in 0.01M phosphate  buffered saline (pH = 7.27). A
1 0  ml inoculum w as  injected intratracheally into each  calf in groups 
C and D.
Immunological, cytological, and chem ical analysis of blood and  
cham ber fluid - The immunological response  to Ph-1 antigens (Ph-1 
whole cell) was  evaluated by indirect enzyme-linked immunosorbent 
a s s a y  (ELISA), using a  modification of the technique described by 
Voller et al. (1979). Briefly, Ph-1 whole cell antigen (propagated 
from a  24-hour  agar  plate culture and s tandardized to contain 109 
CFU/ml) w as  diluted (1:400) into ca rb o n a te /b ica rb o n a te  coating 
b u f f e r  (pH 9.6). Antigen w as  coupled  to microtiter p la te sdd by 
pipetting 1 0 0  pi of antigen solution into each  microtiter well and 
then allowing the plates to dry overnight in a  dry-heat  incubator at 
37C. O ne  hundred microliters of serum or ch am b er  fluid samples  
(diluted 1:800 in 0.01 M phospa te  buffered saline containing Tween 
2 0 e e ) were  pipetted into antigen coa ted  wells and the microtiter 
p la tes  were  then  incubated  in a  humid c h am b er  for 90 minutes.  
Thereaf ter,  plates  were  w ashed  three times with a  solution of 1M 
NaCI containing 0.05 % Tween 20. O ne  hundred  microliters of
dd Immulon® Flat Bottom Plates, Dynatech Lab., Alexandria, VA 
ee Sigma Chemical Co. St Louis, MO
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p e ro x id a se  label led affinity purified g o a t  anti -bovine lgG(H+L)ff 
(diluted 1:500 in p h o s p h a te  buffered sa l ine  co n ju g a te  buffer 
containing 5% goat  serum) were added  to each  well and the plates 
were incubated for 90 minutes in a  humid chamber . Plates were then 
w ash ed  a s  before, using the wash  solution. After ensuring that all 
residual wash  solution had completely drained from the plates, 1 0 0  
|il of subs t ra te / ind ica to r  solution99 w as  ad d ed  to each  well and 
plates  were agitated on a  plate shakerhh until color development (8 - 
10 minutes).  P la tes  were  read  spectrophotometrical ly on a  plate 
r e a d e r ' '  by com par ing  te s t  s a m p le s  to positive controls  from 
inoculated and  recovered  animals.  End-resul ts  were  recorded  a s  
a b so rb a n c e  va lues  x 102 . An absorbance  value greater  than 3 was 
considered indicative of exposure  to Ph-1.
The serological r e sp o n se  to BVDV w as  evaluated  by an indirect 
f luorescent  antibody technique (Corstvet & Downing, 1983).
Differential coun ts  w ere  de te rm ined  using s m e a r s  s ta ined  with 
modified Wright 's stain.  Total leucocyte and  erythrocyte counts,  
e lec t ro ly te s  (Na+, K+, CI-), total proteins,  albumin, and  pH were 
determined using methods described in Phase  II.
Leucocyte viability staining  - Aspirates  of t i ssue  ch am ber  fluid 
w ere  s ta ined  with 1 % trypan blue and  live v e r su s  d e a d  cell
Kirkegaard & Perry Lab., Gaithersburg, MD 
99 ABTS, Kirkegaard & Perry Lab., Gaithersburg, MD 
hh Dynatec Micro-Shaker II, Dynatech Lab, Alexandria, VA 
■' Dynatech Microplate Reader MR 600, Dynatech Lab, Alexandria, VA
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percen tage  w as  determined. Live cells retain the ability to exclude 
trypan blue.
In vivo phagocytic activity of polymorphonuclear leucocytes - This 
w as  a s sa y e d  using acridine orange (AO), a  fluorochrome vital dye 
(Smith & Rommel, 1977). In vivo phagocytosis  w as  a s s e s s e d  using 
wet  mounts  of ch a m b e r  fluid and  AO solution. Viable organisms 
f luoresced green  while nonviable organisms fluoresced red in AO- 
s ta ined  preparat ions .
D eterm ination  o f M IC  and M B C  - The  minimum inhibitory 
concentration (MIC) and minimum bacteriocidal concentration (MBC) 
of su lfad iaz ine / t r im ethopr im  (1/10) for Ph-1 w e re  d e te rm in e d  
using s tandardized techniques  (Lorian, 1986).
Quantitation o f inflam m atory response  - The local inflammatory 
reac t ions  a s  well a s  any  sys tem ic  clinical s igns  resulting from 
inoculation of Ph-1 into t i ssue  cham bers  were quantified using an 
objective and  specific health index (Table 10). Health evaluat ions 
were  recorded  by a  single observer  at 24 hour intervals, starting 
immediatly before Ph-1 inoculation. Daily rectal tem pera tu res  were 
also recorded.
H is to p ath o lo g ica l studies  - Nine days  after Ph-1 inoculation, a 
single tissue  cham ber  was  removed from a  calf in each  of groups A 
and  B. Chamber  tissue w as  fixed in formalin, sectioned, stained with 
hematoxylin and  eos in  an d  eva lu a ted  histologically using light 
microscopy.
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Table 10 - Health index for Ph-1 infection model
Clinical sign Score
Pain sensitivity:
No reaction (flank twitch, head turning, kicking) to moderate digital 
palpation around and over tissue chamber.
Reaction (as above) to moderate digital palpation, but no reaction to 
light digital palpation.
Reaction (as above) to light digital palpation.
Fluid accumulation:
No evidence of fluctuant swelling around or over tissue chamber. 
Mild fluctuant swelling over chamber membrane only; tissue 
cham ber outline clearly discernible.
Moderate swellng around and over tissue chamber; chamber 
outline not discernible.
Severe distension of skin over and around tissue chamber.
Skin rupture.
Peripheral f irmness:
No firmness around periphery of chamber. 
Nonfluctuant peripheral swelling extending less than 
2 cm from tissue chamber edge.
Nonfluctuant peripheral swelling extending more than 
2 cm from tissue chamber edge.
Sample analyses - Sulfadiazine and trimethoprim concentrations in 
serum and cham ber  fluid were determined using a  modification of a 
method reported by Weber  et al. (1983). Two hundred microliters of 
1M KH2 P O 4  and 3 ml ethyl aceta te  (containing 1.25 ug/ml antipyrine
a s  the internal standard) were added  in s eq u en ce  to 0.3 ml sample. 
The combination was  vortexed for 1 minute and then centrifuged at 
600 x g for 15 minutes.  The organic supernatant  was  transferred to
0
1
2
0
1
2
3
4
0
1
2
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a  clean tes t  tube and evaporated to dryness  under N2. The precipitate
w as  redissolved in 250 pi mobile p h a s e  which consis ted  of 25% 
methanol and 75% phospha te  buffer (3% 0.067M Na 2 NPC>4 : 97%
0.067M KH2 P 0 4). Standard solutions of trimethoprim (0.05, 0.1, 0.5,
1, 2.5, 5, 10 pg/ml) and sulfadiazine (0.5, 1, 5, 10, 25, 50, 100, 200 
pg/ml) w ere  p rep a red  by dissolving appropria te  am oun ts  of the 
ant imicrobials in blank sample .  S tandards  were  sub jec ted  to the 
s a m e  analyt ical  p ro c e d u re  a s  the  t e s t  s a m p le s .  Twenty five 
microli ters  of e x t r a c ted  s a m p le s  w ere  in jected into a  high- 
p e r f o r m a n c e  liquid  c h r o m a t o g r a p h x fitted with a  variable 
w av e len g th  de tec tory  se t  at  225 nm. A 30 cm 3.9 mm ID reverse 
p h a s e  (C-18) columniJ w as  used.  Mobile p hase  flow rate was  0.75 
m l /m inu te .
The d eg ree  of protein binding of sulfadiazine and trimethoprim was 
s tudied ,  using th e  1 2 -hour blood and  c h a m b e r  fluid s a m p le s  
collected from ca lves in group B before and after Ph-1 inoculation. 
An ultrafiltration technique,  identical to the one  descr ibed  under 
P h ase  III, was  employed.
P h arm aco k in e tic  an a lyses  - Coefficients and exponen ts  of the 
disposition curves that bes t  described the change  in sulfadiazine and 
tr imethoprim co n cen t ra t io n s  in se rum  and  c h a m b e r  fluid after 
administration were g enera ted  by iterative least s q u a re s  regression 
analysis,  using a  computer  program (Brown & Manno, 1978). Areas
x Model 1090, Hewlett-Packard Co., Palo Alto, CA 
y Spectromonitor III, Lab Data Control, Riviera Beach, FL 
jj Phenomonex, Bondex® 10 C18, Rancho Palos Verdes, CA
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under the serum and chamber  fluid curves were calculated using the 
t rapezo ida l  rule (E dw ards  & P e n n e y ,  1982). The  ex ten t  of 
antimicrobial distribution into ch am ber  fluid w as  determined using 
the ratio of the a re a s  under the chamber  fluid and serum curves. The 
time taken to achieve peak  concentra tions  in ch am ber  fluid were 
calculated using differential calculus (Edwards & Penney,  1982).
The pe rcen tage  of protein-bound sulfadiazine and trimethoprim was 
calculated in the s am e  manner  that the percentage  of protein-bound 
phenylbutazone was  calculated in P h ase  III.
S ta tis tic a l ana lys is  - Pharm acok ine t ic  v a lu e s  descr ib ing  the 
disposi tion of su lfadiazine/ tr imethoprim  in se ru m  and  c h am b e r  
fluids collected from group B, before and after inoculation, were 
com pared  using Wilcoxon's sign rank tes t  for paired observat ions 
(Steel  & Torrie,  1980). The Mann-Whitney t e s t  for unpaired  
obse rva t ions  w a s  u s e d  to co m p a re  pharmacokinet ic  p a ram e te r s  
calculated from the disposition curves  of ca lves  in groups D and B 
(after Ph-1 inoculation) (Steel & Torrie, 1980). The method of 
orthogonal polynomials served  to character ize  the time course  for 
accumulat ion  of antimicrobials  within t i s su e  c h a m b e r s  (Steel & 
Torrie,  1980).  Antimicrobial c o n cen t ra t io n s  within c h a m b e r s  in 
groups  B and D were compared using unpaired t tests.  The effect of 
virus inoculation on blood cell pa ram e te rs  w as  de termined using 
Dunnett 's  tes t  (Steel & Torrie, 1980). All other values  were analyzed 
by dividing the  exper iment into 3 time periods and  analyzing data  
from each  of th e se  periods separately.  Unpaired t tests  were used 
to ana lyze  d a ta  from sa m p les  collected during the  first period,
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which s ta r ted  immediately before bacterial inoculation and  ended  
immediately before the initiation of antimicrobial therapy. Analyses 
conducted  on th e se  d a ta  were directed at the identification of viral 
effects.  The second  period included the five days  of antimicrobial 
therapy. During this period, the effect of antimicrobial therapy and 
BVDV preinfect ion  a s  well a s  the  in terac t ion  b e tw e e n  the 
antimicrobials and BVDV, was  studied using a  combination of a  2 X 2 
factorial and  repeated  m ea su re s  des ign (Table 11) (Steel & Torrie, 
1980). A similar des ign  w as  used  to analyze  d a ta  from the last 
period which extended from the termination of therapy to the end of 
the experiment.
Table 11 - Analysis of variance for data  from periods 2 and 3.
Source of variation df
Virus 1
Antimicrobial 1
Virus X Antimicrobial 1
Error (a) 16
Time 4
Time X Virus 4
Time X Antimicrobial 4
Time X Virus X Antimicrobial 4
Error (b) 64
Total 99
The method of orthogonal con tras ts  w as  used  to identify trends  
within e a c h  of the  t r e a tm e n t  g roups .  Total leucocyte  counts ,  
erythrocyte counts,  and colony forming units were normalized by log
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t r a n s fo rm a t io n .  Differential  l e u co cy te  p e r c e n t a g e s ,  leucocy te  
viability percen tages ,  and  acridine orange  phagocytosis  percen tages  
were  normalized by arcs ine  transformation (Steel & Torrie, 1980). 
Differences between m eans  were considered significant at  P < 0.05.
R e s u l t s :
Serum and cham ber  fluid antimicrobial disposition curves  were well 
d e s c r ib ed  by the  tw o-com par tm en t  and  o n e -co m p ar tm e n t  open  
models,  respectively. Pharmacokinet ic  terms were calculated using 
the  appropria te  model-specific equa t ions  (Baggot,  1977) and  are  
p resen ted  in Tables  12 & 13. Antimicrobial concentrat ions  increased 
fairly slowly in c h a m b e r  fluids, reaching maximum concentra t ions  
approximately 3 to 6  hours  after administration (Figs. 40 & 41). 
T h e r e a f t e r ,  c o n c e n t r a t i o n s  d e c r e a s e d  m o re  s low ly  th a n  
corresponding serum  concentrat ions.  Despite the  long half-lives of 
elimination from c h a m b e r  fluid, antimicrobial accumulat ion at the 
s ite  of infection w a s  not o b s e rv e d  (Table 14). The  ratio of 
t r im e thopr im  c o n c e n t r a t i o n  to su l f a d ia z in e  c o n c e n t r a t i o n  in 
c h am b e r  fluid w as  approximately 1 to 10. During the  period of 
th e ra p y ,  c o n c e n t r a t i o n s  of su lfad iaz ine / t r im e thopr im  rem a in ed  
ab o v e  the  minimum inhibitory and  bacteriocidal concentra t ions  (1 
pg/ml for sulfadiazine and  0 .1 j ig/ml for trimethoprim) es tab l ished  
in vitro.
Comparisons  between pharmacokinetic param eters  calculated before 
a n d  af te r  Ph-1 inoculation in g roup  B, sh o w e d  tha t  infection 
affected the disposition of th e se  antimicrobials in both serum and
Table 12 - Pharmacokinetic values derived from each calf's (n = 5) trimethoprim serum and chamber  
f.luid disposition curves, before inoculation (Noninfected-Group B), after Ph-1 inoculation (Ph-Group B),
and after both Ph-1 and BVDV inoculation (Ph+BVD-Group D)
Determinant Noninfected-Group B Ph-Group B Ph+BVD-Group D
Serum
*1/2 (8 ) (hours) 5.100 (4.721-5.481) 5.942 (4.810-9.776) 7.034 (6.276-12.749)
Vd(area) (ml/kg) 3111 (2521-4385) 5948 (5423-9755) 5456 (4110-7333)
Clg (ml/hourkg) 454 (341-554) 692 (491-857) 561 (274-798)
Chamber fluid 
*1 /2 (b) (hours) 15.491 (4 .280-20.528) 9.081 (5.028-13.359) 7.894 (5.666-12.222)
AUC/AUCS 1.106 (0.546-1.478) 1.962 (1.515-2.400) 1.740 (0.998-2.009)
C(max) (M-O/ml) 0.73 (0.46-0.88) 0.89 (0.74-1.26) 1.09 (0.68-1.23)
T(max) (hours) 6.003 (3.774-8.518) 2.487 (1.720-4.424) 3.130 (2 .503-8.691)
^TMP^SDZtmaxl 0.127 (0.106-0.143) 0.139 (0.079-0.156) 0.107 (0.089-0.150)
CTMP/CSDZ[24] 0.096 (0.065-0.125) 0.086 (0.075-0.091) 0.096 (0.089-0.102)
Values represent medians (range).
Table 13 - Pharmacokinetic values derived from each calf’s  (n = 5) sulfadiazine serum and chamber 
fluid disposition curves, before inoculation (Noninfected-Group B), after Ph-1 inoculation (Ph-Group B),
and after both Ph-1 and BVDV inoculation (Ph+BVD-Group D)
Determinant Noninfected-Group B Ph-Group B Ph+BVD-Group D
Serum
t l / 2 (B) (hours) 3 .253  (2.782-4.705) 3.567  (2 .570-8.285) 4.227 (3.716-7.946)
^ d (area )  (ml/kg) 852 (777-962) 1323 (814-3313) 1215 (861-1500)
Clg (ml/hourkg) 189 (125-205) 237 (219-284) 171 (75-279)
Chamber fluid 
t t / 2 (b) (hours) 17.696 (7.005-31.132) 8.726 (4 .690-15 .068) 12.558 (7 .664-16 .955)
AUC/AUCS 0.657 (0.384-0.895) 1.260 (0.949-1.761 1.061 (0.730-1 .487)
C (m ax) (M /ml) 5 .67  (3.74-6.14) 8.62 (5.33-10.01) 9.24 (7 .26-13.27)
^(m ax) (hours) 5.53 (4.76-8.87) 3.34 (2.18-6.19) 2.39 (1.21-6.09)
Values represent medians (range).
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Fia. 40 - Disposition (concentration vs time) curves for trimethoprim in serum (S) and tissue chamber  
fluid (CF) before (N) and after (I) inoculation with Pasteurella haemolytica. Trimethoprim was
administered as  an IV bolus dosage  (5 mg/kg) to calves in group B. _
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Fig. 41 - Disposition (concentration vs time) curves for sulfadiazine in serum (S) and tissue chamber  
fluid (CF) before (N) and after (I) inoculation with Pasteurella haemolytica. Sulfadiazine was 
administered as  an IV bolus dosage (25 mg/kg) to calves in group B.
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c h a m b e r  fluid. P ene tra t ion  (as  d e te rm ined  by A U C j / A U C s ) of
sulfadiazine and  trimethoprim into t issue  cham bers  increased  after 
infection. This w as  reflected in the higher C(maX) and the shorter 
T(max) 'n infected cham bers .  A similar increase  in V,j(area) was  
observed.
Table 14 - Mean (±SD) sulfadiazine (SDZ) and  trimethoprim (TMP) 
concentra t ions  in t i ssue  ch a m b e r  fluid af ter bacterial inoculation 
alone (Group B), and after viral and bacterial inoculation (Group D). 
Values represent concentrations measured  at the end of each dosing 
in terva l .
Time after first 
administration (days)
TMP SDZ
Group B Group D Group B Group D
1 0.18 ±  0.07 0.26 ±  0.11 1.96 ±  0.69 2.35 ±  0.92
2 0.18 ±  0.05 0.26 ±  0 .11* 2.07 ±  0.77 4.24 ±  2.33*
3 0.19 ±  0.03 0.38 ±  0.10* 1.64 ±  0.72 4.41 ±  2.33*
4 0.24 ±  0.09 0.35 ±  0.08 2.63 ±  0.70 4.19 ±  1.24
5 0.16 ±  0.11 0.35 ±  0.12* 2.50 ±  1.52 3.95 ±1.33
* = Value significantly different from corresponding value in Group B
Comparisons  between pharmacokinet ic da ta  derived from groups B 
(Ph-1 inoculated) and D (Ph-1 and BVDV inoculated) after bacterial 
infection, failed to identify any  d ifferences  in sulfadiazine and 
trimethoprim disposition. However,  the  c h am b er  fluid concentration 
ratio of trimethoprim to sulfadiazine, 24 hours after administration 
of the first therapeut ic  d o se  (Ct m p /C s d z [24])> was  'n 9 rouP B
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than in group D. There  was  no difference between these  two groups 
in th e  c h a m b e r  fluid con cen t ra t io n  ratio of t rimethoprim to 
sulfadiazine at peak concentrations (CTMp/CsDz[max])-
P e r c e n t a g e s  of pro te in -bound  su lfad iaz ine  an d  trimethoprim in 
serum were 29.7 ±  8 . 8  % and 18.5 ±15.3 % respectively, indicating
th a t  both a g e n t s  w e re  slightly to m o dera te ly  pro te in -bound .
Attempts to determine the degree  of protein binding of sulfadiazine 
and trimethoprim in sterile and infected cham ber  fluid failed due  to 
problems exper ienced  with the ultrafiltration method.
BVDV inoculation of ca lves  in groups C and D c au sed  brief febrile 
reactions in all animals (Table 15).
Table 15 - Response  of calves in groups C and D to intratracheal
inoculation of bovine viral d iarrhea virus.
Virus isolation from Virus isolation from Febrile 
Calf #  blood leucocytes lung lavage cells response Seroconversion
Group C:
11 + + +  +
12 +  +  + +
13 +  + + +
14 + + + +
15 + +  + +
Group D:
16 +  +  +  +
17 +  +  +  +
18 -  +  +  +
19 +  +  +  +
20  +  +  +  +
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This, coupled with the  isolation of virus from either leucocytes  or 
lung lavage  cel ls,  co l lec ted  3  an d  6  d ay s  af te r  inoculation, 
dem ons t ra ted  that  inoculation resulted in systemic infection of all 
calves  in groups C and D. No systemic clinical signs, other than the 
febrile reactions, were  observed  for a  period of 1 0  days  after viral 
inocula t ion .  The  s u c c e s s  of inocula t ion w a s  conf i rm ed  by 
seroconversion of all ca lves  in these  two groups.
Inoculat ion  of t i s s u e  c h a m b e r s  with Ph-1 r e su l ted  in the  
e s tab l ishm ent  of a  localized soft- tissue infection that  pers is ted  in 
non trea ted  g roups  for the duration of the  experiment .  S am ples  
asp ira ted  from t issue ch am b ers  soon after inoculation were serous  
but b e cam e  more fibrinous with time. Culture of daily blood samples  
failed to de tec t  systemic  sp read  of Ph-1 in any of the t reatment 
g roups.  Except  for mild febrile react ions  one  to two d a y s  after 
bacterial inoculation, no general ized  systemic  clinical s igns  were  
observed.  Examination of sensitivity scores  revealed that, except  for 
a  brief period of m odera te  localized increased  sensitivity shortly 
after Ph-1 inoculation, the  es tab l ishm ent  of soft - tissue infections 
was  achieved without excessive discomfort being experienced by the 
calves  (Tables 16 & 17).
Numbers of CFU/ml of chamber fluid in groups A and C did not change 
with time after Ph-1 inoculation (Fig. 42).  Bacterial num bers  in 
g roups  B and  D d e c r e a s e d  cons ide rab ly  during the  period of 
s u l f a d i a z i n e / t r i m e t h o p r i m  t h e r a p y .  M ean  CFU/m l in t h e  
a n t im ic ro b ia l - t r e a te d  g r o u p s  a p p e a r e d  to r ise  a g a in  a f te r  
termination of therapy, but these  ch an g e s  were not significant. The
Table 16 - Mean (± SD) inflammatory index scores recorded before (day 0) and after Ph-1 inoculation of
calves (n = 5) in groups A and B.
Days after 
inoculation
Sensitivity Fluid accumulation Peripheral firmness Total
Group A Group B Group A Group B Group A Group B Group A Group B
0 0.0 ±  0.0 0.0 ±  0.0 0.0 ±  0.0 0.0 ±  0.0 0.0 ±  0.0 0.0 ±  0.0 0.0 ±  0.0 0.0 ±. 0.0
1 0.8 ±  0.8 0.6 ±  0.5 1.0 ±  0.0 1.0 ±  0.0 1.4 ±  0.5 1.0 ±  0.0 3.2 ±  1.1 3.6 ±  0.5
2 0.0 ±  0.0 0.0 ±  0.0 1.2 ±  0.4 1.6 ±  0.5 2.2 ±  0.4 1.6 ±  0.5 3.4 ±  0.5 3.6 ±  0.5
3 0.0 ±  0.0 0.0 ±  0.0 1.2 ±  0.4 1.6 ±  0.5 1.8 ±  0.4 1.6 ±  0.5 3.0 ±  0.7 2.2 ±  1.1
4 0.0 ±  0.0 0.0 ±  0.0 1 .8 ±  0.4 1.4 ±  0.5 1.8 ±  0.4 1.4 ±  0.5 3.6 ±  0.9 2.0 ±. 1.0
5 0.0 ±  0.0 0.0 ±  0.0 2.0  ±  0.0 1.4 ±  0.5 1.6 ±  0.5 1.4 ±  0.5 3.6 ±  0.5 2.0  ±  1.0
6 0.0 ±  0.0 0.0 ±  0.0 2.0 ±. 0.7 1.0 ±  0.7 1.4 ±  0.9 1.0 ±  0.7 3.4 ±  1.5 1.6 ±  1.1
7 0.0 ±  0.0 0.0 ±  0.0 2.2 ±  0.4 0.8 ±  0.4 1.4 ± 0.5 0.8 ±  0.4 3.6 ±. 0.5 1.4 ±  0.9
8 0.0 ±  0.0 0.0 ±  0.0 2.4 ±  0.5 0.6 ±  0.5 1.0 ± 0.0 0.6 ±  0.5 3.4 ±  0.5 1.2 ±  1.1
9 0.0 ±. 0.0 0.0 ±  0.0 2.2 ±  0.4 0.6 ± 0.5 0.8 ±  0.4 0.6 ±  0.5 3.0 ±  0.7 1.2 ±  0.8
Table 17 - Mean (£ SD) inflammatory index scores recorded before (day 0) and after Ph-1 inoculation of
calves (n = 5) in groups C and D.
Days after 
inoculation
Sensitivity Fluid accumulation 
Group C Group D
Peripheral firmness Total
Group C Group D Group C Group D Group C Group D
0 0.0 £  0.0 0.0 ±  0.0 0.0 £  0.0 0.0 ±  0.0 0.0  ±  0.0 0.0  £  0.0 0.0 £  0.0 0.0 £  0.0
1 1.0 £  0.0 0.8 £  0.4 1.4 £  0.5 1.0 ±  0.0 2.0 ±  0.0 1.8 £  0.4 4.4 £  0.5 3.6 £  0.5
2 0.4 £  0.5 0.4 £  0.5 1.4 ±  0.5 1.6 £  0.5 2.0 £  0.0 1 .8 £  0.4 3.8 £  0.8 3.8 £  0.8
3 0.2 ±  0.4 0.0 £  0.0 1.8 ±  0.4 1.0 £  0.0 1.4 ±  0.5 0.8 £  0.4 3.4 £  1.1 1.8 £  0.4
4 0.0 £  0.0 0.0 ±  0.0 2.0 ±  0.7 1.0 £  0.0 1.0 £  0.0 0.4 £  0.5 3.0 £  0.7 1.4 £  0.5
5 0.0 £  0.0 0.0 £  0.0 2.6 ±  0.5 0.6 ±  0.5 1.0 £  0.0 0.0 £  0.0 3.6 £  0.5 0.6 £  0.5
6 0.0 £  0.0 0.0 £  0.0 3.0 £  0.0 0.4 ±  0.5 1.0 £  0.0 0.0 £  0.0 4.0 £  0.0 0.4 £  0.5
7 0.0 £  0.0 0.0 ±  0.0 3.0 £  0.0 0.2 ±  0.4 1.0 £  0.0 0.0 £  0.0 4.0 £  0.0 0.2 £  0.4
8 0.0 ±  0.0 0.0 ±  0.0 3.0 £  0.0 1.0 ± 0.0 1.0 £  0.0 0.0 £  0.0 4.0 £  0.0 1.0 £  0.0
9 0.0 £  0.0 0.0 £  0.0 3.0 £  0.0 1.0 i  0.7 1.0 £  0.0 0.0 £  0.0 4.0 £  0.0 1.0 £  0.7
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failure to detect a  significant increase in CFU/ml in groups B and D, 
during the period extending from day 6  to day 9, was  associa ted with 
wide variability of data: no growth w as  observed  in one  calf in
group D w h ereas  ano ther  calf in the s a m e  group had 1.5 x 107  
CFU/ml. The apparent  increase in CFU/ml in group B occurred before 
terminat ion of antimicrobial therapy.  Despi te  th e  p r e s e n c e  of 
antimicrobial concentrations  in cham ber  fluid that exceed ed  the MIC 
and MBC for Ph-1, the infections in all except one calf (in group D) 
were  not sterilized. Paired t and factorial ana lyses  failed to show 
any affect of viral infection on ch am b er  fluid bacterial numbers.  
Furthermore, BVDV infection did not affect the response  of Ph-1 to 
ant imicrobial the rapy  (i.e. the re  w a s  no virus x antimicrobial 
in te rac t ion) .
Inflammatory s c o r e s  ref lec ted  the  c h a n g e s  in c h a m b e r  fluid 
bacterial num bers  (Fig. 43). Mean total s co re s  inc reased  rapidly 
after Ph-1 inoculation and remained high in nontreated groups. Mean 
total scores  in groups B and D decreased  during therapy and the mean 
score  in group B remained low for the duration of the experiment. An 
increase  in mean score  in group D, starting 2 days  after the last 
d o s e  of antimicrobial combination, co r responded  to the  apparen t  
resurgence in mean CFU/ml.
Inoculation of BVDV in groups C and D appeared  to c au se  a  decrease  
in leucocyte, absolute neutrophil, and absolute  lymphocyte counts,  3 
and  6  d a y s  af te r  inoculation, but t h e s e  d e c r e a s e s  w ere  not 
significant (Table 18). By 10 days  af ter  viral inoculation, th e se  
white cell va lues  w ere  similar to preinoculat ion va lues .  Ph-1
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infection of t i ssue  ch am b ers  c a u s e d  a  rapid influx of neutrophils 
which replaced mononuclear  cells a s  the dominant  cell type by 24 
hours after inoculation (Fig. 44). The rise in neutrophil numbers  was 
accompanied  by a  slower increase  in total leucocytes/p. I of chamber 
fluid (Fig. 45). Leucocyte numbers  in virus-inoculated calves  were 
lower on day 1 and during the period of antimicrobial therapy than in 
ca lves  not inoculated with virus. This difference w a s  especially 
apparen t  in group D. Calves that received antimicrobial therapy had 
lower cham ber  fluid leucocyte numbers  after termination of therapy 
than  un trea ted  calves .  C ham ber  fluid erythrocyte num bers  in the 
antimicrobial t reatment  groups  increased after Ph-1 inoculation and 
were  significantly higher after termination of therapy than  those  in 
the nontreated groups (Fig. 46). Viral inoculation caused  the chamber  
fluid ery throcyte  num bers  to be higher before  and  during the 
t re a tm e n t  period than  corresponding  num bers  in non-inocula ted 
calves .
Table 18 - Mean (± SD) blood cell parameters  of calves in groups C 
and D before (day 0) and after intratracheal inoculation of BVDV.
Days after BVDV 
inoculation
Leucocyte 
num bers 
(1 0 3 /p l)
Erythrocyte 
numbers 
(1 0 6 /jx i)
Neutrophil
num bers
( 1 0 3 /p l)
Lymphocyte 
numbers 
(1 0 3 /|xl)
0 9.59 ±  1.68 8.86  ±  1.15 2.79 ±  0.85 5.98 ±  1.15
3 7.69 ±  1.31 8.60 ±  1.07 2.21 ±  0.76 4.88 ±  0.90
6 7.74 ±  1.94 9.08 ± 1 .1 3 2.16 ±  0.96 5.15 ± 1.71
10 9.76 ±  3.03 8.86  ±  1.39 2.53 ±  1.99 6.49 ±  0.99
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Rapid c h a n g e s  in the  chemical  composit ion of c h a m b e r  fluid 
followed Ph-1 inoculation. After increasing rapidly during the  first 
48 hours,  total protein concentrations continued to increase  slowly, 
until concen tra t ions  in non-treated  ch a m b e rs  w ere  approximately 
90% of co r respond ing  blood concen t ra t ions  (Fig. 47).  Albumin 
concentrat ions  in cham ber  fluid followed a  similar pattern (Fig. 48). 
Cham ber  fluid pH d e c re a se d  rapidly during the first 24 hours and 
then, excep t  for the  group C pH which continued to d e c re a se ,  
rem ained  s tab le  for the  durat ion of the  exper im en t  (Fig. 49).  
Antimicrobial the rapy  a n d  viral inoculation w ere  found to have 
significant effects on cham ber  fluid pH. The ch an g e s  in total protein 
and pH were  less  pronounced in antimicrobial-treated animals.  K+ 
c o n c e n t ra t io n s  in c h a m b e r  fluids i n c r e a se d  initially and  then 
remained fairly s table  for the duration of the experiment (Fig. 50). 
A nt im icrob ia l  t r e a t e d  c a l v e s  h a d  s ig n i f i can t ly  lower  K+ 
c o n c e n t r a t i o n s  th a n  n o n t r e a t e d  c a lv e s .  C h a n g e s  in N a + 
c o n ce n t ra t io n s  followed a  similar but inverse  pat tern ,  initially 
d e c re a s in g  to r each  s ta b le  c o n cen t ra t io n s  by 48  hours  af ter 
inoculation (Fig. 51).  Ca lves  inoculated with BVDV had lower 
concentrat ions  of Na+ than  other calves. Chloride concentrat ions in 
chamber  fluid were  variable and changes  in th e se  concentrations did 
not follow a  recognizable pattern (Fig. 52).
Leucocyte viability remained high in antimicrobial t rea ted  animals,  
but d e c r e a s e d  significantly in nontrea ted  animals  (Fig. 53). This 
d e c r e a s e  w as  particularly evident  6  days  af ter  Ph-1 inoculation. 
Viral-inoculated ca lv es  had lower leucocyte  viability during the
142
per iod  of ant imicrobia l  th e ra p y  than  o th e r  ca lves .  Bacterial  
phagocytos is  w as  more active in antimicrobial-treated calves  than 
nontreated calves  (Table 19). ELISA absorbance  values in both blood 
and  cham ber  fluid remained s table  for the first 5 days  after Ph-1 
inoculation but then s ta r ted  increasing (Figs. 54 & 55). Antibody 
r e sp o n s e s  and observation of bacterial phagocytosis  by leucocytes 
demonstra ted  the p re sen ce  of an active and functional host defense  
sys tem .
Table 19 - Mean (± SD) % phagocytosis of Ph-1 in chamber  fluids 
collected from calves (n = 5) in groups A, B, C, and D.
Days after 
implantation Group A Group B Group C Group D
1 2 ± 3 5 ±  2 11 ±  9 4 ± 5
2 13 ±  12 6 ±  3 9 ± 5 6 ±  7
3 17 ±  12 21 ± 44 6 ± 1 0 2 ±  2
4 36 ±  48 2 ± 3 14 ± 6 8 ± 4
5 30 ±  15 15 ±  19 22 ±  23 32 ±  25
6 32 ±  39 3 ± 5 36 ±  35 24 ±  38
7 12 ±  16 13 ±  21 10 ±  12 7 ±  8
8 24 ±  37 2 i 4 12 ±  11 8 ±  10
9 13 ± 5 7 i  15 12 ±  12 16 ±  22
The number  of leucocytes/ml of blood increased  immediately after 
Ph-1 inoculation and  then d ec rease d  until the end of the experiment 
(Tables  20, 21, 22, & 23). The ratio of polymorphonuclear  cells to
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l eucocy tes  followed a  similar pattern and  w as  higher  in viral- 
inoculated calves, from 2 to 6  days  after Ph-1 inoculation (Fig. 56). 
Although the number  of eryrthrocytes/ml of blood did not change  
during the  sampling period, numbers  were  consis tent ly higher in 
viral- inoculated animals .
P la sm a  K+ concentra t ions  increased  slowly after Ph-1 inoculation 
and  w ere  higher in viral-inoculated groups.  Although p lasm a Na+ 
c o n cen t ra t io n s  a lso  in c re a se d  in vira l-inoculated g roups ,  t h e s e  
groups had significantly lower Na+ concentrations than other groups, 
during the period of antimicrobial therapy. There  was  no change  in 
p lasma Na+ concentrations in groups A and B.
Histopathological evaluat ion of c h am b e r  t i s su e  rem oved  from a 
non trea ted  calf in group A, revealed the  p r e se n c e  of an acute  
fibrinopurulent inflammatory reaction (Fig. 57). A thick fibrinous 
m em b ra n e  containing num erous  neutrophils ,  m a c ro p h a g es ,  giant 
cells,  lymphocytes  and  erythrocytes  covered  the  su rface  of the 
tissue. Blood vesse ls  were  markedly distended and many capillaries 
lying nea r  the  t i s sue  su rface  had eroded.  S o m e  capillaries were 
s e p a ra t e d  from c h a m b e r  fluid by an endothelia l cell layer only. 
Necrosis  of cells,  particularly neutrophils w as  observed .  Severe  
infiltration of deeper-lying a r e a s  by neutrophils,  p lasm a cells, and 
lymphocytes  w as  evident.  Histopathological c h a n g e s  in cham ber  
t i s su e  rem oved  from an  ant imicrobia l- trea ted calf in group  B 
showed similar, but less  severe ,  inflammatory reactions (Fig. 58). A 
fibrinous membrane was  not observed, although this may have been 
lost during preparation of the t i ssue  section. D eeper  lying a re a s
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were charac ter ized  by per ivascular  infiltrates of p lasm a cells and 
lym phocytes .  Although e ros ion  of superf icial  t i s s u e  w a s  not 
observed,  this t issue  had lost much of the d e n s e  collagen which 
character ized surface  regions in noninfected cham bers  (described in 
Phase  II).
Table 20 - Mean (± SD) cellular and chemical parameters derived from the analysis of blood samples
collected from calves in group A (n = 5) before (day 0) and after Ph-1 inoculation.
Days after 
inoculation pH
Leucocyte
/p l
Erythrocytes
/p l
Total protein 
(g /d i)
Albumin
(g /d i)
Na+
(MEq/l)
K+
(MEq/l)
c i-
(M Eq/l)
0 7.42 ±  0.02 10920 ±. 3006 7.7E+06 ± 1.1E+06 7.0 ±  0.3 3.2 ±  0.1 139 ±  1 4.0 ±  0.2 103 ± 2
1 7.42 ±  0.02 14040 ±. 4709 7.3E+06 ±- 2.1E+06 7.0 ±  0.3 3.1 ±  0.2 137 i 2 4.0 ±. 0.1 100 ±  1
2 7.42 ±  0.02 12860 ±  3752 7.1E+06 ±- 1.6E+06 7.1 ±  0.3 3.0 ±  0.2 139 ± 3 3.9 ±  0.2 103 ±  1
3 7.41 ±  0.02 12200 ±. 3481 7.3E+06 ± 1.4E+06 7.4 ±  0.3 3.0 ±  0.1 138 ± 5 4.3 ±  0.5 102 ±  1
4 7.42 ±  0.02 10020 ±. 2820 7.4E+06 ± 1.8E+06 7.3 ±  0.4 3.0 ±  0.1 139 ± 3 3.9 ±  0.4 103 ± 2
5 7.40 ±  0.05 9360 ±- 2127 7.5E+06 ± 2.0E+06 7.3 ±  0.5 3.1 ±  0.1 138 2 4.3 ±  1.2 103 ± 3
6 7.42 ±  0.03 9240 ±  1955 7.1E+06 ± 1.7E+06 7.3 ±  0.4 3.1 ±  0.1 135 ± 4 4.1 ±  0.5 100 ±  2
7 7.40 ±  0.03 8880 ±. 1956 7.2E+06 ± 1.7E+06 7.2 ±  0.3 3.1 ±  0.1 137 ± 2 4.0 ±  0.3 101 ±  1
8 7.40 ±  0.03 9580 ±  2122 v 7.2E+06 ± 1.6E+06 7.1 ±  0.5 3.0 ±  0.1 138 ± 3 3.9 ±  0.1 101 ± 2
9 7.42 ±  0.03 10480 ±. 2628 7.3E+06 ± 1.5E+06 7.2 ±  0.5 3.1 ±  0.3 139 ± 2 4.3 ±  1.0 101 ± 2
Table 21 - Mean (± SD) cellular and chemical parameters derived from the analysis of blood samples
collected from calves in group B (n = 5) before (day 0) and after Ph-1 inoculation.
Days after 
inoculation pH
Leucocyte
/Hi
Erythrocytes
/p.l
Total protein 
(g /d i)
Albumin
(g /d i)
Na+
(MEq/l)
K+
(M Eq/l)
c i-
(MEq/l)
0 7.40 ±  0.06 11920 ±  4158 7.2 E+06 ±  5.0E+05 7.4 ±  0.6 3.2 ±- 0.2 138 ±  1 3.6 ±  0.3 102 i- 2
1 7.43 ±  0.02 17602 ±  4438 7.0E+06 ± 7.1E+05 7.2 ±  0.4 3.2 ±  0.1 138 ±  1 3.8 ±  0.2 103 ^  1
2 7.43 ±  0.01 15900 ±- 3424 6.7E+06 ± 9.1E+05 7.2 ±  0.4 3.1 ± 0.2 140 i 3 3.6 ±  0.1 101 i 1
3 7.39 ±  0.01 13580 ±- 3628 6.8E+06 ± 8.3E+05 7.7 ±  0.3 3.0 ± 0.1 140 ±  3 4.4 ±  0.5 104 i  1
4 7.42 ±  0.02 12640 ±- 3832 7.1 E+06 ± 6.9E+05 7.6 ±  0.3 3.2 ±  0.2 140 ± 3 4.0 ±  0.4 103 ±  2
5 7.41 ±  0.02 11740 ±- 3412 7.3E+06 ± 7.1E+05 7.6 ±  0.2 3.2 ±  0.3 141 ± 2 4.1 ±  0.5 102 ± 2
6 7.39 ±  0.02 11260 ±- 3576 7.1 E+06 ± 7.7E+05 7.6 ± 0.4 3.1 ±  0.2 138 ±  2 4.0 ±  0.2 101 ± 2
7 7.38 ±  0.02 11240 ±- 3783 7.3E+06 ± 9.0E+05 7.4 ±  0.3 3.2 ±  0.3 140 ±  1 4.0 ±  0.2 102 ±  1
8 7.38 ±. 0.01 11700 ±- 3590 7.0E+06 ± 9.4E+05 7.2 ±  0.4 3.1 ±  0.2 140 ± 2 4.0 ±- 0.1 103 ±-2
9 7.40 ±  0.03 11660 ±- 4914 7.0E+06 ±. 7.0E+05 7.2 ±  0.6 3.2 ± 0.2 138 ± 2 4.9 ±  0.7 103 ± 3
Table 22 - Mean (± SD) cellular and chemical parameters derived from the analysis of blood samples
collected from calves in group C (n = 5) before (day 0) and after Ph-1 inoculation.
Days after 
inoculation pH
Leucocyte
/p l
Erythrocytes
/Hi
Total protein 
(g /d i)
Albumin
(g /d i)
Na+
(MEq/l)
K+
(MEq/l)
c i-
(MEq/l)
0 7.41 ±  0.03 9840 ±  4056 7.9E+06 4.1E+05 6.9 A 0.3 3.0 A 0.3 136 A 0 4.1 A 0.4 101 A 2
1 7.40 ±  0.05 17060 A 5903 7.9E+06 ± 3.9E+05 6.9 A 0.2 3.1 A 0.3 137 a  3 4.1 A 0.4 103 A 2
2 7.42 ±  0.04 15060 ±  5416 7.7E+06 ± 2.8E+05 6.8 A 0.2 2.9 A 0.3 137 A 2 3.9 A 0.2 101 A 3
3 7.39 ±  0.03 12640 A 4152 7.7E+06 ± 4.0E+05 7.2 a  0.3 2.9 A 0.2 137 a  2 3.9 a 0.1 101 a  2
4 7.40 A 0.03 10860 A 3260 7.7E+06 ± 3.9E+05 7.2 A 0.2 2.9 A 0.2 136 A 2 4.0 A 0.3 101 A 2
5 7.39 ±  0.02 10080 ±- 2853 7.9E+06 ± 5.2E+05 7.3 A 0.2 2.9 A 0.2 137 a  2 4.8 a  0.3 101 A 1
6 7.39 ±  0.02 9860 ±- 2053 7.9E+06 ± 4.1E+05 7.2 A 0.2 3.0 A 0.2 136 A 2 4.7 A 0.4 100 A 3
7 7.39 A 0.02 9660 A 1865 7.9E+06 A 4.7E+05 7.2 A 0.3 3.0 A 0.3 138 A 2 4.2 A 0.4 102 A 2
8 7.38 ±  0.02 10080 A 2203 7.8E+06 A 3.2E+05 7.1 A 0.3 3.0 A 0.2 138 A 1 4.1 A 0.2 102 A 1
9 7.41 ±  0.04 10860 A 1519 7.7E+06 ± 3.1E+05 7.0 A 0.3 3.0 a  0.2 139 A 1 4.4 A 0.3 102 A 2
Table 23 - Mean (± SD) cellular and chemical parameters derived from the analysis of blood samples
collected from calves in group D (n = 5) before (day 0) and after Ph-1 inoculation.
Days after 
inoculation pH
Leucocyte
/Hi
Erythrocytes
/Hi
Total protein 
(9 /d l)
Albumin
(g /d i)
Na+
(M Eq/l)
K+
(M Eq/l)
ci-
(MEq/l)
0 7.45 ±  0.02 9680 ±  2043 9.8E+06 ± 1.4E+06 7.2 ±  0.6 2.8 ±  0.6 136 ±  1 3.9 ±  0.5 97 ± 4
1 7.45 ±  0.02 16400 ±  6233 8.9E+06 ± 1.1 E+06 6.9 ±  0.4 3.0 ±  0.3 136 ±  1 3.8 ±  0.4 99 ± 4
2 7.40 ±  0.02 15000 ±. 4736 8.9E+06 ± 7.9E+05 6.9 ±  0.5 2.9 ±  0.2 136 ± 0 3.7 ±  0.2 102 ± 4
3 7.37 ±  0.03 13480 ±- 3371 8.6E+06 ± 6.1E+05 7.1 ± 0.6 2.8 ±  0.3 136 ± 2 4.1 ±  0.1 103 ±  2
4 7.39 ±  0.03 11340 ±- 2405 8.7E+06 ± 6.2E+05 7.1 ±  0.6 2.9 ±  0.2 135 ± 2 3.8 ±  0.2 101 ± 4
5 7.38 ±  0.03 11080 ±  2242 9.0E+06 ± 7.1E+05 7.2 ± 0.6 2.9 ±  0.2 137 ±  2 5.1 ±  0.2 101 ± 5
6 7.38 ±  0.04 12500 ±  2604 8.7E+06 ± 6.2E+05 7.1 ±  0.5 2.9 ±  0.3 134 ±  2 4.4 ±  0.2 99 ± 4
7 7.38 ±  0.02 11040 ±- 2276 8.7E+06 ± 4.0E+05 7.2 ±  0.6 2.9 ±. 0.2 137 ±  2 4.0 i  0.2 101 ± 3
8 7.39 ±  0.02 12320 ±  1582 8.5E+06 ± 6.4E+05 7.1 ±  0.3 2.9 ±  0.3 139 ± 2 4.2 ±  0.1 103 ±  2
9 7.42 ±  0.01 13840 ±. 2194 00 Lj m + o O) H- 4.6E+05 7.1 ±  0.5 3.0 ±  0.3 139 ± 2 4.0 ±  0.2 102 ±  2
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Fig. 42 - Mean bacterial numbers in chamber  fluids collected from 
calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
(Ph+BVD+Rx).
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Fig. 43 - Mean total inflammatory index scores  of calves  (n = 5) in 
groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D (Ph+BVD+Rx).
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Fig. 44 - Mean differential leucocyte numbers in cham ber  fluids 
collected from calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD),
and D (Ph+BVD+Rx).
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Fig. 45 - Mean leucocyte numbers in chamber  fluids collected from 
calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
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Fig. 46 - Mean erythrocyte numbers in chamber  fluids collected from 
calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
(Ph+BVD+Rx).
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Fig. 47 - Mean total protein concentration in cham ber  fluids 
collected from calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD),
and D (Ph+BVD+Rx).
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Fig. 48 - Mean albumin concentrations in chamber  fluids collected 
from calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
(Ph+BVD+Rx).
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Fig. 50 - Mean K+ concentrations  in chamber  fluids collected from 
calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
(Ph+BVD+Rx).
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Fia. 51 - Mean Na+ concentrations in chamber  fluids collected from 
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Fig. 52 - Mean Ch concentrat ions  in cham ber  fluids collected from 
calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
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Fig. 53 - Mean leucocyte viability in cham ber  fluids collected from 
calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
(Ph+BVD+Rx).
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Fig. 54 - Mean ELISA values (absorbance x 102) for chamber  fluids 
collected from calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD),
and D (Ph+BVD+Rx).
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Fig. 55 - Mean ELISA values (absorbance x 102) for blood collected 
from calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
(Ph+BVD+Rx).
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calves (n = 5) in groups A (Ph), B (Ph+Rx), C (Ph+BVD), and D
(Ph+BVD+Rx).
164
Fig. 57 - Photomicrograph (x 175) of t issue within a  non-treated 
chamber  removed 9 days  after Ph-1 inoculation.
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- 58 - Photomicrograph (x 175) of t issue within an  antimicrobial- 
t reated cham ber  removed 9 days  after Ph-1 inoculation.
CHAPTER 5
DISCUSSION
1. P h ase  I - Developmental studies
S u b cu tan eo u s  implantation of "prototypal" t issue  cham bers  resulted 
in the  formation of peripheral fluid compar tments  which could be 
sampled  over an ex tended  period of time. Fluid composition within 
t h e s e  ch am b e rs  w as  com parab le  to fluid composition within other 
types  of t issue cham bers  (Bengtsson et al., 1984), and approached 
the  theoret ical  composi tion of interstitial fluid (Hal jamae et al.,
1974) a s  time after implantation progressed.  The e a s e  of sampling 
and  the ability to collect serial fluid volumes large enough for drug 
a s s a y ,  without  cau s in g  overt  bleeding into the c h am b er ,  are
important a d v a n t a g e s  a s s o c i a t e d  with this c h a m b e r  des ign .  In 
contrast  to other types of t issue  cham bers  (Bengtsson et al., 1984),
the  "prototypal" ch am b e r  w as  not obliterated by ingrowing tissue,
and  yielded large vo lum es  of fluid 8  w e ek s  after implantation. 
Furthermore, p e rcu taneous  aspiration coupled with strict adherence  
to sterile technique,  prevented microbial contamination of cham ber  
fluid during sampling.  T h e s e  charac te r is t ics  m ake this type of 
c h a m b e r  des ign  well su ited  for u se  in pharmacokinet ic  s tudies  
involving repeated  sampling of cham ber  fluid.
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A s e p t ic  im p lan ta t ion  of s u b c u t a n e o u s  t i s s u e  c h a m b e r s  is 
co m pl ica ted  by the  a c u t e  inflammatory e d e m a  result ing from 
surgical manipulation. Accumulation of an inflammatory exuda te  
around the chamber ,  immediately after implantation, s e rv e s  a s  an 
ideal medium for the  su p p o r t  an d  multiplication of bacter ial  
c o n ta m in a n t s .  This  p rob lem  is fu r ther  c o m p o u n d e d  by the  
preferabil i ty  of utilizing local a n a l g e s i a  ra ther  than  ge n e ra l  
a n e s th e s ia  in the bovine species.  Despite the use  of half-thickness 
su tu res  and  the ca re  taken to e n su re  asep t ic  implantation of all 
ch am b ers  in study #1, bacterial contamination occurred. Therefore, 
antimicrobial cover  during s u b s e q u e n t  su rge r ie s  w as  cons idered  
ju s t i f i a b le ,  a n d  p r o v e d  e f fec t ive  in c o m b a t t i n g  b a c te r ia l  
contamination of newly implanted chambers .
The rate and extent of penetration of pharmacological agen ts  into 
s u b c u ta n eo u s ly  implanted t issue  c h a m b e r s  is influenced by the 
composition and shape  of the chamber (Holm et al., 1978 ). Chamber  
composition can be expected to influence both the extent and nature 
(vascularity) of t issue  encapsulat ion occurring around the chamber  
af ter implantation. This, in turn, de te rm ines  the th ickness  of the 
barrier be tw een  the circulation and c h am b er  fluid, through which 
diffusing so lu tes  must  pass .  According to Fick's law, the rate of 
diffusion of solutes  is inversely proportional to the thickness  of the 
barrier they must  t raverse .  Therefore, pharmacological  agen ts  can 
be  expec ted  to diffuse very slowly into thickly encapsula ted ,  poorly 
vascularized  t issue  cham bers .  This type of cham ber  could not be 
u sed  to rep resen t  the interstitial fluid s p a c e  where  few diffusional
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barriers  exist . Although the  t i ssue  ch am b ers  in this study were 
constructed  using a  fairly nonreactive thermoplastic, coating with a 
s i l i c o n e -b a s e d  a d h e s i v e  re su l ted  in improved p en e t ra t io n  of 
ant ipyrine into a  "prototypal" t i s su e  c h am b e r .  The  improved 
penetration must have resulted from a  reduction in the d eg ree  of 
t issue encapsulation rather than the type of t i ssue response ,  since 
microscopic examination failed to reveal any differences in tissue 
histology between coated and uncoated chambers.
Tissue ch am b er  s h a p e  de te rm ines  the ratio of diffusible surface 
a rea  to chamber  fluid volume. The importance of this ratio has  been 
well d e m o n s t r a t e d  in vitro (Van Etta et al., 1982).  According to 
Fick's law of diffusion, a  high ratio results in a  g rea te r  rate of 
penetration of a  given agent.  In this study, changing the shape  of the 
cham ber  from the "prototypal" to "final" design served to increase  
the ratio of chamber  surface  a rea  to volume. This was  accomplished 
without changing the volume of the chamber . More perforations, of a 
larger  d iameter ,  could now be drilled through the b a s e  of the 
cham ber  cup, thus  increasing the ratio of diffusible surface a rea  to 
cham ber  volume. The inclusion of perforations in the walls of the 
cham ber  further en h an ced  the exposure  of cham ber  fluid to tissue
f
surface  area .  This resulted  in increased  penetrat ion of antipyrine 
which w a s  maxim ized  in th e  "final" d e s ig n .  The  improved 
performance of the chamber  was  achieved without loss of any of the 
beneficial character is tics  assoc ia ted  with the "prototypal" chamber,  
e.g. e a s e  of sampling and chamber fluid volume.
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2. P h a se  II - Histological, cvtoloaical. and chemical studies
If a  subcu taneous  cham ber  is to serve  a s  a  model to estimate the 
in ters ti t ia l  c o n c e n t r a t i o n  of an t im icrob ia l  a g e n t s ,  it is of 
fundamenta l  importance that  the composition of cham ber  fluid be 
rep resen ta t ive  of interstitial fluid. However,  a  direct comparison 
between th ese  two fluids is difficult since the exact  composition of 
interstitial fluid has  not yet been  accurately determined.  The many 
m odels  and  m ethods  u s e d  to ex tract  interstitial fluid from the 
intercellular s p ace  can all be expected  to influence the composition 
of the fluid sample .  Never the less ,  Hal jamae et al. (1974) have 
e s t im a ted  the  composit ion of true interstitial fluid by studying 
small quant i t ies  of t i s su e  fluid collected with a  "liquid-paraffin 
cavity" technique.  The composition of this fluid w as  character ized 
by po tass ium  and  sodium concen tra t ions  that were  higher than 
corresponding p lasma concentrations. On the other hand, protein and 
chloride concentrations were lower in t issue fluid.
Except for chloride levels,  which were  higher than corresponding 
serum levels, the  electrolyte composition of t i ssue cham ber  fluid in 
this s tudy  approx im a ted  th e  hypo thes ized  composit ion of true 
interstitial fluid desc r ibed  by Haljamae et al. (1974). The higher 
cation concentra t ions  in t i ssue  c h am b er  fluid, which a p p e a re d  to 
contradict the Donnan effect, can be explained by the p resence  of 
negatively ch a rg e d  nondiffusible macromolecules .  Although th e se  
were  not quant itated  in the p resen t  study, Haljamae et al. (1974) 
have d em o n s t ra ted  high concentra t ions  of g lycosaminoglycans  in 
t i s s u e  c h a m b e r  fluid. T h e s e  nondiffusib le  m o lecu le s  contain
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nega t ive ly -charged  carboxyla te  a n d  sulfate  g ro u p s  which could 
c a u s e  an imbalance  be tween  diffusible an ions  and cat ions. The 
p r e s e n c e  of g ly c o sa m in o g ly ca n s  an d  o th e r  g r o u n d - s u b s t a n c e  
molecules  in the  interstitium e n s u re s  that interstitial fluid is not 
simply an ultrafiltrate of plasma,  but a  dynamic fluid that reflects 
the specific milieu interieur of the tissue being studied. The higher 
chloride levels observed  in t issue cham ber  fluid in this study were 
probably c a u s e d  by an imbalance between the  concentra t ions  of 
nega t ive ly -charged  prote ins  an d  g r o u n d -s u b s ta n c e  m olecu les  in 
p lasm a and  the  interstitial space .  Higher chloride concentrat ions in 
chamber  fluid have also been reported by Bengtsson et al. (1984) and 
Calnan et al. (1972b). The effect of electrolyte imbalances between 
p lasm a and  cham ber  fluid on drug distribution is unknown and has  
yet to be  elucidated.
Despite the considerable effect pH gradients have on the diffusion of 
drugs  (which a re  usually either weak acids or weak  bases ) ,  few 
resea rchers  have a t tempted to study the acid-base  balance between 
blood and tissue chamber  fluid. Those that have addressed  the issue 
have reported conflicting results.  Gerding et al. (1976) recorded pH 
levels that were  higher than the value considered normal for blood, 
w h e re a s  Carbon et al. (1978) m easured  pH levels in cham ber  fluid 
that  ap p e a re d  to be  lower than corresponding p lasm a pH levels. 
Calnan et al. (1972b) failed to find any difference between pH in 
blood and  ch am ber  fluid in spite of a  lower P C 0 2  m e a s u re d  in
cham ber  fluid. The results of the present  study showed that the pH 
in this particular type of t i ssue  c h am b er  w as  consis tent ly lower
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than the corresponding blood pH. This observation can be explained 
by examining the PC0 2  in venous  blood and t issue  cham ber  fluid.
According to the Henderson-Hasselbalch equation: 
pH = pKA + log([HC03-]/0.03 Pco2)
pH is inversely proportional to PC02. The higher P c o 2 m easured  in
tissue chamber  fluid would result in a  pH that was  lower in chamber 
fluid than in blood. The low chamber  PC0 2  can be explained by the
long in te rcap i l la ry  d if fus iona l  d i s t a n c e s  ex is t ing  in t i s s u e  
chambers .  The pH gradient between blood and tissue  chamber  fluid 
can be expected to promote the chamber  fluid accumulation of drugs 
that a re  weak bases .  Indeed, at  equilibrium, a  basic drug with a  pKA
of 8  can  be expected to reach chamber  fluid concentrations that are 
approximate ly  1.5 t imes  higher than  th o se  of blood. However,  
c on t inuous  elimination from the  central  com par tm en t  results  in 
equilibrium seldom being reached.
Most other studies (Calnan et al., 1972b; Chisholm et a l . , 1976; Holm 
et al., 1978) are in agreement  with the low total protein and albumin 
levels recorded  in the  p re sen t  study. The d e g re e  of difference 
between blood and cham ber  fluid levels dep en d s  on the duration of 
implantation (Bengtsson et al., 1986; Bengtsson et al., 1984). The 
higher  concentra t ions  m e a s u re d  soon after implantation coincide 
with the inflammatory e d e m a  as soc ia ted  with surgical manipulation. 
Extravasation of proteins during this period gradually d e c r e a s e s  as  
circulatory regeneration is accompanied  by an increase  in capillary 
integrity. This, coupled with the removal of proteins,  results in a
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progress ive  d e c r e a s e  in c h am b er  fluid concentrat ions,  until levels 
a re  reached  that  a re  less  than 50% of corresponding p lasma levels. 
That  capillaries never  beco m e  completely impermeable  to proteins 
is dem ons t ra ted  by the low concentrat ions of protein m easu red  in 
peripheral lymph (Barza, 1981). The concentration of albumin within 
a  per ipheral  focus  may affect the  distribution of protein-bound 
drugs  into that focus. At equilibrium, drugs  that a re  highly protein- 
bound will reach lower concentra t ions  in com par tments  that have 
lower albumin concentrations. The change  in albumin concentrations 
with time af ter implantation brings into ques t ion the validity of 
comparing t i ssue  ch am ber  penetration da ta  derived from chambers  
implanted for differing per iods of time.
The composit ion and number  of cellular const i tuents  in cham ber  
fluid are  determined by capillary integrity and  the nature of the 
inflammatory r e sp o n s e  occurring within the t i s sue  chamber .  The 
rapid d e c r e a s e  in red blood cells shortly after implantation was  
indicative of the  rapid healing that  had occurred.  Similar rapid 
d e c r e a s e s  in red cell counts  were reported by Tight et al. (1975). 
T he  low red cell co u n ts  tha t  p e r s i s ted  af te r  40 d a y s  p o s t ­
implantation probably originated from small hem orrhages  cau sed  by 
sam ple  aspiration. Sixty days  after implantation, red cell counts  in 
cham bers  used  in this study were considerably lower than counts  in 
spherical cham bers  implanted in rabbits (Tight et al., 1975).
The linear d e c r e a s e  in white cell counts  w as  a s so c ia ted  with a 
concomitant  transition from an acu te  inflammatory r e sp o n se  to a 
low-grade chronic inflammatory response .  During the  early acu te
173
inflammatory phase ,  polymorphonuclear cells predominated,  but a s  
the inflammatory p ro ce ss  subs ided  an d  b e c a m e  more chronic in 
nature ,  m ononuclear  ce l ls  em e rg e d  a s  the  dominant  cell type. 
Similar obse rva t ions  have  been  reported by r e s e a r c h e r s  using 
spherical  c h am b ers  in rabbits (Gerding et al., 1976; Tight et al.,
1975). The high an d  rapidly changing red and  white cell counts  
observed  in cham bers  soon after implantation in the p resen t  study 
indicate that the consti tuents  of th ese  cham bers  are  not yet stable 
and that they should not be used  for pharmacokinetic purposes  until 
at  least  30 days  after implantation.
Examination of t issue in and around ti ssue cham bers  confirmed the 
conclus ions  s u g g e s te d  by the leucocyte differential counts .  The 
acute  inflammatory e d e m a  seen  soon after implantation is typical of 
the type of reaction often encountered in well vascularized serous  
cavities (Smith et al., 1972). Precipitation of protein and deposition 
of fibrin during this p h a s e  results in a lmost complete  obliteration 
of the  c h a m b e r  cavity. As the  inflammatory reaction subs ides ,  
fibroblastic infiltration of the  p ro te inaceous  precipi ta te results  in 
progressive organization of cham ber  t issue and a  reduction in the 
proportion of the chamber  occupied by tissue. The changes  occurring 
during this latter p h a s e  a re  typical of a  chronic  proliferative 
in f lam m ato ry  r e a c t io n  (Smith  et al., 1972) .  Proliferative 
encapsulat ion of subcutaneously-si tuated foreign bodies  ap p e a r s  to 
be a  particularly well deve loped  re sp o n se  in the  bovine species .  
Piercy (1978) reported that  cham bers  recovered from ruminants,  10 
w e e k s  af te r  implantat ion,  had  th icker  c a p s u l e s  than  similar
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c h a m b e r s  r e c o v e r e d  from d o g s .  D e s p i te  th e  p r o g r e s s i v e  
consolidation of c h am b er  t issue, vascularization of this t issue  did 
not a p p e a r  to d e c re a se .  Indeed, even  in the most  consolidated  
regions, many capillaries were s e e n  e m b ed d ed  be tween layers of 
co l lagen .  This o bse rva t ion  s u g g e s t s  tha t  the  pene t ra t ion  of 
pharmacological  ag en ts  into t issue  cham b ers  used  in the present  
s tudy may not be  affected by increasing consolidation, s ince the 
increase in the thickness  of diffusional barriers is offset by a  well- 
deve loped  vascular  system.  Extensive vascularizat ion of chamber ,  
t issue has  also been  reported in other s tudies  conducted in cows 
(Bengtsson et al., 1986).
The progressive d e c rea se  in the proportion of the chamber  occupied 
by tissue ensured that the chambers  could be used over an extended 
period of time and that there w as  sufficient fluid to allow multiple 
sam pl ing  during p h a rm a c o k in e t i c  s tu d ie s .  This  f e a tu re  w as  
co n s id e re d  important  b e c a u s e  the  rate of fluid entry into the 
chamber  after drainage w as  slow.
3. P h a s e  III- Pharmacokinetic studies
The  goal  of this  p h a s e  w a s  to c h a r a c t e r i z e  th e  dynam ic
t
c o m m u n i c a t i o n  b e t w e e n  b lood  a n d  c h a m b e r  fluid. T he  
pharm acok ine t ic  re la t ionship  b e tw ee n  t h e s e  two co m p ar tm e n ts  
d e p e n d s  on the nature of the diffusional barrier existing between 
them. Transport of most pharmacological agen ts  ac ro ss  membrane 
barriers  occurs  by diffusion through lipid m em b ra n e s  or filtration 
through aqueous  channels  or pores.  In this study, specific exogenous
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and endogenous  agents  were chosen to investigate each  of these  two 
diffusional routes.
Both antipyrine and phenylbutazone traverse  biological barriers by 
diffusing through lipid m em branes ,  a  character is t ic  they  have  in 
common with most antimicrobial agen ts .  Although antipyrine and 
p h e n y l b u t a z o n e  a r e  bo th  c l a s s i f i e d  a s  n o n s te r o id a l  an t i ­
inflammatory ag e n ts  and  belong to the s a m e  chemical group (the 
p y r a z o l o n e s ) ,  t h e y  differ  widely  with r e s p e c t  to the i r  
pharm acokine t ic  disposi tion in cattle.  Antipyrine is metabolized 
fairly rapidly an d  c o n s e q u e n t ly  h a s  a  shor t  t i / 2 ( B) in cattle
(Delpechin et al., 1985). The rate of elimination of antipyrine has 
been  u se d  a s  a  marker  to study the activity of hepat ic mixed- 
function ox idases .  Antipyrine is well distributed both intracellularly 
and extracellularly and its volume of distribution is considered to be 
a  good estimate of the volume of total body water (Hix at al., 1959). 
This ex tens ive  distribution corre la tes  well with the  low d eg ree  of 
protein binding exhibited in serum (< 10%) (Clarke et al., 1985). In 
contrast to antipyrine, phenylbutazone is metabolized very slowly in 
cattle and  has  a  t-|/2 (B) lasting severa l  d ay s  (Eberhardson  et al.,
1979). Phenylbutazone is highly protein-bound in bovine p lasma and 
consequen t ly  has  a  low volume of distribution. In t h e s e  studies,  
antipyrine and phenylbutazone served a s  markers to represent  lipid- 
s o lu b le  a n t im ic ro b ia l s  with d iffer ing p ro te in  b ind ing  a n d  
dispos i t ional  cha rac te r is t ic s .
The t i s sue  c h am b er  and  skin window fluid disposition curves  for 
both antipyrine and phenylbutazone were  character ized by delayed
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p e a k s ,  a n d  e l im ina t ion  hal f - l ives  t h a t  w e r e  lo n g e r  than  
c o r r e s p o n d in g  s e ru m  elimination half-lives.  In th e  c a s e  of 
antipyrine, this resul ted  in se rum  concentra t ions  dropping below 
cham ber  fluid and skin window concentrations  during the latter part 
of th e  el imination p h a s e .  This  re la t ionsh ip  b e tw e e n  s e ru m  
concentrat ions  and concentrat ions in t issue  cham ber  fluid and skin 
window fluid can  be explained in te rm s  of a  two-compartment  
pharmacokinet ic  model,  where  diffusion into and out of a  "deep"
peripheral compartment  is slower than elimination from the central
compartment.  Factors governing the rate of diffusion into and out of 
the  per ipheral  c o m p ar tm e n t  include: (1 ) the ratio of diffusible 
surface a r e a  to compar tment  volume; and (2 ) the distance separating 
the two compartments .  The relatively small diffusible surface a rea  
to volume ratio of the  t i s sue  c h a m b e r  and  the  fibrous t issue  
encapsula t ion  observed  in P h a s e  II explain the slower  elimination 
from t i s s u e  c h a m b e r s  co m p a re d  with the  skin window model.
T h e o r e t i c a l  p e r i p h e r a l  c o m p a r t m e n t  l e v e l s  a p p r o x i m a t e d  
c o r r e s p o n d in g  s e ru m  c o n c e n t r a t i o n s  of both an t ipyr ine  and
phenylbutazone during the  elimination phase .  Concentrat ions  in the 
th e o re t ic a l  c o m p a r tm e n t  i n c r e a s e d  rapidly to a c h i e v e  p e a k  
concentra t ions  that  were  much higher than peak  concentrat ions  in 
c h a m b e r  fluid and  skin window fluid. T h e se  theoret ical  curves  
d esc r ib e  a  two-com partm ent  open  model in which the  rate  of 
t rans fe r  b e tw e e n  a  "shallow" per ipheral  co m p a r tm e n t  and  the 
central compartment  is similar to the  rate  of elimination from the 
central compartment.
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Histological s tud ies  indicate that the  "true" sof t- tissue interstitial 
compar tment  is character ized by a  large diffusible surface  a r e a  to 
volume ratio and  very small diffusion d is tances .  Therefore ,  the 
theoretical peripheral compar tment  model a p p e a r s  to be the most 
appropria te  method of es timating antimicrobial concen tra t ions  in 
normal  u n m a n ip u la te d  inters t i t ium. However ,  this  d o e s  not 
invalidate the use  of either the skin window model or the chamber  
fluid model, s ince  bacterial infection usually involves som e  degree  
of fluid accumulat ion and  encapsulation which slows diffusion into 
and  out of the infected focus. Indeed, application of the theoretical 
com par tment  model to infected t i ssues  may result  in considerable  
o v e r - e s t i m a t i o n  of a n t im ic ro b ia l  i n te r s t i t i a l  p e n e t r a t i o n .  
Furthermore, the theoretical compartment model cannot  be used to 
e s t i m a t e  in ters t i t ia l  c o n c e n t r a t i o n s  of highly p ro te in -b o u n d  
antimicrobials .  P h e n y lb u taz o n e  c o n cen t ra t io n s  pred ic ted  by the 
theoretical peripheral compar tment  model were  higher than serum 
concen t ra t ions ;  a  s ituation which is highly unlikely when one  
cons iders  the high d eg ree  of protein binding of phenylbutazone and 
the  low protein concentra t ions  in interstitial fluid.
Although concentrat ions in skin window fluids probably approximate 
t rue  noninfec ted  interstit ial  c o n c e n t ra t io n s  more c lose ly  than 
t i s s u e  c h a m b e r  co n cen t ra t io n s ,  the  u se  of the  skin window 
compar tment  p resen ts  several technical problems. Abrasion of the 
de rm is  without  cau s in g  any  b leeding is difficult, an d  protein 
concentra t ions  in skin window fluids vary greatly according to the
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severity of the inflammatory r e sp o n s e  and  the  duration of skin 
chamber  application.
The comparison between antipyrine and  phenylbutazone dispositions 
demonstra ted  the importance of protein binding. Despite the longer 
t-|/2 (B) °f phenylbutazone,  t issue  cham ber  penetration of antipyrine 
(as  de te rm ined  by A U C j / A U C s ) w a s  significantly g rea ter .  This 
relationship be tw een  protein binding and  distribution w as  further 
under lined by the poor  penetra t ion of pheny lbu tazone  into skin 
window fluids, which had  very low protein concentra t ions .  Peak  
pheny lbu tazone  concentra t ions  in skin window fluids were  lower 
than in t issue cham ber  fluids, w hereas  skin window fluid antipyrine 
concentrations were higher than tissue cham ber  concentrations.
The progressive fibrosis of cham ber  tissue, coupled with d e c re a se s  
in total protein and  albumin concen t ra t ions  o b se rv ed  in most  
cham bers ,  s u g g e s te d  that  penetration of antimicrobials (especially 
t h o s e  tha t  a r e  highly pro te in-bound)  into c h a m b e r  fluid may 
d e c r e a s e  a s  t ime after implantation increases .  However,  several  
r e sea rchers  have reported increased penetration into cham bers  that 
have been  implanted for longer periods of time. Adam et al. (1978) 
found that concentrat ions  of cefradine in tissue  cham bers  implanted 
for 3 days  in hum ans  were  lower than concentrat ions  in chambers  
sampled 21 days  after implantation. Studies  conducted by Luthman 
et al. (1984)  show ed  tha t  the  penetra t ion  of severa l  different 
antimicrobials increased  from 3 to 5 w eeks  after t i ssue  cham ber  
implanta t ion  in cat t le .  In th e  p r e s e n t  s tudy,  c h a m b e r  fluid 
penetration of both low protein-bound antipyrine and highly protein-
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bound phenylbutazone did not ch a n g e  with time after implantation. 
T h e se  resul ts  can  be explained  by the fairly small proportional 
d ec rease  in chamber  fluid albumin occurring between 30 and 50 days 
(±1 0 %) and the extensive vascularization that c o m p en sa te s  for the 
progressive  fibrosis of cham ber  tissue.  Thus, a  "window" has  been 
es tablished  during which time penetration of both low protein-bound 
an d  high p ro te in -bound  an t im icrob ia ls  c a n  b e  s tu d ied  with 
reasonable  a s su ran ce  that ch an g es  in disposition are  not related to 
inconsis tencies  in the  s tage  of maturation of individual chambers .
Diffusion of n o n l ip id -so lu b le  m o l e c u l e s  a c r o s s  b io logical  
m embranes  depends  on filtration through aqueous  channels  or pores.  
The rate of diffusion through these  pores depends  on the pore size as  
well a s  the molecular size and charge  of the solute molecule.  The 
effect of pore  s ize  and  molecular  s ize  can  be  illustrated by 
considering the renal excretion of urea, albumin, and  creat inine 
(Guyton, 1981). Urea, which has  a  small molecular diameter ,  is 
freely filtered by the  glomerulus and then reabsorbed  in proportion 
to tubular permeability and the osmotic gradient  existing across  the 
tubular  m embrane .  In contras t  to urea, the fairly large molecular 
d iam e te r  of albumin resu l ts  in its exclusion from glomerular  
filtrate, despite  the large d iameter  of glomerular pores.  Creatinine 
represents  an intermediate between urea  and albumin. Although it is 
freely filtered through glomerular pores ,  its molecular s ize and  low 
lipid solubility preven t  renal tubular  reabsorpt ion.  In this study, 
endogenous  urea, creatinine, and albumin were used  a s  markers to
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study the distribution of nonlipid-soluble drugs  into t issue cham ber  
fluid.
Similar ra tes  of penetra t ion of urea  and  creat in ine  into t issue
cham bers  indicated the existence of aqueous  channels  that allowed 
unimpeded t ransfer  of the  larger creatinine molecules .  However, 
th e se  channels  were small enough to severely restrict the transport 
of albumin which pen e t ra ted  ch a m b e r  fluid very slowly. T hese  
results indicate that  smaller  nonlipid-soluble molecules  have ready 
a c c e s s  to t i s sue  c h a m b e r  fluid and  tha t  the  c h a m b e r s  a re  in
con t inu i ty  with t h e  v a s c u l a r  c o m p a r t m e n t .  O th e r  s tu d i e s  
investigating the influx of radiolabelled Na+ and B r  have reported 
similar conclusions (Carbon et al. , 1977; Calnan et al., 1972b). Slow
p e n e t r a t i o n  of a lb u m in  in d ic a te d  t h a t  t h e  p e rm e a b i l i ty
character is tics  of the diffusion barrier between blood and chamber  
fluid were  similar to those  of capillary endothelial walls and  that 
s u b cu ta h eo u s  implantation of the t issue ch am b ers  resulted in the 
formation of true ex travascular  interstitial compar tments .
4. P h a s e  IV - Antimicrobial efficacy studies
The median serum ti / 2 ( B )  o f  sulfadiazine in noninfected ca lves  in
i
the present  study (3.3 hours) was  comparable  to the results of other 
studies .  Nielsen and  R asm u ss e n  (1977) reported a  t-j/ 2 ( B )  °f 2 -5  
hours in cows, and Shoaf et al. (1986) reported a  t i / 2 (B) of 4.4 hours
in newborn calves. Davilyanada and R asm u ssen  (1974) recorded a 
serum t-|/ 2 ( B )  f ° r trimethoprim (1.2 hours) which was  much shorter 
than the t i / 2 ( B )  recorded in the p re sen t  study (5.1 hours).  This
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d i s c r e p a n c y  m ay h a v e  b e e n  re la ted  to d i f f e ren ce s  in the  
physiological s ta tu s  of the  experimental  animals .  The lactating 
cows used in the Davilyanada and Rasm ussen  (1974) study could be 
expec ted  to excre te  trimethoprim more rapidly than the calves  in 
t h e  p r e s e n t  s tudy .  B as ic  an t im ic rob ia ls ,  like t r imethopr im ,  
distribute well into milk which has  a  slightly lower pH than blood.
P e n e t r a t i o n  of s u l f a d i a z in e  a n d  t r im e th o p r im  into s te r i le  
s u b cu ta n eo u s  t issue ch am b ers  in ca lves  has  been  investigated by 
Piercy (1978). Unfortunately, that  study omitted a  pharmacokinetic 
a n a ly s i s  of s e ru m  a n d  c h a m b e r  fluid c o n c e n t r a t io n  d a ta .  
Never theless ,  sulfadiazine concentrat ions in the  Piercy (1978) study 
a p p ea red  to reach higher peaks  than sulfadiazine concentrat ions  in 
the  p r e s e n t  s tudy.  However,  the  t imes  taken  to reach  peak
concentrat ions in the two s tudies  were similar. Peak  cham ber  fluid 
concentra t ion  ratios  of trimethoprim to sulfadiazine reported  by
Piercy (1978) and  in the p re sen t  study do not a g re e  with the  
apparen t  volumes of distribution of the two antimicrobials. Both the
p r e s e n t  s tudy  an d  S h o a f  et al. (1986)  repo r ted  vo lu m es  of
distribution for trimethoprim that  were  higher  than sulfadiazine 
vo lum es  of distribution,  yet,  d e sp i te  the  ant imicrobia ls  being 
i n j e c t e d  in to  t h e  c i r c u l a t i o n  a t  a  r a t io  of 1:5 
( tr imethoprim:sulfadiazine) ,  the  concentra t ion  ratios in c h am b e r  
fluid were  less  than 1:10. Similar concentrat ion ratios have  been 
found in synovial fluids (Shoaf et al., 1986).  T h e se  resul ts  imply 
that trimethoprim b e c o m es  s e q u e s te r e d  so m ew h ere  other  than  in 
s o f t - t i s su e  in ters ti t ium.
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Inocula t ion of Ph-1 into s u b c u ta n e o u s ly - im p la n te d  c h a m b e r s  
resulted in an increase in leucocyte numbers and an accumulation of 
fibrin. The rise in cham ber  fluid leucocyte numbers was  largely due 
to a  rapid influx of neutrophils which replaced mononuclear  cells as  
the dominant cell type. The higher erythrocyte numbers in chamber  
fluids from treated animals may have been  c a u se d  by the repeated 
sampling of cham ber  fluid during the pharmacokinetic study period. 
C hanges  in blood total leucocyte and neutrophil levels were typical 
of the  r e s p o n s e s  s e e n  with most  localized infections. An initial 
mobilization of cells was  followed by sequestrat ion in the focus of 
infection and a  d e c r e a s e  in circulating cell numbers.  The localized 
inflammatory r e s p o n s e s  tha t  re su l ted  in the  formation of a 
fibrinopurulent t issue ch am ber  exudate  have also been  reported in 
lung t i s s u e  (Lopez et al., 1986; Yates ,  1982). In fact, the  
degranulation of infiltrating neutrophils is thought  to be a  major 
c a u se  of lung injury (Slocombe et al., 1985). The chemo-at t rac tants  
responsible for the influx of neutrophils have not been  conclusively 
identified, but ongoing research  involving pulmonary inoculation of 
components  of Ph-1 has  shown that inoculation of cytotoxin or dead  
decapsu la ted  organisms c a u s e s  lung lesions that are  more severe  
and  typical of les ions  c a u s e d  by whole viable organisms,  than 
in o cu la t ion  of c a p s u l e  a n t ig e n  ( C o r s tv e t  R .E. ,  p e r s o n a l  
c o m m u n i c a t i o n ,  1 9 8 7 ) .  T h e  r a p id  i n c r e a s e  in t h e  
neu t roph i l /m onocy te  ratio tha t  followed Ph-1 inoculation into 
tissue cham bers  has  also been reported in the lung (Lopez et al., 
1986). Although an extrapulmonary model cannot  be expected  to 
dupl icate  the  many specific inflammatory reac t ions  occurring in
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pulmonary t issue,  s u b c u ta n e o u s  c h a m b e rs  provided a  model that  
singled out what s eem ed  to be the most important components  of the 
inflammatory response  s een  in pneumonic pasteurellosis.
Es tab l i shm en t  of a  Ph-1 infection within t i s sue  c h a m b e r s  was  
accompanied by marked changes  in the composition of chamber  fluid. 
Both total protein and albumin concentrations increased rapidly soon 
af te r  inoculation an d  rem ained  high for the  durat ion of the 
experiment.  The rise in albumin concentrat ions  correlated well with 
the  his topathological  c h a n g e s  o b se rv e d  in infected c h am b ers .  
Distension of blood v e s s e l s  and  erosion of su rface  capillaries 
indicated the development  of a  more intimate relationship between 
blood and  c h a m b er  fluid. Indeed, the p r e s e n c e  of extravascular  
erythrocytes in the fibrinous membrane covering the infected tissue 
and  the increase  in erythrocyte numbers  in cham ber  fluid, confirm 
that  there  w as  a  breakdown in the diffusional barrier between the 
two com par tm en ts .  Although a  large proportion of the increased  
c h a m b e r  fluid total protein concentrat ion could have been  due  to 
influx of albumin from blood, the increase in cham ber  fluid albumin 
concentra t ions  w as  not large enough  to accoun t  for the two-fold 
in c rease  in total protein concentra t ions.  In addition to structural 
proteins derived from the destruction and lysis of cells, an increase 
in fibrinogen concentrat ions  may have contributed to the increased 
total protein concentra t ions .  Fibrinogen is thought  to provide a  
d e fen se  agains t  injury by migrating into extravascular s p a c e s  where 
the resulting deposition of fibrin can  localize and confine invasive 
d i s e a s e  p ro ce sse s  (Schalm, 1970). Raised p lasma fibrinogen levels
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have  long been  a s so c ia te d  with the  p r e s e n c e  of inflammatory
d isease  (Coles, 1986).
The rapid d ec rease  in chamber  fluid pH could have been caused  by a 
number of contributing p rocesses .  Cell lysis followed by the release 
of many organic ac ids  may have been  p r e ce d e d  by anaerob ic  
metabol ism and  the  formation of lactate .  In addition, bacterial 
phagocytos is  by neutrophils is accom pan ied  by a  rapid drop in 
intracellular pH (Cheville,  1983). Instability and  lysis of th e se
neutrophils would contribute further to the drop in chamber  fluid pH.
Increases  in serum and chamber  fluid K+ concentrat ions  after Ph-1 
inoculation correlated well with the extensive cell d am ag e  observed 
in the histopathological sections. Large am ounts  of intracellular K+ 
a re  re leased  with destruction of cell m em branes .  An increase  in 
ex tracel lu lar  K+ may also have been  ca u se d  by an exchange  of 
extracellular  H+ ions for intracellular K+ ions.
In th e  p r e s e n t  s tudy ,  t i s s u e  c h a m b e r  p e n e t ra t io n  of both 
su l fad iaz ine  an d  tr imethoprim in c r e a s e d  af te r  infection. This 
finding can  be expla ined by the  inc reased  permeability of the
diffusional barrier existing be tween blood and  c h am b e r  fluid. In 
addit ion to the  v a s c u la r  d a m a g e  s e e n  on h is topatho log ica l  
examination, increases  in permeability were probably also caused  by 
the  r e l e a se  of many vasoac t ive  a g e n t s  during the  inflammatory 
process ,  e.g.; histamine and serotonin. Increases  in total protein and 
albumin concentra t ions  in infected ch am b er  fluids may also have 
played a  role in the increased  penetration of antimicrobials,  since
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this would increase  the amount  of protein-bound sulfadiazine and 
trimethoprim in tissue chambers .  The lower pH measured  in infected 
cham ber  fluid could have been  partly responsible for the increased 
penetrat ion of trimethoprim (pKa = 7.6). Ames et al. (1983) have 
s tud ied  the  pulmonary t i s su e  distribution of oxytet racycl ine in 
ca lves  experimental ly infected with Pasteurella  haem olytica  and 
have  reported similar resul ts .  Although the  t i s sue  h om ogena te  
method which w a s  u se d  te n d s  to over-es t im ate  true interstitial 
c o n c e n t r a t i o n s ,  th ey  n e v e r t h e l e s s  found  c o n c e n t r a t i o n s  of 
oxytetracycline that were g rea ter  in the lungs of infected animals 
than  in the  lungs of healthy controls.  T h e se  resul ts  a re  further 
supported  by another  t issue hom ogena te  study which investigated 
the  penetra t ion  of erythromycin into P as teu re lla  haem olytica- 
infected calves  (Burrows, 1985). Although this study did not include 
healthy control animals, penetration of erythromycin into pneumonic 
lung a r e a s  of infected an im als  w a s  a s  high or h igher  than 
penetration into nonaffected lung t i ssues  in the sam e  animals.
The increase  in Vcj(a rea ) of both sulfadiazine and  trimethoprim 
recorded here may have been  related to the increased penetration 
into infected ch a m b e rs .  However,  this a lone  d o e s  not offer a  
satisfactory explanation, s ince it is unlikely that  sequestra t ion  of 
the antimicrobials in such  a  small volume of infected t issue  and 
cham ber  fluid could account  for a  significant increase in Vd(area)- 
A m es  et al., (1983) reported  tha t  the  Vd(area)  and *1 / 2 ( 13) 
oxy te t racyc l ine  i n c r e a s e d  w hen  c a lv e s  w e re  inocu la ted  with 
P a s te u re lla  h a e m o ly tic a . In this  in s tance ,  accum ula t ion  of
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oxytetracycline in the  relatively large volume of the pneumonic  
lungs offered a  plausible explanation for the increased  V^area)-  
Several studies have reported changes  in Vd(area) and t i / 2 (B) c au sed  
by febrile react ions (Groothuis et al., 1980; Baggot, 1977). It has  
b ee n  s u g g e s t e d  that fever  e n h a n c e s  the  t i s sue  penetra t ion  of 
antimicrobials,  which reduces  the proportion of total d o s e  in the 
c en t ra l  c o m p a r tm e n t .  With l e s s  an t im icrob ia l  av a i lab le  for 
elimination from the  central compartment,  the  rate of elimination 
d e c r e a s e s  (Baggot,  1977). Although t i / 2 (B) did ap pear  to increase
after infection in the present  study, this change  was  not significant.
Administration of sulfadiazine/trimethoprim to ca lves  in g roups  B 
and D resulted in a  rapid d ec rease  in chamber  fluid bacterial counts 
a n d  s u b s i d e n c e  of local ized inflammation su r rounding  t i s s u e  
chambers .  T h e se  favorable therapeutic re sp o n ses  were  accompanied 
by changes  in chamber  fluid composition that were less marked than 
those  in nontreated groups. Lower K+ concentrations, higher pH and 
lower  to tal p ro te in  c o n c e n t r a t i o n s  in a n t im ic ro b ia l - t r e a te d  
cham bers  indicated that  cell destruction within th ese  cham bers  was  
not a s  s ev e re  a s  the cell destruction occurring within cham bers  in 
non trea ted  animals .  Fur thermore,  lower c h am b e r  fluid leucocyte  
n u m b ers  a t  the  end  of the  exper imenta l  per iod s u g g e s t  that  
antimicrobial therapy either promoted the removal of, or inhibited 
the  production of factors responsible for leucocyte chemotaxis.  The 
amelioration in the severity of the localized inflammatory response  
indicated by t h e s e  c h a m b e r  fluid composi t ional  c h a n g e s  w as
187
reflected by the s h a rp  d e c r e a s e s  in inflammatory health index 
scores .
The main tenance  of high leucocyte viability in antimicrobial-treated 
groups dem onstra tes  the protective effect of antimicrobials on host 
d e f e n s e s  and the positive synergism between antimicrobials and 
h o s t  d e f e n s e s .  Antimicrobia ls  probably  m a in ta ined  leucocyte  
viability by preventing d a m a g e  from bacterial-produced and -induced 
toxins an d  by prevent ing  d ram at ic  composi t ional  c h a n g e s  in 
extracellu lar  fluid which lead to leucocyte instability (Cheville,
1983). The de layed  d e c r e a s e  in leucocyte  viability observed  in 
non t rea ted  g roups  indicates  that  the  p r o c e s s e s  respons ib le  for 
extensive leucocyte dam ag e  take a  fairly long time to develop. This 
delay corre lates  well with the evidence that pneumonic Ph-1 lesions 
a re  c a u s e d  by infiltrating leucocytes  and  not the bacterium itself 
( S lo c o m b e  et al., 1985) .  The  posit ive in teract ion b e tw e e n  
antimicrobials and host  d e f e n se s  was  further em phas ized  by the 
higher percent  phagocytosis  s een  in antimicrobial-treated groups.
Although t i s s u e  c h a m b e r  c o n c e n t ra t io n s  of su l fad iaz ine  and  
t rimethoprim rem ained  ab o v e  minimum inhibitory concentra t ions  
(e s tab l i sh e d  in vitro) for the duration of therapy, Ph-1 infections 
were not sterilized in most calves. Indeed, bacterial counts appeared 
to start increasing in group B before the termination of therapy. This 
early apparent  increase in group B mean CFU/ml was  associated with 
lower cham ber  fluid antimicrobial concentrat ions  than were present  
in group D. Possible rea so n s  for the discrepancy in cham ber  fluid 
antimicrobial c oncen t ra t ions  and  in vitro sensitivity (MIC, MBC)
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results include: (1 ) antimicrobial protein binding and  inactivation at 
the  site of infection; (2 ) intracellular localization and  protection of 
bacter ia;  and  (3) rapid development  of bacterial res is tance  to the 
a n t im ic rob ia ls .
A n t i m i c r o b i a l  i n a c t i v a t i o n  m a y  o c c u r  by e n z y m a t i c  
b io transformation ,  nonenzym at ic  inactivation, c h a n g e s  in redox 
potential and pH, and binding to proteins (Barza, 1981). Enzymatic 
biotransformation cannot  be considered a s  a  c a u s e  of antimicrobial 
inactivation in the p resen t  exper iment  b e c a u s e  the drug a s say  was 
c o n d u c t e d  using a  highly specif ic ,  h ig h -p e r fo rm a n c e  liquid 
chrom atograph ic  method which differentiates be tween  the parent  
antimicrobial and its metabolites.  Nonenzymatic inactivation due  to 
binding of antimicrobials to consti tuents  of purulent exuda tes  has 
been  reported (Vandaux & Waldvogel, 1980; Bryant, 1984; O'Keefe et 
al., 1978). However this has  usually been associa ted  with the use of 
am inog lycos ides  and  penicillins. Inhibition by po tent ia ted  sulfas 
may be  reversed by adding the end products of one-carbon transfer 
react ions ,  e.g.  pur ines  and  pyr imadines  (Ferguson  & Weissfeld,
1984). T hese  com pounds  may be p resen t  in purulent material a s  a 
result of t issue breakdown. Changes  in pH and binding to proteins in 
infected chamber  fluid must also be considered. A dec rease  in pH has 
been  associa ted  with a  reduction in the activity of erythromycin and 
aminoglycosides  (Lorian & Sabath ,  1970; S t rau sb au g h  & Sande ,  
1978). Although both sulfadiazine and trimethoprim are only slightly 
to m o dera te ly  p ro te in -bound ,  the  i n c r e a se d  prote in  levels  in 
chamber  fluid could have caused  a  20 % to 30 % reduction in active
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an t im ic ro b ia l  c o n c e n t r a t i o n s  which ,  c o u p le d  with r e d u c e d  
antimicrobial activity d u e  to a  d ec re a se  in pH, could have allowed 
the survival of a  viable population of bacteria.  Drug inactivation by 
binding to proteins could not be detected by liquid chromatographic 
a s say  b ecau se  this method detected both protein-bound and -unbound 
sulfadiazine  and  trimethoprim concentrat ions.
There  is evidence that phagocytosed bacteria may be protected from 
th e  b ac te r io c id a l  e f fe c t s  of an t im icrob ia ls  (Mandel l ,  1973).  
In tra leucocy t ic  b a c te r i a  may b e  insens i t ive  to ant imicrobials  
b ec a u se :  (1 ) so m e  less  lipid- soluble antimicrobials are  unable  to 
diffuse into intracytoplasmic phagosom es ,  or (2 ) slowed metabolism 
of "resting" b ac te r ia  r e n d e r s  them insensi t ive to antimicrobial 
bacter iocidal  effects .
Although bac ter ia l  r e s i s t a n c e  to sulfadiazine/ t r imethoprim d o e s  
occur,  res is tance  to the  combination is less  common than it is to 
either  of the  a g e n t s  a lone  (Mandell & Sande ,  1985). Res is tance  
usually develops  by mutation or by transfer of genetic material from 
one  bacter ium to another .  However, development  of res is tance  to 
potentiated sulfas usually takes  a  long time to develop (McAllister, 
1976). It is unlikely that  sulfadiazine/trimethoprim therapy  in this 
experiment could have resulted in the selection of a  more resistant 
strain of Ph-1.
One should also consider the effect of the presence  of a  foreign body 
( subcutaneous  t issue chamber)  on the com petence  of host defense  
m echanism s .  Clinical ev idence has  shown that  the p re sen ce  of a
190
foreign body (eg. prosthetic cardiac valves) reduces  the likelihood of 
effective antimicrobial therapy despite  administration of high d o se s  
for long per iods of time (Sande  & Mandell, 1985). Zimmerli et al. 
(1982) reported that guinea  pigs were far more suscep tab le  to the 
e s ta b l i s h m e n t  of a  local ized so f t - t i s sue  infection w hen  small 
n u m b e r s  of S . a u r e u s  w e r e  in jec te d  into s u b c u t a n e o u s  
polymethacryla te  and  polytetrafluoroethylene c h a m b e r s  than  when 
higher numbers  of CFU were injected into s u b c u ta n e o u s  pouches.  
Although opsonization of S.aureus  was  adequa te  during the first hour 
of infect ion, it had  d e c r e a s e d  by 20 hours .  Fur therm ore ,  
polymorphonuclear  cells from sterile cham ber  fluid showed lower 
bacteriocidal and phagocytic activity than those  isolated from blood 
or peritoneal exudate  after short or long term stimulation.
Effective antimicrobial therapy relies on the  cooperat ion of host 
d e f e n se  m echan ism s .  This is particularly true when bacter iostatic 
d o s e s  of antimicrobials are  used.  The importance of this interaction 
is d e m o n s t r a ted  by the  reduced  efficacy of many antimicrobial 
a g e n t s  when they  a re  u sed  concurrently with cort icosteroids.  In 
addition, combination of immunostimulants  (eg. levamisole) and 
antimicrobials resul ts  in more effective trea tment  of clinical c a s e s  
of BRD than  antimicrobials a lone (Miles, 1984). There  is clinical 
evidence that exposure  to BVDV may impair host d e fe n se s  agains t 
b a c t e r i a l  in fec t ion  a n d  p r e d i s p o s e  c a t t l e  to p n e u m o n i c  
p a s te u re l lo s i s  (H am oud et al., 1981).  This ev id en ce  h a s  been  
confirmed experimentally (Corstvet & Panciera,  1982). Despite the 
f requen t  u s e  of bac ter ios ta t ic  antimicrobials  in the  therapy  of
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pneumonic  pasteurel los is ,  the  possib le  interaction be tw een  viral- 
induced immunosuppression and antimicrobial efficacy has  not been 
adequa te ly  investigated.
Athough viral inoculation ap p e a re d  to c a u s e  a  d e c r e a s e  in total
leucocyte, neutrophil,  an d  lymphocyte num bers  by 6  days  after
inoculation, t h e s e  c h a n g e s  were  not significant. However,  the 
observation that th e se  cell numbers  had returned to preinoculation 
v a lu e s  by day  1 0  s u g g e s t s  that  the re  w a s  a  slight, t ransien t  
leucopenic effect of BVDV. Lymphocyte depletion has  been a  common 
finding in s tudies  involving both sev e re  and  mild BVDV infections 
(Tyler & Ramsey,  1965; Roth et al., 1981). The suppress ive  effects 
of BVDV on lymphocytes have been  supported by in vitro s tudies  
(Truitt & Shechmeis ter ,  1973). Preinoculation of ca lves  with BVDV 
in the present  study had no effect on either the multiplication of Ph- 
1 in t i s s u e  c h a m b e r s  or the  r e s p o n s e  of the  bac ter ium  to 
sulfadiazine/t r imethoprim therapy.  This lack of viral effect  may
have been  related to the transient nature of the apparent  changes  in 
leucocyte  numbers ,  which implied that hos t  d e f e n s e s  may have 
recovered  from any a d v e r s e  viral effects  by the  time of Ph-1 
inoculation. If this were true, it would contradict the conclusions  of 
s tud ies  conduc ted  using pulmonary models.  In t h e s e  pulmonary
studies,  ca lves  were more susceptable  to Ph-1 inoculation (because  
of impaired host  defenses)  10 days  after BVDV inoculation than 6  
days  after inoculation (Corstvet & Panciera,  1982). However,  despite 
the lack of interaction between BVDV, antimicrobials, and CFU, viral 
inoculation did a p p ea r  to inhibit neutrophil chemotaxis.  The higher
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circulating proportion of neutrophils  in vira l- inoculated ca lves  
s u g g e s t e d  a  d e p r e s s e d  c h e m o ta c t i c  r e s p o n s e  a n d  r e d u c e d  
sequestrat ion at the site of infection. This conclusion was  supported 
by the lower ch am ber  fluid leucocyte numbers  obse rved  in viral- 
inoculated calves. BVDV has  been  recognized to inhibit chemotaxis 
of phagocyt ic  cells (Ketelsen et al., 1979). BVDV also c au se d  a  
d e c r e a s e  in leucocyte  viability during the antimicrobial t rea tment  
p h ase .  However, this effect w as  not large enough  to result  in 
c h a n g e s  in antimicrobial efficacy. The lack of any interaction 
between BVDV and Ph-1 numbers  in cham ber  fluids su g g es t s  that 
BVDV may p re d isp o se  an imals  to pneum onic  pas teu re l los is  by 
impairing specific lung d e fen ses  and not systemic defenses .
The r easons  for the differences in erythrocyte numbers,  electrolyte 
concen t ra t ions  and  pH o b se rv ed  in virus- inocula ted g roups  are  
unclear and further investigation is required before conclusions can 
be drawn from these  observations.
Despite strict isolation of all calves, the mean antibody absorbance  
value of group D, m easu red  immediately before Ph-1 inoculation, 
w as  higher than that m easured  during serological screening prior to 
initiation of the  expe-riment. Antibody a b s o rb a n c e  v a lu es  of all 
g roups  increased  during the experimental  period. T h e se  increases  
w ere  particularly notable  af ter  terminat ion of therapy .  Indeed, 
c h am b er  fluid values  in two groups (A and D) even a p p ea red  to 
d e c r e a s e  between 3 and 5 days  after Ph-1 inoculation. This could 
have been  du e  to a  consumption of antibody which, during that 
period, outstripped antibody production. The su b seq u en t  increase in
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antibody concentration could have been due to increased production 
that exceeded  consumption. Similar responses  in serum and chamber  
fluid s u g g e s t  tha t  sy s tem ic  immunoglobulins  hav e  a c c e s s  to 
per ipheral,  infected com par tm en ts .  However,  local production of 
immunoglobul ins  p robab ly  a lso  o ccu r red  a s  h is topathologica l  
evaluation revealed many plasma cells infiltrating cham ber  tissue.
The demonstrat ion of bacterial phagocytosis,  polymorphonuclear cell 
viability, an d  r e sp o n s iv e  ant ibody c o n c e n t r a t io n s  su p p o r t  the 
con ten t ion  tha t  so f t - t i s sue  infect ions e s ta b l i s h e d  within t h e s e  
t issue  ch am b ers  provide a  model that can be used  to study the 
r e s p o n s e  of bacter ia  to specific levels of antimicrobials,  in the 
p resence  of functional host defenses .
fCHAPTER 6  
SUMMARY AND CONCLUSIONS
Modification in design (from "prototypal" to "final") and coating with 
a  s il icone-based adhes ive  resulted in an improvement in the extent 
of drug penetration into subcutaneously  implanted t issue  chambers .  
T h e se  t i s sue  ch am b e rs  did not b e co m e  obliterated by ingrowing 
t issue  before 60 days  after implantation and contained enough fluid 
to allow th e  repet i t ive sampl ing  required  in pharm acok ine t ic  
s tudies .  P e rc u ta n e o u s  aspiration of ch a m b e r  fluid w as  achieved 
without microbial contamination of cham ber  fluid or overt bleeding.
Cy to log ica l  a n d  c h e m ic a l  in v e s t ig a t io n  r e v e a l e d  th a t  the  
c o m p o s i t io n  of c h a m b e r  fluid a p p r o a c h e d  th e  th e o re t ic a l  
composit ion of t rue  interstitial fluid a s  t ime af ter  implantation 
increased .  Erythrocyte and  leucocyte  num bers  d e c r e a s e d  sharply 
immediately after implantation and  had reached  s table  numbers  by 
40 days  after implantation. At this s tage ,  chamber  fluid samples  had 
lower total protein and  albumin concentrat ions,  higher K+ and Ch 
concentrations, and lower pH than corresponding blood samples .
Histopathological evaluat ion revea led  that  implantation of t issue  
c h a m b e r s  w a s  followed by an immedia te  a c u te  inflammatory 
rea c t io n  which w a s  la te r  r e p l a c e d  by c h ro n ic  low -grade  
pro l i fe ra t ive  inf lammation .  D e sp i te  p r o g r e s s i v e  f ibros is  and
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encapsulation of t i ssue chambers ,  the vascularity of cham ber  tissue 
did not diminish with time after implantation. By 40 d a y s  after 
implantation, the cellular and  chemical  cons t i tuen ts  of ch am b er  
fluid had stabilized enough to allow use  of the model to study drug 
d is t r ibu t ion .
Distribution of l ipid-soluble antipyrine and  p h en y lb u tazo n e  into 
ch am b er  fluids was  well described using a  one-compartment  - open 
pharmacokinet ic model. Slow penetration of th e se  two ag en ts  into 
c h a m b e r  fluid, and  ch am b er  fluid elimination half-lives that  were 
cons ide rab ly  longer  than  se rum  elimination half-lives, su g g es te d  
that the  distribution of lipophilic agen ts  could also be described by 
a two-compartment open model,  where  diffusion into and out of a 
"deep" peripheral com par tment  w as  s lower  than elimination from 
the  central  com par tm en t .  Thus, the u se  of t h e s e  c h a m b e r s  to 
e s t i m a t e  p e n e t ra t io n  of an t imicrobia ls  into infec ted  regions ,  
par t icu la r ly  t h o s e  w h e re  th e r e  is e x u d a t e  a ccu m u la t io n  or 
encapsulation,  is appropriate.
Rapid diffusion of water-soluble urea and  creatinine from blood into 
cham ber  fluid indicated the p resence  of aqueous  channels  that were 
large en o u g h  to allow the  un im peded  t ransfe r  of the  larger 
creat in ine  molecules .  Extremely slow penetrat ion of albumin into 
t i s s u e  c h a m b e r  fluid s u g g e s t e d  t h a t  t h e  p e r m e a b i l i t y  
ch a rac te r i s t i c s  of the  diffusional barrier s ep a ra t in g  blood and 
ch am b e r  fluid were  similar to those  of capillary endothelial walls, 
and that t issue  cham b ers  formed true interstitial compartments .
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Inocula t ion of Ph-1 into t i s s u e  c h a m b e r s  r e su l ted  in the  
es tab l ishm ent  of a  localized soft t i ssue  infection which remained 
confined to the paralumbar  fo s sa  area .  The p a th o g en es is  of the 
infection was  character ized by an accumulation of fibin and  a  rapid 
influx of neutrophils  which rep laced  m ononuc lea r  cells a s  the 
dominant  cell type. These  responses  are considered to be important 
co m ponen ts  of the  pa thogenes is  of pulmonary lesions. Therefore, 
t i ssue  cham b ers  provide an extrapulmonary model that  singles out 
s o m e  of the  m ore  important  c o m p o n e n t s  of the  pneum on ic  
inflammatory response .
Inoculation of Ph-1 into t i s sue  c h a m b e r s  w as  ac co m p an ied  by 
marked c h a n g e s  in the composition of cham ber  fluid. Increases  in 
protein and albumin concentrations, a  dec rease  in pH, and disruption 
of ch am b er  t i ssue  vascula ture  were  a s soc ia ted  with a  significant 
i n c r e a s e  in t h e  p en e t r a t io n  of su l fad iaz ine / t r im ethopr im  into 
infected t issue cham bers  compared  with noninfected cham bers .  The 
increased penetration w as  accompanied by increases  in the Vd(area)
for both sulfadiazine and  trimethoprim. This ch an g e  w as  probably 
c au sed  by the brief febrile response  occurring after inoculation.
Although su lfad iazine/ t r imethopr im adminis tra t ion resu l ted  in a 
favorable therapeutic response  and rapid d ec re a se s  in cham ber  fluid 
bacterial counts,  the Ph-1 infections were  not steril ized. Bacterial 
populations survived despite  the main tenance of apparen t  chamber  
fluid a n t im ic rob ia l  c o n c e n t r a t i o n s  th a t  e x c e e d e d  minimum 
bacteriocidal levels.  The most probable  r e a so n s  for this lack of 
absolu te  efficacy included: (1 ) d e c re a se d  antimicrobial activity due
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to low ch a m b e r  fluid pH; and  (2) increased  protein binding and 
s u b s e q u e n t  antimicrobial inactivation.
Bacterial  p h ag o cy to s is  and  leucocyte  viability w ere  higher  in 
a n t i m i c r o b i a l - t r e a te d  g r o u p s .  T h e s e  r e s u l t s  i l lu s t ra te  th e  
synerg is t ic  rela tionship  b e tw een  antimicrobial a g e n t s  a n d  host  
de fenses .
Although BVDV inoculation c a u s e d  d e c r e a s e s  in t i ssue  cham ber  
leucocyte  viability an d  neutrophil seques t ra t ion  in infected t issue 
c h a m b e r s ,  th e re  w a s  no ef fect  on Ph-1 growth within t i ssue  
ch am b ers  or the re sp o n se  of Ph-1 to antimicrobial therapy. These  
results  s u g g e s t  that  BVDV may p red ispose  cattle to pneumonic  
pasteurel losis  by affecting host de fense  mechanisms specific to the 
lung. Fur thermore ,  t h e s e  resul ts  indicate tha t  this soft  t i s sue  
in fec t ion  m ode l  c a n  b e  u s e d  to s tu d y  th e  e f fe c t  of 
immunomodulators  on antimicrobial efficacy.
Demonstration of responsive antibody titers, bacterial phagocytosis ,  
and  high leucocyte viability within cham ber  fluids all a t test  to the 
p re sen ce  of functional immune responses .  This shows that  this soft 
t i ssue  infection model, e s tabl ished  by inoculation of subcu taneous  
tissue cham bers ,  can be  used  to study the response  of bacteria  to 
spec i f ic  c o n c e n t r a t io n s  of an t imicrobia ls  in the  p r e s e n c e  of 
functional host de fenses .  This last conclusion satisfies the ultimate 
objective of the study.
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APPENDIX
Glossary of pharmacokinetic terms
Disposition in serum w as  described by the two-compartment model, 
using the biexponential equation:
where  Cs is the concentration of the drug in serum at time t; A and B 
a re  th e  zero-t ime se ru m  drug concentra t ion  in te rcep ts  of the 
biphasic  disposition curve; and a lpha and beta  are  the hybrid rate 
c o n s ta n t s  rela ted  to s lo p es  of the  distribution an d  elimination 
p h a s e s ,  respect ively. Pharmacokinet ic  te rm s  a s so c ia t e d  with the 
two-compartment model a re  defined a s  follows:
C°s Zero-time concentration of drug in serum following
C s = Ae('a|Pha x t) + Be(-beta x 0
administration of an intravenous bolus dose.
Half-life of distribution after intravenous
a d m in is t ra t ion .
*1 / 2 ( 8 ) Half-life of elimination from serum.
Apparent volume of the central compartment.
V d(area) Apparent volume of drug distribution based  on total 
a rea  under the serum drug concentration versus 
time curve.
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Vd(ss) Steady sta te  volume of distribution.
Clg Total body clearance.
AUCS Area under the serum drug concentration versus
time curve.
Disposition in "peripheral compar tments" (tissue cham ber  fluid and 
skin window fluid) w as  described  by the one-compartment  model, 
using the biexponential equation:
Cj  = De('deIta x t) + Be('b x t)
w h e r e  Cj is the  concentra t ion  of the drug in the "peripheral 
compar tment"  at  t ime t; D and  B are  the  zero-t ime "peripheral 
c o m p a r tm e n t"  drug co n ce n t ra t io n  in te rc e p ts  of th e  b iphas ic  
disposition curve; and delta and b are  the rate cons tants  related to 
s l o p e s  of t h e  d i s t r ib u t io n  ( a b s o r p t i o n  into " p e r ip h e ra l  
com par tm ent" )  an d  elimination (from "peripheral compartment")  
p h a s e s ,  respectively.  Pharmacokinet ic  pa ram e te rs  a s so c ia te d  with 
the one-compartment model a re  defined a s  follows:
t 1 /2 (b) Half-life of elimination from the "peripheral
compar tment" .
AUCj  Area under the "peripheral compartment" drug
concentration versus  time curve.
C(max)
T(m ax)
CTMp/CsDz[max]
C TMP/C SDZ[2 4 ]
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Maximum (peak) concentration achieved in the 
"peripheral compartment".
Time taken to achieve maximum concentrations 
in the "peripheral compartment".
Ratio of peak trimethoprim and sulfadiazine 
concentrations in t issue cham ber  fluid.
Chamber  fluid concentration ratio of 
t rimethoprim to sulfadiazine, 24 hours after 
antimicrobial adm in is t ra t ion .
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